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Mes mesityl 
MOM methoxymethyl 
M.p. melting point 
MS mass spectrometry 
NaDA sodium diisopropylamide 
NMR nuclear magnetic resonance 
o ortho 
PEPPSI pyridine-enhanced precatalyst preparation stabilization and initiation 
PFA perfluoroalkoxy alkane 
Ph phenyl 
Piv pivaloyl 
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t tert 
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1 Overview 
According to predictions of the United Nations Population Fund the world population of today 
7.55 billion will grow to over 11.1 billion people by 2100.1 Increasing population, rising age of the 
population as well as a claim for high living standards all over the world create a demand for safe supply 
in food, pharmaceuticals and new materials. Major contributions to the development and progress in all 
of these fields are provided by organic chemists.2 As an example over 95% of the top 200 prescribed 
drugs in the United States in 2016 contain small organic molecules as the active pharmaceutical 
ingredient.3 Thus, organic chemistry is constantly facing the challenge of developing new efficient 
methods for the synthesis of fine chemicals and related products. A broad entry for the synthesis of 
organic molecules is offered by organometallic chemistry.4 With their reactivity depending on the 
polarity of the nonmetal-metal bond, organometallic reagents can be employed as bases, nucleophiles 
and catalysts. Highly reactive and often unstable organometallic compounds containing lithium, sodium 
or magnesium show a distinct ionic bond character due to a high difference in electronegativity between 
the metal and the adjacent atom. In contrast, milder and less reactive organometallic compounds 
containing for example zinc or boron with a more covalent metal-nonmetal bond offer a higher stability 
and functional group compatibility. With its broad variety in reactivity the organometallic toolbox thus 
offers suitable reagents for many synthetic tasks.  
In addition to the task of synthesizing new molecules, demand for environmentally friendly and efficient 
methods has increased dramatically.5 Thus, the utilization of continuous flow setups for the laboratory 
scale marked a disruptive breakthrough in organic chemistry.6  
In flow chemistry, reagents are pumped in a continuously flowing stream through a reactor zone 
allowing an efficient and safe handling of reactions. Flow systems exist in all levels of complexity from 
being able to perform a single step reaction to advanced reaction sequences including several steps and 
workups (Scheme 1). 
                                                     
1
 United Nations, Department of Economic and Social Affairs, Population Division, World Population 
Prosepects: The 2017 Revision, Key Findings and Advance Table, ESA/P/WP/248. 
2
 a) M. MacCoss, T. A. Baillie, Science 2004, 303, 5665; b) D. P. Rotella, ACS Chem. Neurosci. 2016, 7, 1315. 
3
 N. A. McGrath, M. Brichacek, J. T. Njardarson, J. Chem. Ed. 2010, 87, 1348.  
4
 Handbook of Functionalized Organometallics Vol. 1 and 2 (Ed.: P. Knochel), Wiley-VCH, Weinheim, 2005.  
5
 a) B. M. Trost, Science 1991, 254, 1471; b) P. A. Wender, V. A. Verma, T. J. Paxton, T. H. Pillow, Acc. Chem. 
Res. 2008, 41, 40; c) C.-J. Li, B. M. Trost, Proc. Natl. Acad. Sci. USA 2008, 105, 13197; d) C. A. Kuttruff, M. D. 
Eastgate, P. S. Baran, Nat. Prod. Rep. 2014, 31, 419.  
6
 For an introduction and overview, see: a) B. Gutmann, D. Cantillo, C. O. Kappe, Angew. Chem. Int. Ed. 2015, 
54, 6688; b) T. Glasnov, Continuous-Flow Chemistry in the Research Laboratory, Springer, Cham, 2016; c) M. 
B. Plutschack, B. Pieber, K. Gilmore, P. H. Seeberger, Chem. Rev. 2017, 117, 11796. 
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Scheme 1: Schematic representation of a typical continuous flow setup.7  
In a basic setup, pumps deliver reagents and solvents at a fixed flow rate and quantity to the reactor. 
While in most cases liquids are pumped, advanced setups allow the feed of gases and slurries thus 
expanding the range of possible reactions. Reagents are combined and mixed in a mixing device. While 
in a simple setup mixing is achieved by diffusion of the reagent streams after a Y- or T-piece in a 
laminar flow or a vortex,8 highly sophisticated micromixers accelerate this process immensly. Mixing 
efficiency plays a crucial role for continuous flow reactions when using highly reactive compounds, for 
which reaction rates are typically faster than conventional mixing times in batch reactors.9 A variety of 
reactors can be connected to the mixing unit.10 Basic setups contain coiled or chip reactors that can be 
heated or cooled. Column reactors offer the possibility to lead the reaction stream over a solid phase 
containing for example a catalyst or scavengers. In addition, photochemical reactors allow light-induced 
reactions in flow with a high photonic efficiency.11 Furthermore, ultrasound, microwave or 
electrochemical reactors can be introduced into flow systems expanding the reaction scope. After the 
reactor, a back pressure regulator (BPR) controls the upstream system pressure allowing for example 
to process reactions in the liquid phase above the boiling point of the reaction media. Moreover, 
different analytical devices like inline IR or NMR-monitoring can be added to the flowsystems allowing 
efficient monitoring and screening of the reaction conditions.12 Additionally, work-up operations can 
be included in the flow system. By connecting more pumps and reactors, complete reaction sequences 
can be conducted in one setup allowing highly efficient preparations of synthetic targets.13  
                                                     
7
 Flow Chemistry, Vol. 1, Fundamentals (Eds.: F. v. Darvas, V. Hessel, G. Dorman), De Gruyter, Berlin, 2014.  
8
 S. Schwolow, J. Hollmann, B. Schenkel, T. Röder, Org. Process Res. Dev. 2012, 16, 1513; and references 
therein.  
9
 a) E. A. Mansur, M. Ye, Y. Wang, Y. Dai, Chin. J. Chem. Eng. 2008, 16, 503; b) J. Aubin, M. Ferrando, V. 
Jiricny, Chem. Eng. Sci. 2010, 65, 2065; c) L. Capretto, W. Cheng, M. Hill, X. Zhang in Microfluidics: 
Technologies and Applications (Ed.: B. Lin), Springer, Berlin, 2011; d) C.-Y. Lee, C.-L. Chang, Y.-N. Wang, L.-
M. Fu, Int. J. Mol. Sci. 2011, 12, 3263; e) J. M. Reckamp, A. Bindels, S. Duffield, Y. C. Liu, E. Bradford, E. 
Ricci, F. Susanne, A. Rutter, Org. Process Res. Dev. 2017, 21, 816. 
10
 a) T. Wirth, Mircroreactors in Organic Synthesis and Catalysis, Wiley-VCH, Weihnheim, 2008; b) P. Watts, 
C. Wiles, Micro Reaction Technology in Organic Synthesis, CRC Press, New York, 2011.  
11
 a) J. P. Knowles, L. D. Elliott, K. I. Booker-Milburn, Beilstein J. Org. Chem. 2012, 8, 2025; b) C. Cambié, C. 
Bottecchia, N. J. W. Straathof, V. Hessel, T. Noel, Chem. Rev. 2016, 116, 10276.  
12
 a) J. Yue, J. C. Schouten, T. A. Nijhuis, Ind. Eng. Chem. Res. 2012, 51, 14583; b) J. Reizmann, K. F. Jensen, 
Acc. Chem. Res. 2016, 49, 1786; c) V. Sans, L. Cronin, Chem. Soc. Rev. 2016, 45, 2032; d) D. C. Fabry, E. 
Sugiono, M. Rueping, React. Chem. Eng. 2016, 1, 129.  
13
 J. C. Pastre, D. L. Browne, S. V. Ley, Chem. Soc. Rev. 2013, 42, 8849.  
A. INTRODUCTION    5 
Overall, the advances in continuous flow chemistry allow a transformation of past organic synthetic 
approaches of all kinds into a more rapid automated set of synthetic operations providing an entry into 
a more sustainable future.14  
2 Organometallic Chemistry in Continuous Flow 
Especially in the field of organometallic chemistry, continuous flow offers numerous advantages 
compared to classical batch approaches to control highly reactive reagents.15 Foremost, only a minimal 
amount of highly reactive intermediate is present at any time of the reaction, allowing a safer handling 
of hazardous intermediates.16 Secondly, performing the reaction in a flow setup enables a better heat 
transfer between the reaction system and the environment, providing a narrow temperature profile and 
thus preventing the formation of hot spots and thermal runaways. Moreover, fast reactions with highly 
reactive organometallic intermediates can be conducted in a controlled manner through precise 
residence time control by defined flow rates, reactor volumes and rapid mixing of reaction streams. By 
using advanced setups with several pumps and reactors, multipstep reaction sequences can be performed 
without the exposure of any reactive or hazardous organometallic intermediates to the environment. 
Finally, scale-up, which is often limited under batch conditions for organometallic reactions, is possible 
without further optimization by simply extending the run time of a reaction. In addition, reproducibility 
of experimental conditions and results is ensured through the precise control and automation of 
continuous flow setups.  
2.1 Preparation of Organometallic Reagents in Continuous Flow 
Since the first synthesis of an organometallic reagent by de Gassicourt17 in 1760 and pioneering 
contributions by Frankland18 and Grignard19 various entries to polyfunctional organometallic 
compounds have been found. The three most commonly used strategies include oxidative insertion, 
halogen-metal exchange and directed metalation (Scheme 2). In addition, transmetalation opens the 
way to a broad range of other organometallic compounds.  
                                                     
14
 Sustainable Flow Chemistry: Methods and Applications (Ed.: L. Vaccaro), Wiley-VCH, Weinheim, 2017.  
15
 Flash Chemistry, Fast Organic Synthesis in Microsystems (Ed.: J.-i. Yoshida), Wiley, Chichester, 2008.  
16
 M. Movsisyan, E. I. P. Delbeke, J. K. E. T. Berton, C. Battilocchio, S. V. Ley, C. V. Stevens, Chem. Soc. Rev. 
2016, 45, 4892.  
17
 D. Seyferth, Organometallics 2001, 20, 1488.  
18
 a) E. Frankland, Liebigs Ann. Chem. 1849, 71, 171; b) D. Seyferth, Organometallics 2001, 20, 2940.  
19
 a) V. Grignard, Compt. Rend. Acad. Sci. Paris 1900, 130, 1322; b) D. Seyferth, Organometallics 2009, 28, 
1598. 
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Scheme 2: Preparation of organometallic reagents via different pathways.  
All of these preparation methods have been transferred to continuous flow in recent years taking 
advantage of the above described features of flow setups.  
2.1.1 Oxidative Insertions 
Direct insertion of elemental metal is one of the most convenient and straightforward methods to prepare 
organometallics.20 This method was first described in 1849 by Frankland who reacted ethyliodide with 
zinc leading to diethylzinc.18a In 1900, the French chemist Grignard reacted magnesium turnings with 
methyl iodide in diethyl ether yielding the first organomagnesium compounds and thus marking a 
breakthrough for organometallic chemistry.19 The direct insertion of zinc into carbon-halogen bonds 
proceeds with a high functional group tolerance but requires elevated temperatures and long reaction 
times. In contrast, direct insertions of magnesium display a much narrower functional group tolerance 
but take place in shorter times. In addition, elemental magnesium easily adopts a passivation layer of 
magnesium oxide or magnesium hydroxide upon storage. Thus, activation with additives like iodine,21 
1,2-dibromoethane,22 or DIBAL-H23 is required to facilitate insertion. To achieve a high functional 
group tolerance, Knochel and coworkers developed an oxidative insertion in the presence of LiCl for a 
variety of metals including zinc,24 magnesium,25 manganese,26 aluminum,27 and indium28 under mild 
conditions. 
                                                     
20
 a) Handbook of Grignard Reagents (Eds.: G. S. Silvermann, P.E. Rakita), Marcel Dekker, New York, 1996; b) 
Grignard Reagents, New Developments (Ed.: H. G. Richey jr.), Wiley & Sons, New York, 2000. 
21
 H. Gold, M. Larhed, P. Nilsson, Synlett 2005, 1596.  
22
 W. E. Lindsell in Comprehensive Organometallic Chemistry I, Vol 1 (Eds.: G. Wilkinson, F. G. S. Stone, G. E. 
Ebel) Pergamon Press, Oxford, 1982.  
23
 U. Tilstam, H. Weinmann, Org. Process Res. Dev. 2002, 6, 906.  
24
 a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; b) N. 
Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358; c) A. 
Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. 
25
 a) F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802; 
b) F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192. 
26
 Z. Peng, P. Knochel, Org. Lett. 2011, 13, 3198.  
27
 a) T. D. Blümke, Y.-H. Chen, Z. Peng, P. Knochel, Nat. Chem. 2010, 2, 313; b) T. D. Blümke, T. Klatt, K. 
Koszinowski, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9926.  
28
 a) Y.-H. Chen, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 7648; b) Y.-H. Chen, M. Sun, P. Knochel, Angew. 
Chem. Int. Ed. 2009, 48, 2236.  
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Conducting oxidative insertions in continuous flow allows a safer handling of the exothermic reaction 
conditions and a higher process intensity due to shorter reaction times. Alcázar and coworkers reported 
an oxidative insertion of zinc into alkyl and benzylic halides with subsequent Negishi29 cross-coupling 
(Scheme 3).30 A solution of an organohalide is passed over a packed bed of zinc particles which are 
activated prior to insertion with TMSCl and 1,2-dibromoethane. The reaction is finished within 10 min 
and gives a steady concentration of the organozinc reagent over a long period of time tolerating sensitive 
groups like nitriles and esters.  
 
Scheme 3: Continuous synthesis of organozinc halides and subsequent Negishi cross-couplings.30 
Similar setups have been reported for the oxidative insertion of magnesium into aryl and alkyl halides.31 
After activation of granulated magnesium in a packed bed reactor with DIBAL-H, TMSCl and 1-bromo-
2-chloroethane, magnesium reagents can be generated in a constant concentration at ambient 
temperature and subsequently reacted with a variety of electrophiles (Scheme 4). Conducting oxidative 
insertions in continuous flow allows an on-demand preparation of the metalorganic reagents in a 
controlled and reproducible reaction setup under mild conditions.  
                                                     
29
 a) E. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; b) E. Negishi, Acc. Chem. Res. 
1982, 15, 340. 
30
 a) N. Alonso, L. Z. Miller, J. de M. Muñoz, J. Alcázar, D. T. McQuade, Adv. Synth. Catal. 2014, 356, 3737; b) 
M. Berton, L. Huck, J. Alcázar, Nat. Protoc. 2018, 13, 324. 
31
 a) A. A. Grachev, A. O. Klochkov, V. I. Shiryaev, Russ. J. Appl. Chem. 2012, 85, 629; b) P. A. Storozhenko, 
A. A. Grachev, A. O. Klochkov, V. I. Shiryaev, Russ. J. Appl. Chem. 2013, 86, 397; c) M. Goldbach, E. Danieli, 
J. Perlo, B. Kaptein, V. M. Litvinov, B. Blümich, F. Casanova, A. L. L. Duchateau, Tetrahedron Lett. 2016, 57, 
122; d) L. Huck, A. de la Hoz, A. Díaz-Ortiz, J. Alcázar, Org. Lett. 2017, 19, 3747. 
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Scheme 4: Oxidative insertion of magnesium into alkyl and aryl halides using continuous flow.31d 
2.1.2 Halogen-Metal Exchange 
Another commonly used method for preparing organometallic reagents is the halogen-metal exchange. 
Driving force of this reaction is the formation of the more stable organometallic species (sp > sp2vinyl 
>sp2aryl>sp3prim>sp3sec>sp3tert).32 Under optimized batch conditions, halogen-lithium exchange reactions 
have to be conducted at temperatures down to −100 °C to permit a moderate functional group 
tolerance.33 The high reactivity and instability of organolithium compounds originates from the strongly 
ionic character of the newly formed carbon-lithium bond. In contrast, magnesium-halogen exchanges 
generate more stable organometallic intermediates. After pioneering work of Prévost34 and Villieras35, 
Knochel demonstrated the potential of the iodine-magnesium exchange using i-PrMgCl and PhMgCl 
on substrates bearing sensitive functionalities like ester or nitro groups.36 A major improvement was 
the addition of one equivalent LiCl, leading to the so called “Turbo-Grignard”, a reagent with 
remarkably higher reactivity allowing a bromine-magnesium exchange.37  
                                                     
32
 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733.  
33
 a) W. E. Parham, L. D. Jones, J. Org. Chem. 1976, 41, 2704; b) W. E. Parham, L. D. Jones, J. Org. Chem. 1976, 
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A major breakthrough in halogen-metal exchanges was made by Yoshida and coworkers employing 
continuous flow technology.38 By precise time control using highly advanced flow systems with 
reaction times down to 0.002 s it was possible to tolerate even nitro or nitrile groups at moderate 
temperatures of −20 °C.38i In addition, this setup enabled halogen-lithium exchanges that are not 
possible under batch conditions at all. Thus, for example, a ketone containing arylhalide could be 
subjected to a halogen-lithium exchange with in flow generated mesityl lithium without attack at the 
functional group.38e After subsequent electrophilic quench in flow of the highly reactive intermediate 
polyfunctional arenes could be isolated in high yields without the need to protect the ketone 
functionality (Scheme 5).  
 
Scheme 5: Ultrafast iodine-lithium exchange using MesLi in continuous flow with subsequent electrophilic 
quench.38g  
Ley and coworkers transferred the halogen-magnesium exchange using i-PrMgCl·LiCl to a continuous 
flow setup, thereby allowing the preparation of a wide range of organomagnesium reagents at room 
temperature without the need for energy-intensive cryogenic conditions as employed in batch mode and 
significantly shortening the reaction time (Scheme 6).39 Formation of the Grignard reagent could be 
monitored inline by an IR device. The metalorganic intermediates were quenched inline with aldehydes 
providing diarylmethanols in high yields.  
                                                     
38
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1110; e) H. Kim, A. Nagaki, J.-i. Yoshida, Nat. Commun. 2011, 2, 264; f) Y. Tomida, A. Nagaki, J.-i. Yoshida J. 
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Scheme 6: Halogen-magnesium exchange in continuous flow at ambient temperature and subsequent quench with 
aldehydes.39b 
2.1.3 Directed Metalation 
While for oxidative insertion or halogen-metal exchange a halogen-carbon bond needs to be present in 
the molecule, in directed metalation the organometallic compound is formed directly from a hydrogen-
carbon bond. Alkyl-lithium bases as n-BuLi, s-BuLi or t-BuLi and strong lithium amides like lithium 
diisopropylamide (LDA) or TMPLi (TMP = 2,2,6,6-tetramethylpiperidyl) are commonly used for these 
metalations. 40 To enhance functional group tolerance a range of TMP bases including TMPZnCl·LiCl,41 
(TMP)2Zn·2MgCl2·2LiCl,42 TMPZnOPiv·LiCl,43 TMPMgCl·LiCl,44 (TMP)2Mg·2LiCl,45 
                                                     
40
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(TMP)2Fe·2MgCl2·4LiCl,46 (TMP)2Mn·2MgCl2·4LiCl,47 (TMP)4Zr·4MgCl2·6LiCl,48 and 
(TMP)3La·3MgCl2·5LiCl49 were developed. These bases differ in reactivity and regioselectivity and 
thus offer a broad toolbox for the metalation of organic substrates and subsequent reactions with 
electrophiles.50  
While strong lithium and magnesium bases display high reactivity and thus need to be conducted at 
cryogenic temperatures, milder bases containing for example zinc as a metal often require elevated 
temperatures and long reaction times. Both of these problems can be overcome by using continuous 
flow chemistry. For instance, functionalized heterocycles and acrylates could be metalated using 
TMPMgCl·LiCl under convenient conditions (30 s, 25 °C) in continuous flow avoiding cryogenic 
temperatures and achieving higher yields than in a comparable batch procedure (Scheme 7).51  
 
Scheme 7: Metalation of 2,3-dichloro-5-(trifluoromethyl)pyridine in the presence of TMPMgCl·LiCl and 
subsequent iodolysis in continuous flow and batch.51a 
Furthermore, highly reactive LDA could be employed for a Barbier lithiation generating unstable 
carbamoyllithium intermediates which could be trapped in situ with various electrophiles including 
carbonyl compounds leading for example to α-hydroxy amides in high yields (Scheme 8).52 The 
metalation proceeds at ambient temperature and is easily scaled up. In addition to this nucleophilic 
amidation, thioamidation is described for similar conditions (25 °C, 48 s).  
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Scheme 8: Continuous flow generation of carbamoyllithium intermediates in the presence of various electrophiles 
at ambient temperature.52  
On the other hand, zincations of sensitive arenes and heteroarenes could be achieved using 
(Cy2N)2Zn·2LiCl in a continuous flow setup at temperatures between 25 and 100 °C within relatively 
short reaction times of 10 min (Scheme 9).53 The use of a back pressure regulator permits to run 
reactions at temperatures above the boiling point of the solvent thus allowing zincations that would be 
hard to conduct under batch conditions. The resulting organozinc reagents could be trapped with various 
allylic bromides in the presence of a copper catalyst and aryl iodides in the presence of a palladium 
catalyst in high yields.  
 
Scheme 9: Continuous flow zincations of sensitive (hetero)arenes followed by reaction with electrophiles leading 
to functionalized (hetero)aromatic compounds.  
2.1.4 Transmetalation  
Organometallic compounds bearing a carbon-metal bond are easily transmetalated into another 
organometallic compound by addition of a metal salt. Driving forces are the formation of a more 
covalent bond between the new metal and the carbon as well as the lattice energy of the product metal 
halide. The transmetalation leads to a modification in selectivity and reactivity of the newly formed 
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carbon-metal bond. While lithium bases offer a broad entry into organometallic chemistry, the high 
reactivity of the generated lithium intermediates limits their application and requires harsh reaction 
conditions such as cryogenic temperatures. Transmetalation to less reactive organometallic compounds 
containing for example magnesium, zinc, boron, aluminum or copper leads to a reduced basicity of the 
organometallic species bearing a more covalent carbon-metal bond and thus to a more stable 
organometallic species.  
 
Scheme 10: In situ trapping metalation of aromatic substrates.54  
Knochel and coworkers developed an in situ trapping metalation, in which metalation of an aromatic 
substrate with TMPLi is conducted in the presence of a THF-soluble metal salt such as MgCl2, ZnCl2 
or CuCN∙2LiCl.54 The reaction of TMPLi with the aromatic substrate is more than six times faster than 
the reaction of TMPLi with the metal salt (Scheme 10). The lithiated intermediate is directly 
transmetalated to the more stable organometallic species. Reactivity of TMPLi under batch conditions 
is only efficiently controlled at −78 °C. Cryogenic temperatures could be avoided transferring this 
procedure to continuous flow. It was shown, that in situ trapping metalations using TMPLi in the 
presence of various metal salts could be conducted at 0 °C within 40 s using a commercially available 
flow setup tolerating sensitive functional groups (Scheme 11).55 Efficient mixing and control of reaction 
heat inhibit side reactions that occur under conventional batch conditions.  
 
Scheme 11: In situ trapping metalation in continuous flow and batch of ethyl 4-bromobenzoate using TMPLi in 
the presence of ZnCl2·2LiCl.55  
Furthermore, an in situ trapping flow metalation of a broad range of functionalized arenes, heteroarenes 
and arylate derivatives using the economic amide base lithium dicyclohexylamide (Cy2NLi) is possible 
under flow conditions in 40 s at 0 °C (Scheme 12).56 All of these metalations are easily scaled up without 
further optimization.  
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Scheme 12: Continuous flow in situ trapping metalation of (hetero)arenes followed by reaction with electrophiles 
leading to functionalized (hetero)arenes.56 
2.2 Organometallic Reactions in Continuous Flow 
In addition to the advantageous preparation of organometallic reagents in continuous flow, other 
organometallic reactions benefit from being conducted in flow. For instance, different cross-couplings, 
both hetero- and homogenous, are reported under flow conditions.57 Buchwald and coworkers report 
the synthesis of biaryls by Negishi cross-couplings29 of fluoro- and trifluoromethyl-susbtituted arenes 
and heteroarenes (Scheme 13a).58 In addition to convenient metalation conditions in continuous flow, 
good cross-coupling yields are achieved in short residence times. A heterogenous approach is reported 
by Organ and coworkers using an immobilized palladium precatalyst in a packed bed reactor (Scheme 
13b).59 The silica-supported Pd-PEPPSI-i-Pr enables Negishi cross-couplings29 at room temperature 
within 10 min of aryl halides with alkylzinc reagents with a minor decay in activity of the catalyst over 
15 h of continuous reaction being observed. Buchwald and coworkers developed an advanced setup for 
Suzuki-Miyaura cross-couplings60 allowing an automatic optimization of reaction conditions due to 
included analytical and feedback devices in the continuous flow setup.61 Reaction optimization with 
screening of palladium source, ligand and continuous variables was completed within 96 experiments.  
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Scheme 13: a) Homogeneous58 and b) heterogenuos59 Negishi cross-couplings29 in continuous flow.  
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Conducting photoredox catalysis using organometallic catalysts in continuous flow allows direct 
irradiation of the reaction medium leading to a higher photonic effiency and thus to shorter reaction 
times. In addition, reactions can be scaled up without a limit which is reached quickly under batch 
conditions. For instance, reaction time of Ru-catalyzed oxidation of tetrahydroisoquinolines through 
iminium formation could be reduced from 3 h to 30 s by conducting it in flow (Scheme 14).62  
 
Scheme 14: Oxidation of tetrahydroisoquinoline in batch and flow.62 
Precise reaction times in continuous flow setups enable to control tandem chemical transformations that 
are often difficult to control under batch conditions because they proceed rapidly through multiple 
unstable reactive intermediates. For example, Yoshida and coworkers designed a flow microreactor 
platdorm controlling tandem isomerizations of o-lithiated aryl benzyl ethers (Scheme 15).63 Depending 
on the reaction time, three intermediates can be selectively trapped to obtain the desired products.  
 
Scheme 15: Control of tandem isomerization of o-lithiated aryl benzyl ethers in continuous flow.63  
Highly advanced flow platforms combining multiple reaction steps and inline workups have been 
developed to allow the synthesis of important pharmaceuticals minimizing labor-intensive and 
repetitive operations. Many of these setups incorporate organometallic reactions which can be safely 
conducted without exposure of highly reactive and hazardous reagents under controlled and 
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reproducible conditions.64 For example, an efficient flow synthesis of the breast cancer drug tamoxifen 
is described by Ley and coworkers, yielding after 80 min of continuous collection tamoxifen in 84% 
yield which is enough material for over 900 days of treatment for one patient (Scheme 16).65 Key step 
in the flow setup is the generation of a highly reactive organolithiumspecies. 
 
Scheme 16 Continuous-flow telescoped synthesis of (E/Z)-tamoxifen.65 Intermediate cooling or heating loops for 
reagents are left out for clarity. 
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3 Objectives 
Based on previous results of directed metalations and in situ trapping metalations of aromatic substrates 
in continuous flow, the metalation and in situ trapping metalation of substituted azobenzenes in 
continuous flow should be investigated. It was envisioned that under flow conditions the metalation of 
substituted azobenzenes would be possible without attack of the nitrogen double bond and would not 
require cryogenic temperatures allowing a late stage functionalization of photoswitches based on 
azobenzene cores (Scheme 17). 
 
Scheme 17: Continuous flow metalation and in situ trapping metalation of substituted azobenzenes.  
Furthermore, the in situ trapping metalation in continuous flow at mild temperatures should be extended 
to the functionalization of 1,2-dicyanobenzenes and related benzonitriles giving access to functionalized 
building blocks for the synthesis of phthalocyanines. Particularly, a scale-up procedure needed to be 
developed to overcome scale-up problems when executing the reaction under batch conditions (Scheme 
18).66  
 
Scheme 18: Continuous flow in situ trapping metalation of 1,2-dicyanobenzene.  
Moreover, it was proposed to transfer the concept of in situ trapping metalations to an in situ trapping 
halogen-lithium exchange in continuous flow where halogen-lithium exchange is faster than 
transmetalation of the exchange reagent with a metal salt additive. Especially aromatic compounds 
containing highly sensitive groups such as isothiocyanates or azides that are not tolerated under batch 
halogen-lithium exchange conditions should be investigated (Scheme 19).67  
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Scheme 19: In situ trapping halogen-metal exchange of highly sensitive (hetero)arenes using continuous flow.  
Finally, a flow procedure for the sodiation of arenes and heteroarenes using the soluble base sodium 
diisopropylamide should be developed. It was anticipated that precise time control and efficient mixing 
enabled by continuous flow would allow sodiation of (hetero)arenes that decompose upon batch 
sodiation and thus broaden the scope of sodiation chemistry, which is a promising alternative to 
commonly used lithiations (Scheme 20).68  
 
Scheme 20: Sodiation of arenes and heteroarenes in continuous flow.  
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1 Selective Lithiation, Magnesiation and Zincation of Unsymmetrical 
Azobenzenes Using Continuous Flow 
1.1 Introduction 
Azobenzenes (1) function as versatile photoswitches that can be cycled between their cis- and trans-
configuration with light (Scheme 21).69 Their synthetic accessibility,70 small size and robust switching, 
paired with a low rate of photobleaching makes them excellent building blocks for the incorporation 
into more complex optical devices.71 Photopharmaceuticals, for instance, contain azobenzene units as 
on- and off-switches which allow the control of biological functions with a high spatiotemporal 
resolution of light.72  
 
Scheme 21: Isomerization of azobenzenes (1).69 
It is noteworthy, that the switching-wavelengths, the stability of the cis- and trans-isomers, and the 
switching kinetics are strongly influenced by the substitution pattern of the azobenzene core.73 
Therefore, the syntheses of elaborate photopharmaceuticals and the fine-tuning of the desired 
photoswitching properties rely on the availability of efficient synthetic methods for the direct 
functionalization of azobenzenes (1).74 One approach for preparing functionalized azobenzenes (1) is 
their metalation with strong bases. Thus, lithiation under standard conditions with TMPLi is reported 
at cryogenic temperatures of −78 °C using a large excess TMPLi and subsequent quenching with CO2 
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or TMSCl.75 Alternatively, the selective lithiation of unsymmetrical azobenzenes (1) was only realized 
using a halogen-lithium or a tin-lithium exchange.76 
The generation of reactive organometallic intermediates can be greatly improved using continuous 
flow.77 Recently, Knochel and coworkers have shown that the metalation of polyfunctional aromatics 
can be advantageously realized using a continuous flow setup. Especially practical was the use of in 
situ trapping metalation procedures where a mixture of the aromatic substrate and ZnCl2 or MgCl2 was 
treated in a commercial flow reactor with TMPLi at 0 °C.78 The success of this procedure relies on the 
fact that the lithiation of the aromatic substrate with TMPLi is faster than the transmetalation of TMPLi 
with MgCl2 or ZnCl2 (Scheme 22).79 Both approaches, the direct metalation as well as the in situ 
trapping metalation provide entries to the functionalization of unsymmetrical azobenzenes (1).  
 
Scheme 22: In situ trapping metalation of aromatic substrates.  
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1.2 Lithiation of Methoxy-Substituted Azobenzenes 
First, the attention was turned to the less sensitive 4-methoxyphenyl-2-phenyldiazene (2a). Its reaction 
with TMPLi, completed within 20 s at 0 °C in THF using a flow rate of 3 mL min−1, produced the 
aryllithium 3a and afforded after an iodine (4a) quench 1-(3-iodo-4-methoxyphenyl)-2-phenyldiazene 
(5a) in 55% yield (Scheme 23). In contrast, adding TMPLi at 0 °C under batch conditions to azobenzene 
2a lead mostly to decomposition and a mixture of products as indicated by GC-analysis. Similarly, 
1-(3,5-dimethoxyphenyl)-2-(4-methoxy-phenyl)-diazene (2b) was lithiated under the same conditions 
providing after iodolysis the corresponding iodo-substituted azobenzene 5b in 73% yield. In the case 
of 3-methoxyphenyl-2-phenyldiazene (2c), the lithiation with TMPLi is only moderately selective 
furnishing after iodolysis two easily separable ortho-substituted products (5c' and 5c'') in a 3:1 ratio and 
59% yield.  
 
Scheme 23: Lithiation of methoxy-substituted azobenzenes (2) in continuous flow.  
In addition to iodine, various other electrophiles were used successfully such as Bu2S2 (4b) leading to 
azobenzene 5d (Table 1, entry 1). Aryl bromides 4c – e afforded in the presence of a palladium catalyst 
(4 mol % Pd(dba)2, 8 mol % DavePhos) after transmetalation of the lithiated azobenzene to the 
corresponding zinc reagent with ZnCl2 diazenes 5e – g and 5k (entries 2 – 4 and 8). Furthermore, 
quenching with benzaldehyde (4f) or allyl bromide (4g) in the presence of 10% CuCN·2LiCl80 lead to 
azobenzenes 5h – i (entry 5 – 6). Reaction with propylene oxide (4h) afforded after transmetalation to 
the corresponding Grignard reagent, using MgCl2·LiCl and 10% CuI as catalyst, diazene 5j (entry 7). 
The structure of compound 5g was confirmed by X-ray analysis.81 
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Table 1: Functionalized methoxy-substituted azobenzenes of type 5 obtained via lithiation in continuous flow and 
subsequent trapping with an electrophile (E+) in batch.  
Entry Azobenzene Electrophile (E+)[a] Product/Yield[b] 
 
 
 
 
1 2a 4b 5d: 83%[c] 
 
 
 
 
2 2a 4c 5e: 63%[e],[f] 
 
 
 
 
3 2a 4d 5f: 69%[e],[f] 
 
 
 
 
4 2a 4e 5g: 83%[g] 
 
 
 
 
5 2a 4f 5h: 58%[c],[h],[i] 
 
 
 
 
6 2b 4g 5i: 90%[c],[j] 
 
 
 
 
7 2b 4h 5j: 78%[c],[h],[k] 
 
 
 
 
8 2b 4c 5k: 90%[c],[f] 
[a] Yield based on electrophile used as limiting reagent. [b] Yield of isolated, analytically pure product. 
[c] 0.8 equiv. E+. [d] 0 °C, 10 min. [e] 0.7 equiv. E+. [f] 1.1 equiv. ZnCl2, 4 mol% Pd(dba)2, 8 mol% DavePhos, 
25 °C, 12 h. [g] 1.1 equiv. ZnCl2, 0 °C, 15 min; then 0.8 equiv. E+, 4 mol% Pd (dba)2, 8 mol% DavePhos, 25 °C, 
12 h. [h] 1.1 equiv. MgCl2·LiCl. [i] 0 °C, 5 h. [j] 10 mol% CuCN·2LiCl, 25 °C, 1 h. [k] 10 mol% CuI, 25 °C, 
12 h. 
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1.3 In Situ Trapping Metalation of Functionalized Azobenzenes 
Although the lithiation with TMPLi under flow conditions was satisfactory with the relatively low 
functionalized diaryl diazenes 2a – c the use of more sensitive azobenzenes bearing a fluoro-, bromo- 
or cyano-substituent required an in situ trapping metalation procedure using ZnCl2.  
 
Scheme 24: In situ trapping procedure allowing the zincation and iodolysis of various unsymmetrical azobenzenes 
of type 6 in continuous flow. 
Thus, the treatment of a mixture of 4-fluorophenyl-2-phenyldiazene (6a) (1.0 equiv.) and ZnCl2 
(0.5 equiv.) with TMPLi (1.5 equiv.) under flow conditions (3.0 mL min−1, 0 °C, 20 s) led to a highly 
regioselective lithiation of 6a in ortho-position to the fluoro-substituent giving after transmetalation 
with ZnCl2 the corresponding arylzinc reagent 7a which was quenched with iodine (4a) providing the 
desired azobenzene 8a in 85% yield. Similarly, the fluoro-, bromo- and cyano-substituted diazenes 6b, 
6c and 6d were regioselectively lithiated, transmetalated to the zinc species and iodinated affording the 
unsymmetrically azobenzenes 8b, c and d in 66 – 83% yield (Scheme 24). The structure of compound 
8d was confirmed by X-ray analysis.82 This procedure was extended to a range of other electrophiles. 
Thus, a bromination of 6a directly performed with Br2 (4i) on a gram scale provided the bromo-
derivative 8e in 74% isolated yield without further optimization (Table 2, entry 1). A copper-catalyzed83 
allylation with allyl bromide (4g) provided the 3-allylated azobenzene 8f in 85% yield (entry 2). The 
zinc intermediate 7a undergoes various Negishi cross-couplings84 with aryl iodides using 2 mol% 
Pd(OAc)2 and 4 mol% SPhos85 leading to the unsymmetrical azobenzenes 8g – j in 69 – 83% yield 
(entries 3 – 6).  
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Similarly, the cyano-substituted azobenzene 6d was zincated under the same conditions in ortho-
position to the cyano-substituent and arylated via a Negishi cross-coupling84 providing azobenzene 8k 
in 67% yield (entry 7).  
Table 2: Functionalized fluoro- and cyano-substituted azobenzenes of type 6 obtained via an in situ trapping 
procedure in continuous flow using ZnCl2 and subsequent trapping with an electrophile  (E+) in batch.  
Entry Azobenzene Electrophile (E+) Product/Yield[a] 
 
 
 
 
1 6a 4i 8e: 74%[b] 
 
 
 
 
2 6a 4g 8f: 85%
[c],[d] 
83%[d],[e] 
 
 
 
 
3 6a 4j 8g: 73%[c],[f] 
 
 
 
 
4 6a 4k 8h: 76%[c],[f] 
 
 
 
 
5 6a 4l 8i: 69%[c],[f] 
 
 
 
 
6 6a 4m 8j: 83%[c],[f] 
 
 
 
 
7 6d 4m 8k: 67%[f],[g] 
[a] Yield of isolated, analytically pure product. [b] 3.0 equiv. E+, on a gram scale, 0 °C, 1 h. [c] 1.1 equiv. E+. 
[d] 10 mol% CuCN·2LiCl, 0 °C, 1 h. [e] 2.0 equiv. E+, on a gram scale, 0 °C, 1 h. [f] 2 mol% Pd(OAc)2, 4 mol% 
SPhos, 25 °C, 3 h. [g] 0.8 equiv. E+, yield based on electrophile used as limiting reagent.   
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Scheme 25: In situ trapping procedure allowing the magnesiation of unsymmetrical azobenzenes and 
subsequent electrophilic quench in continuous flow. 
This in situ trapping metalation procedure was extended for preparing Grignard reagents which are 
more reactive than organozinc species and are much better suited for reactions with aldehydes or acyl 
chlorides. Thus, the azobenzene 8e was mixed with MgCl2·LiCl (0.5 equiv.) and reacted with TMPLi 
(1.5 equiv.) in a continuous flow setup (3 mL min−1, 0 °C, 20 s) providing magnesium intermediate 7b. 
After quenching in batch with TMSCl (4n) the silylated azobenzene 8l was obtained in 92% yield 
(Scheme 25).  
Table 3: Functionalized fluoro-substituted azobenzenes of type 8 obtained via an in situ trapping procedure in 
continuous flow using MgCl2·LiCl and subsequent trapping with an electrophile (E+) in batch.  
Entry Azobenzene Electrophile (E+)[a] Product/Yield[b] 
 
 
 
 
1 6a 4f 8m: 77%[c] 
 
 
 
 
2 6a 4o 8n: 74%[c] 
 
 
 
 
3 6a 4p 8o: 81%[d] 
 
 
 
 
4 6a 4q 8p: 78%[d] 
[a] Yield based on electrophile used as limiting reagent. [b] Yield of isolated, analytically pure product. 
[c] 0.8 equiv. E+, 0 °C, 3 – 5 h. [d] 0.8 equiv. E+, 1.1 equiv. CuCN·2LiCl, 0 °C, 2 h.  
This procedure was extended for performing quenching reactions with benzaldehyde (4f) or acyl 
chlorides using azobenzene 6a as starting material. Thus, quenching of the corresponding magnesiated 
azobenzene 7c with benzaldehyde (4f) or 4-fluoro-benzaldehyde (4o) provided the hydroxy-azobenzene 
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derivatives 8m and 8n in 77% and 74% yield, respectively (Table 3, entries 1 – 2). Similarly, quenching 
reactions with acid chlorides 4p and 4q in the presence of CuCN·2LiCl (1.1 equiv.) furnished the 
corresponding acyl-substituted azobenzenes 8o and 8p in 81% and 78% yield (entries 3 – 4). 
This method was further applied to the highly functionalized azobenzene 9. Its tetra-ortho-chloro 
substitution pattern enables visible-light photoswitching which makes it a valuable synthetic 
intermediate for photopharmaceuticals that target complex animal tissues.73 This additional 
functionalization proceeded smoothly through an in situ trapping zincation using TMPLi followed by a 
batch-iodination and afforded the selectively iodinated azobenzene 10 in 65% yield (Scheme 26). The 
structure of compound 10 was confirmed by X-ray analysis.86 
 
Scheme 26: In situ trapping metalation procedure allowing the zincation and iodolysis of the tetra-ortho-chloro-
substituted azobenzene 9 in continuous flow. 
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2 Selective Zincation of 1,2-Dicyanobenzene and Related Benzonitriles in 
Continuous Flow Using In Situ Trapping Metalations 
2.1 Introduction 
The metalation of polyfunctionalized aromatics and heterocycles pioneered among others by Snieckus87 
is a key reaction of the expedited functionalization of these unsaturated building blocks for applications 
in pharmacy, agrochemistry and material science.88 Of special importance is the functionalization of 
1,2-dicyanobenzenes (11a) since derivatives of such scaffolds may be used for heterocyclic syntheses 
and for the elaboration of phthalocyanines (12) with potential applications in solar cells (Scheme 27).89 
 
Scheme 27: Example synthesis of the phthalocyanine scaffold (12) starting from 1,2-dicyanobenzene (11a).90 
Recently, Knochel and coworkers have shown that the performance of the so called in situ trapping 
metalations91 for polyfunctionalized aromatics can be advantageous since the produced lithium 
intermediate is immediately trapped with metallic salts such as MgCl2·2LiCl, ZnCl2, CuCN·2LiCl or 
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LaCl3·2LiCl.92 Preliminary experiments with 1,2-dicyanobenzene (11a) have shown that the addition 
of TMPLi93 (1.2 equiv.) to a mixture of 11a with the metal salt ZnCl2  at −78 °C first lead to the lithiation 
of the arene followed by transmetalation with the metal salt to afford an ortho-zincated intermediate 
13a and provided after iodolysis the desired 3-iodo derivative (14a) in 80% yield. Further experiments 
showed that the generation of the lithium species and in situ trapping with ZnCl2 required a temperature 
of −78 °C in batch and cannot be scaled-up without further optimization (Scheme 28). 
 
Scheme 28: Batch-conditions for the functionalization of 1,2-dicyanobenzene (11a).  
Recently, Knochel and coworkers reported that in situ trapping metalations can be performed at mild 
conditions using a continuous flow setup.94 In this procedure, the substrate, here 1,2-dicyanobenzene 
(11a) is mixed with ZnCl2 (0.5 equiv.) in THF and this solution is mixed in continuous flow with a THF 
solution of TMPLi (ca. 0.6 M, 1.5 equiv.). Such a mixing is done at 0 °C (and not cryogenic 
temperatures as for the batch procedure) and requires only 20 s reaction time. Herein, the successful 
use of this setup to prepare a range of functionalized 1,2-dicyanobenzenes of type 14 as well as some 
related polyfunctionalized benzonitriles of type 15 is reported. 
2.2 Zincation of 1,2-Dicyanobenzenes 
The treatment of a mixture of 1,2-dicyanobenzene (11a, 1.0 equiv.) and ZnCl2 (0.5 equiv.) with TMPLi 
(1.5 equiv.) under flow conditions95 (3.0 mL min−1, 0 °C, 20 s) led to a regioselective lithiation of 11a, 
giving after transmetalation with ZnCl2 the corresponding diarylzinc reagent (13a), which was 
quenched with iodine (16a), providing 3-iodo-1,2-dicyanobenzene (14a) in 88% yield (Scheme 29). 
Using the same stoichiometry in a batch reaction lead to a lower conversion and poorer yields were 
obtained.  
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Scheme 29: Continuous flow setup for in situ trapping metalations of 1,2-dicyanobenzene (11a) using TMPLi 
in the presence of ZnCl2. 
This in situ generation of a zincated dicyanobenzene such as 13a can be used to perform reactions with 
various classes of organic electrophiles. Thus, collecting the flow stream in a flask containing an allylic 
bromide such as 3-bromocyclohexene (16b) or ethyl 2-(bromomethyl)acrylate (16c) and 10 mol% 
CuCN·2LiCl96 on an approximately 0.5 mmol scale gave the allylated products 14b and c in 81% and 
76% yield (Table 4, entries 1 – 2).  
Table 4: Functionalized 1,2-dicyanobenzenes of type 14 obtained via an in situ trapping procedure in continuous 
flow using ZnCl2 and subsequent trapping with an electrophile (E+) in batch.  
Entry Electrophile (E+)[a] Product/Yield[b] Entry Electrophile (E+)[a] Product/Yield[b] 
 
 
 
 
 
 
1 16b 14b: 81%[c] 5 16f 14f: 78%[d] 
 
 
 
 
 
 
2 16c 14c: 76%[c] 6 16g 14g: 76%[d] 
 
 
 
 
 
 
3 16d 14d: 57%[d] 7 16h 14h: 87%[e] 
 
 
 
 
 
 
4 16e 14e: 74%[d] 8 16i 14i: 82%[e] 
[a] 1.1 equiv. of E+ were used. [b] Yield of isolated, analytically pure product. [c] Obtained in the presence of 
10 mol% CuCN·2LiCl, 0 °C, 2 h. [d] Obtained after transmetalation with 1.1 equiv. of CuCN·2LiCl, 0 °C, 2 h. 
[e] Obtained using 2 mol% Pd(OAc)2 and 4 mol% SPhos, 25 °C, overnight. 
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Similarly, copper-mediated acylations with 3-chlorobenzoyl chloride (16d) or 2,4-dichlorobenzoyl 
chloride (16e) afforded the functionalized 1,2-dicyanobenzene derivatives (14d – e) in 57% and 74% 
yield (entries 3 – 4). Ketones 14f – g were obtained in 76 – 78% yield after transmetalation of zincated 
intermediate 13a to the corresponding copper derivative using CuCN·2LiCl96 and acylation with 
cyclopropanecarbonyl chloride (16f) or thiophene-2-carbonyl chloride (16g, entries 5 – 6). Zinc 
intermediate 13a underwent various Negishi cross-couplings97 with 4-iodoanisole (16h) or ethyl 
4-iodobenzoate (16i) using 2 mol% Pd(OAc)2 and 4 mol% SPhos98, leading to the desired products 
14h – i in 76 – 87% yield (entries 7 and 8).  
 
Scheme 30: 8 mmol scale-up for the in situ trapping metalation of 1,2-dicyanobenzene (11a).  
The scale-up of these in situ trapping metalations in flow is readily performed and does not require 
further optimization. It is realized by simply extending the collection time of the metalated species in 
batch. Thus, the flow metalation of 1,2-dicyanobenzene (11a) was performed on a 8 mmol scale for the 
Negishi cross-coupling97 with 4-iodo-1,2-dimethylbenzene (16j, 2 mol% Pd(OAc)2, 4 mol% SPhos,98 
Scheme 30) leading to the biphenyl 14j in 77% yield. In addition, a 10 mmol scale-up for the reaction 
of the zincated 1,2-dicyanobenzene (13a) with iodine (16a) led to 14a in 87% yield.  
 
Scheme 31: Continuous flow setup for the in situ trapping procedure of related functionalized benzonitriles 11b 
and 11c. 
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Table 5: Related functionalized benzonitriles of type 15 obtained via an in situ trapping procedure in continuous 
flow using ZnCl2 and subsequent trapping with an electrophile (E+) in batch.  
Entry Benzonitrile Electrophile (E+) Product/Yield[a] 
 
 
 
 
1 11b 16a 15a: 79%[b] 
 
 
 
 
2 11b 16b 15b: 88%[c],[d] 
 
 
 
 
3 11b 16h 15c: 80%[d],[e] 
 
 
 
 
4 11c 16a 15d: 82%[b] 
 
 
 
 
5 11c 16c 15e: 58%[c],[d] 
 
 
 
 
6 11c 16h 15f: 80%[d],[e] 
[a] Yield of isolated, analytically pure product. [b] 1.1 equiv. of E+ was used. [c] Obtained in the presence of 
10 mol% CuCN·2LiCl, 0 °C, 2 h. [d] 0.8 equiv. of E+ was used. [e] Obtained using 2 mol% Pd(OAc)2 and 4 mol% 
SPhos, 25 °C, overnight.  
Furthermore, the in situ trapping metalation procedure was extended for the zincation of 
1,3-dicyanobenzene (11b) and 3-methoxybenzonitrile (11c) (Scheme 31). Thus, the treatment of a 
mixture of 1,3-dicyanobenzene (11b, 1.0 equiv.) and ZnCl2 (0.5 equiv.) with TMPLi (1.5 equiv.) under 
flow conditions (5.0 mL min−1, −78 °C, 45 s) led to a regioselective lithiation of 11b in 2-position, 
giving after transmetalation with ZnCl2 the corresponding diarylzinc reagent (13b), which was 
quenched with iodine (16a), providing the desired product 15a in 79% yield (Table 5, entry 1). A 
copper-catalyzed allylation96 with 3-bromocyclohex-1-ene (16b) provided the 2-allylated 
1,3-dicyanobenzene (15b) in 88% yield (entry 2). Pd-catalyzed Negishi cross-coupling97 
(2 mol% Pd(OAc)2 and 4 mol% SPhos98) with 4-iodoanisole (16h) furnished the arylated 
1,3-dicyanobenzene (15c) in 80% yield (entry 3). Similiary, 3-methoxybenzonitrile (11c) was 
regioselectively lithiated and transmetalated to the zinc species (13c) in continuous flow (4.0 mL min−1, 
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0 °C, 45 s), and iodinated, allylated, and cross-coupled, leading to the desired products 15d – f in 
58 – 82% yield (entries 4 – 6). 
2.3 Functionalization of 1,2-Dicyano-3-iodobenzene Using Continuous Flow 
The iodinated dicyanobenzene (14a) can be further modified to extend the variety of precursors for 
phthalocyanines. Thus, an iodine-magnesium exchange reaction in continuous flow (1.5 mL min−1, 
25 °C, 20 s) was realized by the reaction of 14a with i-PrMgCl·LiCl (0.9 equiv.).99 Subsequent 
quenching with 1,2-bis(chlorodimethylsilyl)ethane (16k, 0.6 equiv.) produces the desired product 17, 
which could act as an interesting precursor for the synthesis of bridged phthalocyanines (12)100, in 60% 
yield while in batch only 30% was isolated. (Scheme 32).  
 
Scheme 32: Iodine-magnesium exchange by the reaction of 14a with i-PrMgCl∙LiCl. 
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 A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. 
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 a) D. M. Drew, C. C. Leznoff, Synlett 1994, 623; b) C. C. Leznoff, D. M. Drew, Can. J. Chem. 1996, 74, 307. 
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3 Preparation of Polyfunctional Diorgano-Magnesium and -Zinc Reagents 
Using In Situ Trapping Halogen-Lithium Exchange of Highly 
Functionalized (Hetero)aryl Halides in Continuous Flow 
3.1 Introduction 
Organolithiums are key organometallic intermediates in organic synthesis.101 The halogen-lithium 
exchange reaction is a standard preparation of organolithium compounds102  and provides access after 
transmetalation to a broad variety of other useful organometallic species.103 The scope of halogen-
lithium exchange reactions is limited by the presence of sensitive functional groups in these unsaturated 
substrates,102c,103d precluding the presence of an ester, a nitro, an azide or an isothiocyanato group.104 
These drawbacks were avoided to some extent by the use of cryogenic temperatures102c, special 
protecting groups105 or by fast consecutive transmetalations to less reactive organometallics.101f,106 
Continuous flow setups have emerged as a powerful tool for solving synthetic problems.107 Thus, 
Yoshida and others have utilized ultra-fast mixing and precise reaction time control of custom-made 
flow setups for achieving the generation of lithiated arenes bearing ester, isothiocyanate, cyano or nitro 
groups.108 Recently, Knochel and coworkers have shown that the scope of metalations of arenes 
(Ar – H) with a strong base like TMPLi is dramatically increased by performing these metalations in 
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the presence of metallic salts (M – Y).109 The resulting organometallics (Ar – M) are much more stable 
than the initially generated lithium reagents and can be broadly functionalized with a variety of 
electrophiles (E+). The scope and reaction conditions of this in situ trapping procedure are further 
improved by switching from a batch to a continuous flow setup (Scheme 33a).110 Aware of the fast rate 
of the halogen-lithium exchange,111 an analogous in situ trapping exchange procedure was envisioned 
(Scheme 33b). Herein, a halogen-lithium exchange performed in the presence of metallic salts for the 
convenient functionalization of sensitive (hetero)arenes using continuous flow technology is reported 
(Scheme 33b). 
 
Scheme 33: (a) In situ trapping metalation and (b) in situ trapping exchange using commercially available 
continuous flow setups.  
3.2 Optimization of Reaction Conditions 
First, the reaction conditions of the bromine-lithium exchange for 4-bromobenzonitrile (18a) using 
n-BuLi as exchange reagent were optimized (Table 6). Optimized flow conditions without the addition 
of a metal salt led after quenching with allyl bromide (21a, 2.5 equiv.) and CuCN·2LiCl112 (10 mol%) 
to the allylated arene 20a in 17% GC-yield (entry 1). This low yield may be due to the competitive 
addition of the newly generated aryllithium or n-BuLi to the cyano group. Addition of the well-soluble 
MgCl2·LiCl to the aryl bromide 18a and further optimization of the flow rate, reaction time and 
temperature led to the magnesiated species 19a and increased the GC-yield of the allylated product 20a 
to 85% (entries 2 – 7). Instead of MgCl2·LiCl, also ZnCl2 or CuCN·2LiCl were used as in situ 
transmetalating agents leading to 20a in 71 – 82% GC-yield (entries 8 – 9). To confirm the order of 
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exchange and transmetalation the metal salts (M – Y) were premixed with n-BuLi in batch at −78 °C 
for 20 min. The resulting zinc- or magnesium base was injected in flow using the established conditions. 
In the case of the zinc species no reaction occurred (entry 10)113 and in the case of the magnesium 
species only 26% GC-yield of the allylated arene 20a were obtained (entry 11) confirming the reaction 
order of the halogen-lithium exchange with n-BuLi and subsequent transmetalation with the premixed 
metal salt. 
Table 6: Optimization of the in situ trapping bromine-lithium exchange for 4-bromobenzonitrile (18a) using 
n-BuLi as exchange reagent leading to allylated benzonitrile 20a. 
 
Entry 
 
M–Y 
(equiv.) 
n-BuLi 
equiv. 
Temperature 
[°C] 
Flow rate 
[mL min−1] 
Time 
[s] 
Yield of 20a 
[%][a] 
1 – 1.5 0 6.0 2.50 17 
2 MgCl2·LiCl (1.1) 1.5 0 6.0 2.50 57 
3 MgCl2·LiCl (0.5) 1.1 0 6.0 2.50 62 
4 MgCl2·LiCl (0.5) 1.5 0 1.0 15.0 68 
5 MgCl2·LiCl (0.5) 1.5 0 16.0 0.94 78 
6 MgCl2·LiCl (0.5) 1.5 25 6.0 2.50 38 
7 MgCl2·LiCl (0.5) 1.5 0 6.0 2.50 85 
8 ZnCl2 (0.5) 1.5 0 6.0 2.50 82 
9 CuCN·2LiCl (1.1) 1.5 0 6.0 2.50 71 
10 ZnCl2 (0.5)[b] 1.5 0 6.0 2.50 0 
11 MgCl2·LiCl (0.5)[b] 1.5 0 6.0 2.50 26 
[a] GC-yield determined using dodecane as an internal standard. [b] Metallic salt M – Y mixed with n-BuLi in 
batch at −78 °C and then injected in flow.  
3.3 In Situ Trapping Halogen-Lithium Exchange on Sensitive Substrates 
The intermediate magnesium species 19a was used in various quenching reactions with electrophiles. 
Thus, an iodolysis led to aryl iodide 20b in 70% isolated yield (Table 7, entry 1). The addition of 
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diarylmagnesium 19a to benzaldehyde (21c) provided benzylic alcohol 20c in 83% yield (entry 2). 
Batch acylation of the magnesium reagent 19a in the presence of CuCN·2LiCl with acyl chlorides such 
as 3-chlorobenzoyl chloride (21d) and pivaloyl chloride (21e) led to the expected ketones 20d and e in 
85% and 78% yield (entries 3 – 4). Alternatively, an in situ trapping bromine-lithium exchange in the 
presence of CuCN·2LiCl (instead of MgCl2·LiCl) produced arylcopper 19b which reacted similarly 
with benzoyl chloride (21f) providing benzophenone 20f in 80% yield (entry 5). The range of substrates 
was extended to various other sensitive bromobenzonitriles 18b and 18c which were converted in a 
comparable way to the corresponding diarylmagnesium species (19c and 19d) under appropriate 
conditions (0 °C, 9 mL min−1, 1.7 s). Thus, after batch-quenching with ketones, allyl bromides or acyl 
chlorides in the presence of CuCN·2LiCl the corresponding products 20g – l were obtained in 68 – 78% 
yield (entries 6 – 11).  
Table 7: In situ exchange transmetalation for sensitive aryl iodides and bromides of type 18 leading via 
intermediate diorganozincs or -magnesiums of type 19 to polyfunctional arenes of type 20. 
Entry Metal species  [T, flow rate, t] Electrophile (E
+) Product/Yield[a] 
 
 
 
 
1 19a (0 °C, 6 mL min−1, 2.5 s)[b] 21b[c] 20b: 83% 
 
 
 
 
2 19a (0 °C, 6 mL min−1, 2.5 s)[b] 21c[d] 20c: 70% 
 
 
 
 
3 19a (0 °C, 6 mL min−1, 2.5 s)[b] 21d[e],[f] 20d: 85% 
 
 
 
 
4 19a (0 °C, 6 mL min−1, 2.5 s)[b] 21e[e],[f] 20e: 78% 
 
 
 
 
5 19b (0 °C, 6 mL min−1, 2.5 s)[b] 21f[f] 20f: 80% 
 
 
 
 
6 19c (0 °C, 9 mL min−1, 1.7 s)[b] 21g[d] 20g: 73% (d.r. = 84:16) 
 
 
 
 
7 19c (0 °C, 9 mL min−1, 1.7 s)[b] 21h[d] 20h: 70% 
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Table 7 continued 
 
 
 
 
8 19c (0 °C, 9 mL min−1, 1.7 s)[b] 21i[g] 20i: 68% 
 
 
  
9 19c (0 °C, 9 mL min−1, 1.7 s)[b] 21j[e],[f] 20j: 78% 
 
 
 
 
10 19d (0 °C, 9 mL min−1, 1.7 s)[b] 21h[d] 20k: 74% 
 
 
  
11 19d (0 °C, 9 mL min−1, 1.7 s)[b] 21j[d] 20l: 74% (76%)[h] 
 
 
 
 
12 19e (0 °C, 9 mL min−1, 1.7 s)[i] 21k[g] 20m: 80% 
 
 
 
 
13 19f (0 °C, 12 mL min−1, 25 s)[b] 21l[e],[f] 20n: 68% 
 
 
 
 
14 19f (0 °C, 12 mL min−1, 25 s)[b] 21d[e],[f] 20o: 56% 
 
 
  
15 19f (0 °C, 12 mL min−1, 25 s)[b] 21m[e],[f] 20p: 67% 
 
 
 
 
16 19f (0 °C, 12 mL min−1, 25 s)[b] 21n[e],[f] 20q: 61% 
[a] Yield of analytically pure isolated product. [b] Metal species prepared from the corresponding aryl bromide. 
[c] 2.0 equiv., 10 min, 25 °C. [d] 1.1 – 1.5 equiv., 1 – 2 h, 0 °C. [e] 1.1 equiv. CuCN·2LiCl was added. 
[f] 1.5 equiv., 1 – 2 h, 0 °C. [g] 2.5 equiv., 10 mol% CuCN·2LiCl, 30 min, 0 °C. [h] Reaction performed on 
10 mmol scale, 3 h, 0 °C. [i] Metal species prepared from the corresponding aryl iodide. 
While most examples were performed on a 0.5 mmol scale, these in situ trapping exchange reactions 
can be conveniently scaled up by simply extending the runtime. Thus, benzophenone 20l was prepared 
on a 10 mmol scale in 76% yield (entry 11) without further optimization.114 It was also possible to 
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perform an iodine-lithium exchange on 2-iodobenzonitrile (18d) using similar conditions (0.5 equiv. 
ZnCl2, 0 °C, 6 mL min−1, 2.5 s), providing the diarylzinc species 19e. Allylation with 
3-bromocyclohexene (21k) afforded 1,2-disubstituted benzonitrile 20m in 80% yield (entry 12). 
Remarkably, these exchange reactions proceed at 0 °C in contrast to the standard halogen-lithium 
exchanges in batch which are performed at −78 °C.102,106 Also, electron-rich aryl bromides like 
4-bromoanisole (18e) were in situ transmetalated in the presence of MgCl2·LiCl and quenched with 
various acyl chlorides 21l – n in batch leading to ketones 20n – q in 56 – 68% yield (entries 13 – 16). 
Furthermore, electron-rich aryl bromides 18e and 18f furnished diarylmagnesiums 19f and 19g under 
the established conditions, which after batch-transmetalation with ZnCl2 underwent Negishi cross-
couplings115 with a range of aryl iodides 20b, 21o, and 21p in the presence of Organ’s catalyst 
PEPPSI-i-Pr116 leading to polyfunctional biphenyls 20r – t in 70 – 88% yield (Scheme 34). 
 
Scheme 34: In situ exchange transmetalation and Negishi cross-couplings115 for biphenyl synthesis (20r – t).  
3.4 In Situ Trapping Halogen-Lithium Exchange on Highly Sensitive Substrates 
To further demonstrate the broad applicability of in situ trapping exchange reactions in flow, the 
compatibility of these exchanges with aryl halides bearing challenging functional groups such as an 
ester, a ketone, a nitro, and heterocumulene groups e.g. an azide or isothiocyanate was 
investigated.102 – 106 Notably, only halogen-lithium exchanges of ortho-nitroarenes102,106 and an alkenyl 
iodide containing an aliphatic azide106 at −100 °C under batch conditions are known, as well as several 
flow protocols for ester-, ketone- and nitro-containing arenes applying ultrafast micromixing and 
residence times down to 0.0015 s.108  
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Again, it was found that in the absence of a metal salt 4-iodophenyl azide117 (22a) decomposes 
completely performing the reaction in flow. However, screening of various in situ trapping exchange 
conditions, e.g. addition of soluble metal salts, flow rate and temperature, led to the zincated arene 23a 
and after a batch quench with allyl bromide (21a) to the desired allylated phenyl azide 24a in 72% 
isolated yield (Scheme 35). Scale-up of this reaction from 1 to 5 mmol provided aryl azide 24a in 60% 
yield. The analogous meta-allyl azidobenzene (24b) was obtained in 83% yield (Table 8, entry 1). 
 
Scheme 35: Iodine-lithium exchange in presence of an azide group under various reaction conditions a – c: [a] In 
situ exchange, 0 °C, 2.5 s, 6 mL min−1; 24a: 53% yield. [b] 0 °C, 2.5 s; no salt additive: no product and 
decomposition of reagents. [c] In situ exchange, 40 °C, 1.25 s, 12 mL min−1; 24a: 72% yield (1 mmol); 60% 
(5 mmol).  
Furthermore, nitro-, ketone- and ester-groups were tested because of their pivotal role in organic 
synthesis and well known challenges in organometallic chemistry due to competitive electron transfer 
and nucleophilic addition reactions.104,105 In order to access aryl organometallics with such functional 
groups, the best lithiation exchange reagent was found to be PhLi instead of n-BuLi. Interestingly, also 
with PhLi, the exchange is faster than a competitive transmetalation of PhLi therefore allowing an 
efficient generation of diarylzincs and -magnesiums (23c – h). Thus, bis-(nitroaryl)zincs 
and -magnesiums 23c – f were generated from the corresponding aryl halides 22c – f. Allylation, 
acylation and addition to indole aldehyde 21r or ketone 21h in batch furnished the desired 
functionalized nitro arenes 24c – h in 60 – 93% yield (entries 2 – 7). Similarly, aryl bromide 22g, 
containing a ketone was functionalized by in situ trapping exchange reactions at −40 °C in the presence 
of ZnCl2. Typical quenching conditions led to the allylated products 24i – j from the diarylzinc 23g in 
65 – 78% yield (entries 8 and 9). Furthermore, ethyl 4-iodobenzoate (22h) led to ketones 24k – l and to 
the secondary alcohol 24m via the diarylmagnesium 23h in 70 – 78% (entries 10 – 12). It was further 
possible to perform a bromine-lithium exchange on aryl bromides bearing a para-, meta-, and ortho-
isothiocyanate moiety without subsequent additions to the electrophilic isothiocyanate.104 After various 
copper mediated allylations or acylations,112 the desired products 24n – r were obtained in 60 – 68% 
yield (entries 13 – 17).   
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Table 8: In situ exchange transmetalation for highly sensitive aryl iodides and bromides of type 22 leading via 
intermediate diorganozincs or -magnesiums of type 23 to polyfunctional arenes of type 24. 
Entry Metal species  [T, flow rate, t] Electrophile (E
+) Product/Yield[a] 
 
 
 
 
1 23b (−40 °C, 12 mL min−1, 1.25 s)[b] 21a[c] 24b: 83% 
 
 
 
 
2 23c (−20 °C, 12 mL min−1, 1.25 s)[d] 21k[d] 24c: 93% 
 
 
 
 
3 23c (−20 °C, 12 mL min−1, 1.25 s)[d] 21q[c] 24d: 78% 
 
 
 
 
4 23d (−20 °C, 12 mL min−1, 0.10 s)[d] 21a[c] 24e: 73% 
 
 
 
 
5 23e (−20 °C, 20 mL min−1, 0.06 s)[b] 21r[e] 24f: 60% 
 
 
 
 
6 23e (−20 °C, 20 mL min−1, 0.06 s)[b] 21s[f] 24g: 63% 
 
 
 
 
7 23f (−60 °C, 16 mL min−1, 0.08 s)[b] 21h[e] 24h: 73% 
 
 
 
 
8 23g (−40 °C, 20 mL min−1, 0.06 s)[d] 21k[c] 24i: 78% 
 
 
 
 
9 23g (−40 °C, 20 mL min−1, 0.06 s)[d] 21a[c] 24j: 65% 
 
 
  
10 23h (−40 °C, 16 mL min−1, 0.94 s)[b] 21t[f] 24k: 70% 
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Table 8 continued 
 
 
 
 
11 23h (−40 °C, 16 mL min−1, 0.94 s)[b] 21e[f] 24l: 78% 
 
 
 
 
12 23h (−40 °C, 16 mL min−1, 0.94 s)[b] 21u[e] 24m: 75% 
 
 
 
 
13 23i (−20 °C, 12 mL min−1, 1.25 s)[d] 21v[c] 24n: 68% 
 
 
 
 
14 23j (−60 °C, 18 mL min−1, 0.07 s)[d] 21a[c] 24o: 65% 
 
 
 
 
15 23k (−60 °C, 9 mL min−1, 0.15 s)[d] 21a[c] 24p: 67% 
 
 
  
16 23l (−20 °C, 16 mL min−1, 0.94 s)[d] 21m[f] 24q: 63% 
 
 
  
17 23l (−20 °C, 16 mL min−1, 0.94 s)[d] 21w[f] 24r: 60% 
[a] Yield of analytically pure isolated product. [b] Metal species prepared from the corresponding aryl iodide. 
[c] 2.5 equiv., 10 mol% CuCN·2LiCl, 30 min, 0 °C. [d] Metal species prepared from the corresponding aryl 
bromide. [e] 1.1 – 1.5 equiv., 1 – 2 h, 0 °C. [f] 1.5 equiv., 1.1 equiv. CuCN·2LiCl, 1 – 2 h, 0 °C., 30 min, 0 °C. 
3.5 In Situ Trapping Halogen-Lithium Exchange on Heterocycles 
The preparation of polyfunctional heterocyclic organometallics is of key importance for the 
pharmaceutical and agrochemical industry.118,119 Thus, sulfur- and nitrogen-containing heterocyclic 
halides were subjected to in situ trapping exchange reactions. For instance, 3-bromothiophene (25a) 
was converted to the reactive diheteroarylmagnesium species 26a. Further copper-mediated batch 
acylation112 with 2-bromobenzoyl chloride (21l) led to the heterocyclic bisaryl ketone 27a in 72% yield 
(Table 9, entry 1) and batch addition to ketone 21h led to tertiary alcohol 27b in 77% yield (entry 2).  
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Table 9: In situ exchange transmetalation for highly sensitive aryl iodides and bromides of type 25 leading via 
intermediate diorganozincs or -magnesiums of type 26 to polyfunctional arenes of type 27. 
Entry Metal species [T, flow rate, t] Electrophile (E+) Product/Yield[a] 
 
 
 
 
1 26a (0 °C, 6 mL min−1, 10 s)[b] 21l[c] 27a: 72% 
 
 
 
 
2 26a (0 °C, 6 mL min−1, 10 s)[b] 21h[d] 27b: 77% 
 
 
 
 
3 26b (0 °C, 18 mL min−1, 0.83 s)[e] 21h[d] 27c: 62% 
 
 
 
 
4 26c (0 °C, 6 mL min−1, 53 s)[b] 21a[f] 27d: 63% 
 
 
 
 
5 26d (0 °C, 12 mL min−1, 1.25 s)[b] 21k[f] 27e: 68% 
 
 
 
 
6 26e (−40 °C, 16 mL min−1, 0.08 s)[e] 21a[f] 27f: 70% 
 
 
 
 
7 26f (−40 °C, 20 mL min−1, 0.06 s)[e] 21e[c] 27g: 68% 
 
 
  
8 26g (−20 °C, 9 mL min−1, 1.7 s)[e] 21x[c] 27h: 72% 
 
 
 
 
9 26g (−20 °C, 9 mL min−1, 1.7 s)[e] 21l[c] 27i: 63% 
 
 
 
 
10 26g (−20 °C, 9 mL min−1, 1.7 s)[e] 21y[d] 27j: 59% 
[a] Yield of analytically pure isolated product. [b] Metal species prepared from the corresponding aryl bromide. 
[c] 1.5 equiv., 1.1 equiv. CuCN·2LiCl, 1 – 2 h, 0 °C. [d] 1.1 equiv., 1 – 2 h, 0 °C. [e] Metal species prepared from 
the corresponding aryl iodide. [f] 2.5 equiv., 10 mol% CuCN·2LiCl, 30 min, 0 °C. 
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To expand the range of substrates, different pyridines and pyrimidines were subjected successfully to 
the bromine-lithium exchange. Thus, pyridine derivatives 25b and 25c underwent the in situ trapping 
exchange (entries 3 – 4). Quenching of the bispyridyl-zinc and -magnesium reagents 26b and 26c in 
batch led to the tertiary alcohol 27c and allylated picoline 27d in 62 – 63% yield (entries 3 – 4). 
Furthermore, 5-bromopyrimidine (25d) and the fully substituted iodopyrimidines such as 25e and 25f 
were transmetalated in situ using short reaction times (0.06 – 1.25 s) at −40 to 0 °C (entries 4 – 10). By 
using PhLi, an ester was tolerated providing the allylated and acylated112 pyrimidines 27e and 27f in 
68 – 70% yield (entries 6 – 7). Interestingly, uracil derived, electron-rich iodopyrimidine 25f underwent 
an efficient exchange using the same method and the reactive metal species 26g was quenched with 
different benzoyl chlorides 21x and 21l and aldehyde 21y in subsequent batch reactions leading to 
benzophenones 27h and 27i and alcohol 27j in 59 – 72% yield (entries 8 – 10). 
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4 Sodiation of Arenes and Heteroarenes in Continuous Flow 
4.1 Introduction 
The functionalization of aromatics and heteroaromatics is a central synthetic task especially for the 
elaboration of pharmaceuticals and agrochemicals.120 Lithium bases have been extensively used for the 
metalation of (hetero)arenes and offer broad synthetic possibilities for their subsequent 
functionalization.121 In addition, other milder magnesium and zinc bases have been developed in order 
to achieve a higher functional group tolerance allowing the preparation of polyfunctional aromatics.122 
In the course of these studies, it was realized by Yoshida,123 Knochel124 and others125 that a high 
compatibility with sensitive functional groups can be achieved by performing these metalations under 
flow conditions.126 Such setups have multiple advantages, such as mild reaction conditions (ambient 
temperature metalations), short reaction times and scale-ups without the need of further optimization.127 
In contrast to the use of lithium bases, corresponding sodium bases have not received great attention 
due to the ionic C – Na bond and poor solubility. Since sodium is ca. 1500 times more abundant than 
lithium in the earth crust and lithium demand and prices are increasing in recent years,128 the use of 
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sodium compounds is certainly underexploited in organic synthesis. Already, Schlosser and Mordini,129 
Mulvey,130 and Mioskowski131 have demonstrated the high potential of sodium organometallic 
chemistry. Recently, Collum132 reported sodiations of aromatic and heterocyclic substrates using 
sodium diisopropylamide (NaDA) as a soluble highly reactive base in dimethylethylamine (DMEA) at 
cryogenic temperatures.  
Herein, the first sodiation of arenes and heteroarenes of type 28 in a microflow reactor setup producing 
a broad range of aryl- and heteroaryl-sodium intermediates of type 29 is reported. These organosodium 
reagents react instantly in batch with various electrophiles (E+) of type 30 forming functionalized arenes 
and heteroarenes of type 31 (Scheme 36). The scope of this sodiation in flow is significantly broader 
compared to batch reactions. 
 
Scheme 36: General setup for the sodiation of arenes and heteroarenes of type 28 with NaDA in a microflow 
reactor and subsequent trapping with electrophiles in batch.  
4.2 Optimization of Reaction Conditions 
NaDA was prepared according to a slightly modified procedure by Collum using less equivalents of 
sodium in DMEA and diluted to a 0.2 M solution.132b,133 This concentration was ideal for sodiation 
performed in flow avoiding any precipitation. The reaction conditions were optimized with 
1,3-dichlorobenzene (28a) as a substrate. The sodiated intermediate 29a was instantly quenched with 
iodine in batch at 0 °C. Conversion and product yield were determined by gas chromatography (GC) 
using an internal standard. Using a flow rate of 10 mL min−1, it was possible to achieve full sodiation 
of 28a within 0.5 s at −20 °C (Table 10, entry 4), compared to batch sodiation at −78 °C.132b While the 
                                                     
129
 a) M. Stähle, R. Lehmann, J. Kramar, M. Schlosser, Chimia 1985, 39, 229; b) M. Schlosser, J. Hartmann, M. 
Stähle, J. Kramar, A. Walde, A. Mordini, Chimia 1986, 40, 306; c) A. Mordini, M. Schlosser, Chimia 1986, 40, 
309.  
130
 a) P. C. Andrews, N. D. R. Barnett, R. E. Mulvey, W. Clegg, P. A. O’Neil, D. Barr, L. Cowton, A. J. Dawson, 
B. J. Wakefield, J. Organomet. Chem. 1996, 518, 85; b) J. A. Garden, D. R. Armstrong, W. Clegg, J. Garcia-
Alvarez, E. Hevia, A. R. Kennedy, R. E. Mulvey, S. D. Robertson, L. Russo, Organometallics. 2013, 32, 5481; 
c) A. J. Martínez-Martínez, A. R. Kenneddy, R. E. Mulvey, C. T. O’Hara, Science 2014, 346, 834. 
131
 A. Gissot, J.-M. Becht, J. R. Desmurs, V. Pévère, A. Wagner, C. Mioskowski, Angew. Chem. Int. Ed. 2002, 
41, 340. 
132
 a) Y. Ma, R. F. Algera, D. B. Collum, J. Org. Chem. 2016, 81, 11312; b) R. F. Algera, Y. Ma, D. B. Collum, 
J. Am. Chem. Soc. 2017, 139, 15197; c) R. F. Algera, Y. Ma, D. B. Collum, J. Am. Chem. Soc. 2017, 139, 7921; 
d) R. F. Algera, Y. Ma, D. B. Collum, J. Am. Chem. Soc. 2017, 139, 11544.  
133
 See experimental part for optimized preparation of NaDA.  
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flow rate did not have an effect on the yield (entry 6), changing the reactor diameter during the reaction 
led to more efficient mixing and thus better yields (entry 4 – 5). A longer reactor (0.25 mL, entry 1) or 
higher temperatures (0 °C, entry 2) led to decomposition of the starting material and low product yields. 
Using higher concentrations of NaDA and 1,3-dichlorobenzene (28a) led to blockage of the reactor 
during the reaction (entry 3). Changing the solvent for NaDA from DMEA to PMDTA led to a lower 
GC-yield of 72% (entry 7). Solubility of NaDA in trimethylamine was not high enough to conduct the 
sodiation (entry 8).  
Table 10: Optimization of flow conditions for the sodiation of 1,3-dichlorobenzene (28a) 
 
Entry Base/solvent (equiv.) 
Flow Conditions 
(temperature, flow rate, reactor size) Result 
1 NaDA in DMEA (0.21 M, 1.2 equiv.) 
0 °C, 10 mL min−1 
0.25 mL reactor Decomposition 
2 NaDA in DMEA (0.21 M, 1.05 equiv.) 
0 °C, 10 mL min−1 
0.08 mL reactor with changing diameter 30% GC-yield 
3 NaDA in DMEA (0.50 M, 1.05 equiv.) 
−20 °C, 10 mL min−1 
0.08 mL reactor with changing diameter Blockage 
4 NaDA in DMEA (0.21 M, 1.05 equiv.) 
−20 °C, 10 mL min−1 
0.08 mL reactor with changing diameter 
89% GC-yield 
(84% isolated yield) 
5 NaDA in DMEA (0.21 M, 1.05 equiv.) 
−20 °C, 10 mL min−1 
0.08 mL reactor 84% GC-yield 
6 NaDA in DMEA (0.21 M, 1.2 equiv.) 
−20 °C, 16 mL min−1 
0.08 mL reactor with changing diameter 89% GC-yield 
7 NaDA in PMDTA (0.21 M, 1.05 equiv.) 
−20 °C, 10 mL min−1 
0.08 mL reactor with changing diameter 72% GC-yield 
8 NaDA in Et3N – Solubility not high enough 
4.3 Sodiation of Arenes and Heteroarenes 
2,6-Dichlorophenylsodium (28a) was quenched in batch with iodine (30a) at 0 °C providing aryl iodide 
31a in 84% isolated yield (Table 11, entry 1). Similarly, 29a was quenched in batch with benzaldehyde 
(30b), PPh2Cl (30c, followed by the addition of sulfur), phenylisocyanate (30d), and 
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S-(4-fluorophenyl)benzene-sulfonothioate (30e) affording the expected products 31b – e in 64 – 95% 
yield (entries 2 – 5). Remarkably, no benzyne formation was observed under these flow conditions. In 
addition, substitution reactions (Wurtz-Fittig-couplings) were examined.134 Whereas the use of an allylic 
bromide such as cyclohexenyl bromide (30f) required copper-catalysis,135 methyl iodide (30g) and 
n-butyl bromide (30h) reacted at −40 °C instantly in the absence of any transition metal catalyst with 
the in flow generated arylsodium 29a affording the cross-coupling products 31f – h in 53 – 75% yield 
(entries 6 – 8). 
Table 11: Sodiation of 1,3-dichlorobenzene (28a) using a microflow reactor and subsequent batch quench of the 
intermediate organosodium 29a with various electrophiles of type 30 leading to functionalized dichlorobenzenes 
of type 31. 
 
Entry Electrophile (E+) Product[a] Entry Electrophile (E+) Product[a] 
 
 
 
 
 
 
1 30a[b] 31a: 84% 5 30e[b] 31e: 75% 
 
 
 
 
 
 
2 30b[c] 31b: 95% 6 30f[e] 31f: 75% 
 
 
 
 
 
 
3 30c[d] 31c: 74% 7 30g[f] 31g: 53% 
 
 
 
 
 
 
4 30d[b] 31d: 64% 8 30h[g] 31h: 53% 
[a] Yield of analytically pure isolated product. [b] 2.5 equiv. E+. [c] 1.5 equiv. E+. [d] 2.5 equiv. PPh2Cl, then 
10.0 equiv. S8, overnight. [e] 5 mol% CuCN·2LiCl, 2.5 equiv. E+. [f] 5.0 equiv. E+. [g] 10 equiv. E+. 
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Furthermore, related arenes bearing chloro-, iodo-, fluoro- or trifluoromethyl-substituents were 
subjected to the optimized flow conditions. Thus, 1,3-difluorobenzene (28b) was sodiated at −40 °C 
providing the corresponding arylsodium 29b which was subsequently quenched in batch with 
furan-2-carbaldehyde (30i) providing alcohol 31i in 88% yield (Table 12, entry 1). Alternatively, 
arylsodium 29b was trapped with benzoyl chloride (30j) in the absence of any transition metal catalyst 
leading to benzophenone derivate 31j in 71% yield (entry 2). Flow-sodiation of 2-fluoroiodobenzene 
(28c) and subsequent quench with aldrithiol (30k) led to the corresponding thioether 31k in 62% yield 
(entry 3). In addition, trifluoromethyl-substituted arene 28d was sodiated at −40 °C and quenched with 
5-bromonicotinaldehyde (30l) leading to alcohol 31l in 85% yield (entry 4).  
Table 12: Sodiation of arenes and heteroarenes of type 28 leading via intermediate organosodiums of type 29 to 
polyfunctional arenes and heteroarenes of type 31. 
Entry Substrate  (sodiation temperature) Electrophile (E
+) Product[a] 
 
 
 
 
1 28b (−40 °C) 30i[b] 31i: 88% 
 
 
 
 
2 28b (−40 °C) 30j[c] 31j: 71% 
 
 
 
 
3 28c (−40 °C) 30k[c] 31k: 62% 
 
 
 
 
4 28d (−40 °C) 30l[b] 31l: 85% 
 
 
 
 
5 28e (−20 °C) 30a[c] 31m: 53% 
 
 
 
 
6 28e (−20 °C) 30m[c] 31n: 89% 
 
 
 
 
7 28f (−40 °C) 30n[b] 31o: 68% 
[a] Yield of analytically pure isolated product. [b] 1.5 equiv. E+. [c] 2.5 equiv. E+. 
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Furthermore, the optimized flow conditions were applied to the sodiation of heteroarenes. Thus, 
2-chloropyridine (28e) was sodiated in flow at convenient conditions (−20 °C, 0.5 s at a flow rate of 
10 mL min−1; compared to −78 °C in batch) and the intermediate 2-chloro-3-pyridyl sodium (29e) was 
subsequently trapped with iodine (30a) and dibutyl disulfide (30m) leading to the functionalized 
pyridines 31m and 31n in 53 – 89% yield (entries 5 – 6). Trifluoromethyl-substituted pyridine 28f was 
sodiated in flow and trapped with aldehyde 30n yielding the secondary alcohol 31o in 68% yield 
(entry 7). 
4.4 Sodiation of Sensitive Arenes and Heteroarenes 
This flow sodiation procedure extends considerably the reaction scope of such metalations and applies 
to sensitive substrates that decompose under batch sodiation conditions.132b,136 Thus, for example, 2-
chloropyrazine (28g) cannot be sodiated in batch with NaDA at −78 °C, however under optimized flow 
conditions (−78 °C, 0.5 s using a flow rate of 10 mL min−1) a complete consumption of the starting 
material takes place affording after iodolysis the pyrazine 31p in 65% yield (Scheme 37). 
 
Scheme 37: Sodiation of sensitive heteroarene 2-chloropyrazine (28g) in a microflow reactor and under batch 
conditions and subsequent trapping with iodine (30a) leading to functionalized heteroarene 31p or decomposition.  
In addition to 2-chloropyrazine (28g), 2-fluoropyrazine (28h) and substituted pyridines 28i and 28j that 
decompose upon batch sodiation were successfully sodiated under flow conditions and trapped with 
aldehydes 30o – r yielding functionalized heteroarenes 31q – t in 65 – 97% yield (Table 13, 
entries 1 – 4). Copper-catalyzed135 batch allylation under flow-conditions of sodiated 2-iodothiophene 
(28k) led to functionalized thiophene 31u in 76% yield (entry 5). At −60 °C it was possible to sodiate 
2-bromofluorbenzene (28l) without aryne-formation. Instant reaction of the sodiated intermediate 29l 
with dimethyldisulfide (30s) or benzaldehydes 30t and 30b furnished functionalized arenes 31v – x in 
70 – 81% yield (entries 6 – 8). 
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Table 13: Sodiation of sensitive arenes and heteroarenes of type 28 leading via intermediate organosodiums of 
type 29 to polyfunctional arenes and heteroarenes of type 31. 
Entry Substrate  (sodiation temperature) Electrophile (E
+) Product[a] 
 
 
 
 
1 28g (−78 °C) 30o[b] 31q: 79% 
 
 
  
2 28h (−60 °C) 30p[b] 31r: 97% 
 
 
 
 
3 28i (−78 °C) 30q[b] 31s: 65% 
 
  
 
4 28j (−78 °C) 30r[b] 31t: 77% 
 
 
 
 
5 28k (−78 °C) 30f[c] 31u: 76% 
 
 
 
 
6 28l (−60 °C) 30s[d] 31v: 70% 
 
 
 
 
7 28l (−60 °C) 30t[b] 31w: 80% 
 
 
 
 
8 28l (−60 °C) 30b[b] 31x: 81% 
[a] Yield of analytically pure isolated product. [b] 1.5 equiv. E+. [c] 5 mol% CuCN·2LiCl, 2.5 equiv. E+. 
[d] 2.5 equiv. E+. 
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Addition of organometallics to ketones is always subject to side reactions.137138 Remarkably, the in flow 
generated sodium derivatives of type 29 underwent reactions with ketones of type 32, leading to tertiary 
alcohols of type 33. Thus, polyfunctional arenes and heteroarenes 33a – l were obtained in up to 91% 
yield (Scheme 38). 
 
Scheme 38: Sodiation of (hetero)arenes of type 28 and subsequent batch quench with ketones of type 32 leading 
to tertiary alcohols of type 33.  
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Noteworthy, sodiation of 4-fluorobenzonitrile 34 at −78 °C led to the desired sodium arene 35 without 
the attack at the nitrile functionality. To inhibit double metalation 0.9 equiv. of NaDA were used as the 
limiting reagent. Batch quench of sodiated intermediate 35 with benzaldehyde (30b), ketone 32n and 
disulfide 30k led instantly to functionalized benzonitriles 36a – c in 75 – 81% yield (Scheme 39). 
Additionally, a scale-up139 was possible without any further optimization by simply extending the 
running time. Thus, a scale-up by factor 30 was conducted and functionalized benzonitrile 36a was 
obtained in 76% yield (Scheme 39). 
 
Scheme 39: Sodiation of highly sensitive 4-fluorobenzonitrile (34) and subsequent batch quench with 
electrophiles yielding functionalized benzonitriles 36a – c. 
4.5 Sodiation of Acrylonitriles 
Finally, the attention was turned to the sodiation of α,ȕ-unsaturated nitrile derivatives as these 
compounds are useful building blocks for the synthesis of natural products and heterocycles.140 Using 
the established flow conditions it was possible to sodiate acrylonitriles of type 37 without 
polymerization or other side reactions. Thus, cinnamonitrile (37a) and methoxyacrylonitrile (37b) were 
sodiated at −78 °C in 0.5 s in flow. The sodiated intermediates 38a – b were subsequently quenched 
with aldehydes yielding functionalized acrylonitriles 39a – b in 70 – 93% yield and high selectivity up 
to E:Z < 1:99 (Scheme 39).141 
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Scheme 40: Flow-sodiation of a) cinnamonitrile (37a) and b) methoxyacrylonitrile (37b) and subsequent batch 
quench with aldehydes yielding functionalized acrylonitriles 39.   
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5 Summary 
This work focused on exploiting the advantages of continuous flow setups for sensitive organometallic 
reactions. First, unsymmetrical azobenzenes were metalated with TMPLi under mild conditions (0 °C, 
20 s) without attack of the nitrogen-nitrogen double bond. For sensitive azobenzenes, in situ trapping 
metalations using TMPLi in the presence of ZnCl2 or MgCl2·LiCl provided the metalated intermediate 
which could subsequently be quenched with various electrophiles, affording functionalized 
azobenzenes that are important building blocks for photoswitches. In addition, 1,2-dicyanobenzene and 
related benzonitriles were metalated with TMPLi in the presence of ZnCl2 under convenient flow 
conditions (0 °C, 20 s). Whereas scaling up the reaction in batch proved to be difficult, under flow 
conditions a scale-up was possible without any need of further optimization. Furthermore, the concept 
of in situ trapping metalations was successfully transferred to an in situ trapping halogen-lithium 
exchange. Under flow conditions it was possible to tolerate highly sensitive moieties such as 
isothiocyanats, nitriles, azides and nitro groups at temperatures up to 0 °C which decompose under 
batch halogen-lithium exchange conditions. Finally, a flow procedure for the sodiation of (hetero)arenes 
and acrylonitriles using the diethylmethylamine soluble base sodium diisopropylamide was developed. 
Using precise time control and efficient mixing in continuous flow, (hetero)arenes and acrylonitriles 
which decompose under batch sodiation conditions were sodiated and subsequently quenched with a 
variety of electrophiles, providing after workup functionalized (hetero)arenes and acrylonitriles. This 
sodiation procedure offers an alternative to commonly used lithiation strategies.  
5.1 Selective Lithiation, Magnesiation and Zincation of Unsymmetrical Azobenzenes Using 
Continuous Flow 
A general method for the late-stage-functionalization of unsymmetrical azobenzenes in continuous flow 
was developed. Methoxy-substituted azobenzenes could be metalated at convenient conditions (0 °C, 
20 s) using TMPLi (Scheme 41a), while for azobenzenes containing more sensitive functional groups 
an in situ trapping metalation using ZnCl2 or MgCl2·LiCl was very effective (Scheme 41b). The 
metalated azobenzenes reacted with a variety of electrophiles, providing functionalized azobenzenes in 
high yields. A simple scale-up was possible without further optimization of the reaction conditions. It 
was demonstrated, that even a highly functionalized tetra-ortho-chloro azobenzene that is of interest for 
the preparation of elaborate photopharmaceuticals could be further functionalized by this in situ 
trapping procedure.  
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Scheme 41: a) Metalation and b) in situ trapping metalation of unsymmetrical azobenzenes at mild conditions 
using continuous flow.  
5.2 Selective Zincation of 1,2-Dicyanobenzene and Related Benzonitriles in Continuous Flow 
Using In Situ Trapping Metalations 
 
Scheme 42: In situ trapping metalation of 1,2-dicyanobenzene (11a) in continuous flow providing polyfunctional 
benzonitriles (14).  
A general continuous flow method for the functionalization of 1,2-dicyanobenzene and related 
benzonitriles using in situ trapping metalations with TMPLi in the presence of ZnCl2 under convenient 
conditions (0 °C, 20 s) was developed (Scheme 42). The resulting zinc organometallics were trapped 
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with various classes of electrophiles, providing functionalized benzonitriles in high yields. A simple 
scale-up was possible without further optimization of the reaction conditions. The reaction scope of 
these in situ trapping metalations in flow is broader and needs less equivalents of the base and the metal 
salt than the batch procedures.  
5.3 Preparation of Polyfunctional Diorgano-Magnesium and –Zinc Reagents using In Situ 
Trapping Halogen-Lithium Exchange of Highly Functionalized (Hetero)aryl Halides in 
Continuous Flow 
The concept of in situ trapping metalations was successfully transferred to an in situ trapping halogen-
lithium exchange. The exchange was performed using n-butyllithium or phenyllithium on a broad range 
of bromo- or iodo(hetero)arenes in the presence of various metal salts (ZnCl2, MgCl2·LiCl, 
CuCN·2LiCl) in a commercially available continuous flow setup. The resulting diarylmetal species 
were trapped with various electrophiles, resulting in the formation of polyfunctional (hetero)arenes in 
high yields (Scheme 43). This method enabled the functionalization of (hetero)arenes containing highly 
sensitive moieties such as an isothiocyanate, nitro, azide or ester group. A straightforward scale-up was 
possible without further optimization.  
 
Scheme 43: In situ trapping halogen-lithium exchange for highly sensitive (hetero)aryl halides leading via 
intermediate diorganozinc or diorganomagnesium species to polyfunctional (hetero)arenes. [a] 1.1 equiv. 
CuCN·2LiCl was used, leading to the monoarylcopper intermediate.  
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5.4 Sodiation of Arenes and Heteroarenes in Continuous Flow 
The first sodiation in continuous flow of arenes and heteroarenes using the in diethylmethylamine 
soluble base sodium diisopropylamide was developed. This procedure allows sodiation of arenes and 
heteroarenes containing sensitive functional groups that decompose under batch-sodiation conditions. 
Sodiated intermediates reacted instantly with various electrophiles leading to polyfunctional 
(hetero)arenes in high yields. A scale-up was possible without further optimization. As lithium demand 
and prices have increased in the past years, this method offers an alternative to the commonly used and 
extensively researched lithium bases.  
 
Scheme 44: Sodiation of arenes and heteroarenes in continuous flow using the in DMEA soluble base NaDA.  
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1 General Considerations 
Metalations and in situ trapping metalations with TMPLi and NaDA were carried out with a FlowSyn 
system purchased from Uniqsis. In situ trapping halogen-lithium exchange reactions were carried out 
with a FlowSyn system purchase from Uniqsis or with an E-series easy Medchem systems purchased 
from Vapourtec. Reactor sizes and diameters are specified in the relevant typical procedures. Carrier 
solvents as well as reactant solutions were stored under argon. Quench reactions with electrophiles were 
carried out under batch conditions with magnetic stirring and in flame-dried glassware under argon. 
Syringes which were used to transfer anhydrous solvents or reagents were purged with argon prior to 
use. Yields refer to isolated yields of compounds estimated to be >95% pure as determined by 1H-NMR 
(25 °C) and capillary GC. 
1.1 Solvents 
Solvents were dried according to standard procedures by distillation over drying agents as stated below 
and stored under argon. Otherwise they were obtained from commercial sources and used without 
further purification.  
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and then stored over molecular sieves. 
n-hex was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen.  
DMPU was heated to reflux for 14 h over CaH2 and distilled from CaH2.  
DMEA was heated to reflux for 1 h over sodium benzophenone ketyl and freshly distilled under argon 
and stored under argon.  
Solvents for column chromatography were distilled prior to use. 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. Liquid aldehydes and acyl chlorides were distilled prior to use.  
n-BuLi solution in hexane was purchased from Albemarle and the concentration was determined by 
titration against 1,10-phenanthroline in THF with i-PrOH.142 
PhLi solution in dibutyl ether was purchased from Sigma Aldrich and the concentration was determined 
by titration against 1,10-phenanthroline in THF with i-PrOH.142 
                                                     
142
 H.-S. Lin, A. Paquette, Synth. Commun. 1994, 24, 2503. 
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i-Pr2NH was heated to reflux for 14 h over CaH2, distilled and stored under argon.  
TMPH was distilled prior to use and stored under argon.  
i-PrMgCl·LiCl solution in THF was obtained from Albemarle. 
CuCN∙2LiCl143 solution (1.00 M in THF) was prepared by drying CuCN (8.96 g, 100 mmol) and LiCl 
(8.48 g, 200 mmol) in a Schlenk-flask under vacuum for 5 h at 150 °C. After cooling to 25 °C, dry THF 
(100 mL) was added and stirred until the salts were dissolved. 
ZnCl2 solution (1.00 M in THF) was prepared by drying ZnCl2 (27.3 g, 200 mmol) in a Schlenk-flask 
under vacuum for 5 h at 150 °C. After cooling to 25 °C, dry THF (200 mL) was added and stirred until 
the salts were dissolved.  
MgCl2∙LiCl solution (0.5 M in THF) was prepared by drying LiCl (4.24 g, 100 mmol) in a Schlenk-
flask equipped with a magnetic stirrer and a septum under vacuum for 5 h at 150 °C. After cooling to 
25 °C Mg turnings (2.55 g, 105 mmol) and THF (200 mL) were added. 1,2-Dichloroethane (9.90 g, 
100 mmol, 7.92 mL) was added dropwise over 1 h. The reaction mixture was stirred at 25 °C until gas 
evolution was complete. 
TMPLi solution in THF was prepared by slow addition of n-BuLi (4 mL, 10 mmol, 2.5 M in hexane) 
to a solution of TMPH (1.7 mL, 10 mmol) in THF (10 mL) at −40 °C and stirred for 30 min at −40 °C. 
The concentration was determined by titration against N-benzylbenzamide in THF. The solution was 
warmed to 0 °C before use. The solution could be stored for one day at −40 °C. 
Azobenzenes were prepared according to literature procedures.144. 
NaDA solution (1.00 M in DMEA) was prepared according to a slightly modified procedure reported 
by Collum.145 It was demonstrated that a quantity reduction of sodium dispersion did not influence the 
concentration of resulting NaDA solution. Sodium dispersion (5 mL, 58.3 mmol, 30 wt% in toluene, 
<0.1 mm particle size) was washed with dry DMEA (3×2 mL). Then, dry DMEA (14.4 mL) and dry 
diisopropylamine (4.2 mL, 29.8 mmol) were added. After cooling the solution to 0 °C, isoprene 
(1.52 mL, 15.0 mmol) was added dropwise and the solution was allowed to warm to room temperature 
over 2 h. The concentration of the resulting yellow NaDA solution was determined by titration with 
diphenyl acetic acid. Prior to use the solution was diluted to a concentration close to 0.2 M.  
1.3 Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040 – 0.063 mm, 230 – 400 mesh 
ASTM) from Merck. 
                                                     
143
 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
144
 E. Merino, Chem. Soc. Rev. 2011, 40, 3835. 
145
 F. R. Algera, Y. Ma, D. B. Collum, J. Am. Chem. Soc. 2017, 139, 15197.  
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Thin layer chromatography was performed using aluminum plates covered with SiO2 (Merck 60, 
F-254). The chromatograms were examined under UV light at 254 nm and/or by staining of the TLC 
plate with one of the solutions given below followed by heating with a heat gun: 
- KMnO4 stain: KMnO4 (3.0 g), K2CO3 (20 g), 5% NaOH solution (5 mL), water (300 mL).  
- Seebach’s stain (aka “Magic”): Phosphomolybdic acid (2.5 g), Ce(SO4)2 (1.0 g), conc. H2SO4 (6 mL), 
H2O (94 mL). 
- Neat iodine absorbed on silica gel.  
1.4 Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 400 S 
and BRUKER AMX 600 instruments in CDCl3. Chemical shifts are reported as δ-values in parts per 
million (ppm) relative to the residual solvent peak CDCl3 (δH: 7.26; δC: 77.16) or CD3CN (δH: 1.94; 
δC: 118.26 and 1.32). Abbreviations for signal coupling are as follows: s, singlet; d, doublet; t, triplet; 
q, quartet; m, multiplet; br, broad. If not otherwise noted, the coupling constants given are H-H-coupling 
constants for proton signals and C-F-coupling constants for carbon signals. Due the photochemical 
properties of azobenzenes, the NMR spectra contain mixtures of trans- and cis-isomers. The ratio is 
reported in the analytical section for each compound. The ratio can be altered by irradiation of the 
compound with light at specific wavelengths or thermal relaxation to the trans-isomer in the dark.  
High resolution Mass spectroscopy (HR-MS) electron impact ionization (EI) and low resolution (MS) 
spectra were recorded on a FINNIGAN MAT 95Q instrument. EI was conducted with an electron 
energy of 70 eV. Electrospray ionization (ESI) spectra were recorded on a FINNIGAN LTQ FTICR 
instrument.  
Gas chromatography (GC) was performed on machines of the types Hewlett-Packard 6890 or 5890 
Series II (Hewlett Packard, 5% phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film 
thickness: 0.25 ȝm). The detection was accomplished using a flame ionization detector.  
Infrared spectra (IR) were recorded from 4500 cm−1 to 650 cm−1 on a PERKIN ELMER Spectrum 
BX-59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II Diamond ATR sensor 
was used. Samples were measured neat. The absorption bands are reported in wavenumbers (cm−1). 
Melting points (M.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
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2 Selective Lithiation, Magnesiation and Zincation of Unsymmetrical 
Azobenzenes Using Continuos Flow 
2.1 Typical Procedures (TP) 
 
Scheme 45: General flow setup for the selective lithiation, magnesiation and zincation of unsymmetrical 
azobenzenes.  
Typical Procedure for the lithiation of methoxy-substituted azobenzenes in flow followed by the 
reaction with an electrophile in batch (TP 1): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.54 – 0.64 M in dry THF, 2.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.22 – 0.26 M in dry THF, 1.0 equiv.). The solutions were simultaneously injected 
into separate THF streams (pump A and B, flow rates: 1.50 mL min−1), which passed a pre-cooling loop 
(vol.pre = 1 mL, residence time: 40 s, 0 °C) respectively, before they were mixed in a coiled reactor 
(vol.R = 1 mL, residence time: t1 = 20 s, T1 = 0 °C). The combined streams were collected in a flame-
dried, argon flushed 25 mL flask equipped with a magnetic stirrer and a septum containing the 
electrophile (0.7 – 2.0 equiv.) dissolved in dry THF (1 mL). Then the reaction mixture was further 
stirred for the indicated time (t2) at the indicated temperature (T2). The completion of the reaction was 
checked by GC analysis of reaction aliquots quenched with sat. aq. NH4Cl solution and using dodecane 
or hexadecane as an internal standard. 
Typical Procedure for the in situ trapping metalation with ZnCl2 of unsymmetrical azobenzenes 
in flow followed by the reaction with an electrophile in batch (TP 2): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.30 – 0.61 M in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.20 – 0.41 M in dry THF containing 0.5 equiv. of ZnCl2, 1.0 equiv.). The solutions 
were simultaneously injected into separate THF streams (pump A and B, flow rates: 1.50 mL min−1), 
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which passed a pre-cooling loop (vol.pre = 1 mL, residence time: 40 s, 0 °C) respectively, before they 
were mixed in a coiled reactor (vol.R = 1 mL, residence time: 20 s, 0 °C). The combined streams were 
collected in a flame-dried, argon flushed 25 mL flask equipped with a magnetic stirrer and a septum 
containing the electrophile (0.8 – 2.0 equiv.) dissolved in dry THF (1 mL). Then the reaction mixture 
was further stirred for the indicated time (t2) at the indicated temperature (T2). The completion of the 
reaction was checked by GC-analysis of reaction aliquots quenched with sat. aq. NH4Cl solution and 
using dodecane or hexadecane as an internal standard. 
Typical Procedure for the in situ trapping metalation with MgCl2·LiCl of unsymmetrical 
azobenzenes in flow followed by the reaction with an electrophile in batch (TP 3): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.52 – 0.59 M in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.35 – 0.39 M in dry THF containing 0.5 equiv. of MgCl2·LiCl, 1.0 equiv.). The 
solutions were simultaneously injected into separate THF streams (pump A and B, flow rates: 
1.50 mL min−1), which passed a pre-cooling loop (vol.pre = 1 mL, residence time: 40 s, 0 °C) 
respectively, before they were mixed in a coiled reactor (vol.R = 1 mL, residence time: t1 = 20 s, 
T1 = 0 °C). The combined streams were collected in a flame-dried, argon flushed 25 mL flask equipped 
with a magnetic stirrer and a septum containing the electrophile (0.8 equiv.) dissolved in dry THF 
(1 mL). Then the reaction mixture was further stirred for the indicated time (t2) at the indicated 
temperature (T2). The completion of the reaction was checked by GC-analysis of reaction aliquots 
quenched with sat. aq. NH4Cl solution and using dodecane or hexadecane as an internal standard. 
Typical Procedure for the scale-up of the in situ trapping metalation of unsymmetrical 
azobenzenes in flow followed by the reaction with an electrophile in batch (TP 4): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 6.0 mL) was loaded with TMPLi (0.58 M 
in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 6.0 mL) was loaded with the reactant solution 
(0.39 M in dry THF containing 0.5 equiv. ZnCl2, 1.0 equiv.). The solutions were simultaneously injected 
into separate THF streams (pump A and B, flow rates: 1.50 mL min−1), which passed a pre-cooling loop 
(vol.pre = 1 mL, residence time: 40 s, 0 °C) respectively, before they were mixed in a coiled reactor 
(vol.R = 1 mL, residence time: t1 = 20 s, T1 = 0 °C). The combined streams were collected in a flame-
dried, argon flushed 250 mL flask equipped with a magnetic stirrer and a septum containing the 
electrophile (2.0 – 3.0 equiv.) dissolved in dry THF (10 mL). After 4 min, the injection loops were 
reloaded with the reactant solution and TMPLi, injected into the separate THF streams again and 
collected in the same flask as well. The number of reloads was depending on the desired reaction scale. 
Then the reaction mixture was further stirred for the indicated time (t2) at the indicated temperature 
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(T2). The completion of the reaction was checked by GC analysis of reaction aliquots quenched with 
sat. aq. NH4Cl solution and using dodecane or hexadecane as an internal standard. 
2.2 Preparation of the Products 
(E)-1-(3-Iodo-4-methoxyphenyl)-2-phenyldiazene (5a) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.22 M, 1.0 equiv., 1 mL) and TMPLi (0.54 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask containing iodine (4a, 122 mg, 
0.44 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min at 
25 °C before it was quenched with sat. aq. Na2S2O3 solution (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, 
i-hex:DCM = 19:1) afforded 5a as a red solid (41 mg, 0.12 mmol, 55%). 1H-NMR analysis indicated 
that the sample contains a 10:1.0 mixture of trans- and cis-isomers. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.41 (d, J = 2.3 Hz, 1H), 7.97 (dd, J = 8.7, 2.3 Hz, 1H), 
7.90 – 7.85 (m, 2H), 7.53 – 7.48 (m, 2H), 7.47 – 7.44 (m, 1H), 6.94 (d, J = 8.7 Hz, 1H), 3.97 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 160.2, 152.6, 147.7, 132.6, 130.9, 129.2, 126.7, 122.9, 110.4, 
86.7, 56.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3067, 2937, 2838, 1586, 1564, 1476, 1436, 1388, 1307, 1270, 
1251, 1169, 1133, 1070, 1040, 1014, 921, 895, 813, 765, 688, 666. 
MS (EI, 70 eV): m/z (%) = 339 (13), 338 (100), 261 (36), 233 (79), 218 (17), 203 (15), 105 (11), 78 
(17), 77 (53), 76 (17), 63 (13). 
HRMS (EI): m/z calcd. for [C13H11IN2O]: 337.9916, found 337.9911 (M+). 
M.p. (°C): 88.5 – 89.2. 
(E)-1-(4-Iodo-3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)diazene (5b) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(3,5-dimethoxyphenyl)-
2-(4-methoxyphenyl)diazene (2b, 0.26 M, 1.0 equiv., 1 mL) and TMPLi (0.64 M, 2.5 equiv., 1 mL). 
After injection and metalation the combined streams were collected in a flask containing iodine (4a, 
132 mg, 0.52 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 
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10 min at 25 °C before it was quenched with sat. aq. Na2S2O3 solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex:DCM = 9:1) afforded 5b as a yellow-orange solid (76 mg, 0.19 mmol, 73%). 1H-NMR 
analysis indicated that the sample contains a 15:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (d, J = 9.1 Hz, 2H), 7.10 (s, 2H), 7.02 (d, J = 9.1 Hz, 2H), 
3.99 (s, 6H), 3.89 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.5, 159.9, 154.5, 146.8, 125.0, 114.4, 98.5, 80.4, 56.8, 
55.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3001, 2954, 2934, 2908, 2832, 2168, 2158, 1726, 1601, 1585, 
1499, 1466, 1399, 1321, 1244, 1220, 1212, 1180, 1117, 1031, 1017, 967, 931, 894, 834, 791, 723, 653. 
MS (EI, 70 eV): m/z (%) = 399 (14), 398 (100), 262 (10), 135 (22), 107 (44), 92 (11), 77 (12). 
HRMS (EI): m/z calcd. for [C15H15IN2O3]: 398.0127; found 398.0124 (M+). 
M.p. (°C): 80.1 – 82.1. 
(E)-1-(2-Iodo-3-methoxyphenyl)-2-phenyldiazene (5c') and (E)-1-(4-iodo-3-methoxyphenyl)-2-
phenyldiazene (5c'') 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(3-methoxyphenyl)-2-
phenyldiazene (2c, 0.22 M, 1.0 equiv., 1 mL) and TMPLi (0.56 M, 2.5 equiv., 1 mL). After injection 
and metalation, which was carried out at −20 °C in this case, the combined streams were collected in a 
flask containing iodine (4a, 112 mg, 0.44 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction 
mixture was stirred for further 10 min at 25 °C before it was quenched with sat. aq. Na2S2O3 solution 
(15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were 
dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash 
column chromatography (silica gel, i-hex:DCM = 4:1) afforded 5c' and 5c'' in a ratio of 74:26 as two 
orange solids (44 mg, 0.13 mmol, 59%). 
(E)-1-(2-Iodo-3-methoxyphenyl)-2-phenyldiazene (5c') 
 
1H-NMR analysis indicated that the sample contains a 3:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.07 – 8.01 (m, 2H), 7.61 – 7.48 (m, 3H), 7.39 (t, J = 8.0 Hz, 
1H), 7.30 – 7.22 (m, 1H), 6.92 (dd, J = 8.0, 1.4 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.3, 153.2, 152.5, 131.7, 129.6, 129.3, 123.7, 112.5, 110.2, 
94.5, 56.9. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3058, 3013, 2976, 2940, 1577, 1565, 1457, 1424, 1297, 1264, 
1184, 1150, 1100, 1057, 1015, 1003, 930, 873, 851, 782, 705, 684. 
MS (EI, 70 eV): m/z (%) = 339 (14), 338 (93), 233 (12), 218 (22), 203 (27), 106 (17), 105 (49), 78 (20), 
77 (100), 76 (21), 71 (11), 57 (11), 51 (17), 44 (18), 43 (44). 
HRMS (EI): m/z calcd. for [C13H11IN2O]: 337.9916; found 337.9910 (M+). 
M.p. (°C): 101.6 – 103.3. 
(E)-1-(4-Iodo-3-methoxyphenyl)-2-phenyldiazene (5c'') 
 
1H-NMR analysis indicated that the sample contains a 5:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.95 (d, J = 8.1 Hz, 1H), 7.96 – 7.89 (m, 2H), 7.56 – 7.48 (m, 
3H), 7.39 (d, J = 2.0 Hz, 1H), 7.34 (dd, J = 8.1, 2.0 Hz, 1H), 4.00 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.9, 154.0, 152.6, 139.9, 131.5, 129.3, 123.1, 118.8, 103.3, 
89.9, 56.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3094, 3041, 2977, 2919, 2849, 1901, 1571, 1484, 1463, 1386, 
1304, 1261, 1245, 1188, 1124, 1073, 1034, 1012, 1000, 982, 928, 860, 828, 772, 757, 685, 672. 
M.p. (°C): 100.5 – 101.0. 
(E)-1-(3-(Butylthio)-4-methoxyphenyl)-2-phenyldiazene (5d) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.24 M, 1.0 equiv., 1 mL) and TMPLi (0.59 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask at 0 °C containing Bu2S2 (4b, 34 mg, 
0.19 mmol, 0.8 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min at 
0 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex) 
afforded 5d as red oil (48 mg, 0.16 mmol, 83%). 1H-NMR analysis indicated that the sample contains 
a 6.4:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 – 7.85 (m, 3H), 7.78 (dd, J = 8.6, 2.3 Hz, 1H), 7.52 – 7.43 
(m, 3H), 6.96 (d, J = 8.7 Hz, 1H), 3.98 (s, 3H), 3.00 (t, J = 7.4 Hz, 2H), 1.71 (quint, J = 7.4 Hz, 2H), 
1.52 (sext, J = 7.4 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.0, 152.9, 147.2, 130.6, 129.2, 127.5, 123.2, 122.7, 120.8, 
110.1, 56.4, 31.3, 30.9, 22.3, 13.8. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3068, 2956, 2930, 2871, 2860, 2734, 2558, 1574, 1474, 1435, 
1394, 1304, 1268, 1244, 1169, 1134, 1059, 1020, 954, 919, 876, 810, 764, 687, 662. 
MS (EI, 70 eV): m/z (%) = 301 (11), 300 (64), 196 (11), 195 (100), 139 (11), 77 (56). 
HRMS (EI): m/z calcd. for [C17H20N2OS]: 300.1296; found 300.1296 (M+). 
(E)-1-(4,6-Dimethoxy-[1,1'-biphenyl]-3-yl)-2-phenyldiazene (5e) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.25 M, 1.0 equiv., 1 mL) and TMPLi (0.62 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask containing ZnCl2 (0.28 mL, 1.0 M in 
THF, 0.28 mmol, 1.1 equiv.), 4-bromoanisole (4c, 33 mg, 0.175 mmol, 0.7 equiv.), Pd(dba)2 (5.8 mg, 
4 mol%) and DavePhos (7.9 mg, 8 mol%) dissolved in THF (1 mL). The reaction mixture was stirred 
overnight at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex) afforded 5e as an orange solid (35 mg, 0.11 mmol, 63%). 1H-NMR analysis indicated that 
the sample contains a 9:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.97 – 7.87 (m, 4H), 7.56 – 7.44 (m, 5H), 7.09 (d, J = 8.6 Hz, 
1H), 7.02 – 6.95 (m, 2H), 3.91 (s, 3H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.1, 153.0, 147.0, 131.1, 130.8, 130.5, 130.3, 129.2, 129.2, 
124.7, 124.5, 122.7, 113.7, 111.2, 56.1, 55.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3068, 3001, 2937, 2836, 1609, 1595, 1516, 1486, 1463, 1440, 
1420, 1398, 1262, 1248, 1179, 1125, 1071, 1030, 1024, 907, 833, 769, 690. 
MS (EI, 70 eV): m/z (%) = 319 (22), 318 (87), 317 (12), 214 (20), 213 (100), 198 (34), 182 (12), 155 
(10), 127 (10), 77 (25). 
HRMS (EI): m/z calcd. for [C20H18N2O2]: 318.1368; found 318.1360 (M+). 
M.p. (°C): 91.9 – 92.9. 
(E)-2'-Methoxy-N,N-dimethyl-5'-(phenyldiazenyl)-[1,1'-biphenyl]-4-amine (5f) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.25 M, 1.0 equiv., 1 mL) and TMPLi (0.62 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask containing ZnCl2 (0.26 mL, 1.0 M in 
THF, 0.26 mmol, 1.1 equiv.), 4-bromo-N,N-dimethylaniline (4d, 34 mg, 0.17 mmol, 0.7 equiv.), 
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Pd(dba)2 (5.5 mg, 4 mol%) and DavePhos (7.6 mg, 8 mol%) dissolved in THF (1 mL). The reaction 
mixture was stirred overnight at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). 
The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were dried over 
anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash column 
chromatography (silica gel, i-hex:DCM = 9:1) afforded 5f as a brown solid (39 mg, 0.12 mmol, 69%). 
1H-NMR analysis indicated that the sample contains a 10:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.98 (d, J = 2.5 Hz, 1H), 7.93 – 7.87 (m, 3H), 7.55 – 7.49 (m, 
4H), 7.45 – 7.42 (m, 1H), 7.08 (d, J = 8.8 Hz, 1H), 6.84 – 6.80 (m, 2H), 3.91 (s, 3H), 3.01 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.2, 153.0, 150.0, 147.0, 131.5, 130.4, 130.4, 129.1, 125.7, 
124.5, 123.8, 122.7, 112.3, 111.1, 56.0, 40.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3329, 2934, 2834, 1599, 1584, 1500, 1463, 1406, 1320, 1243, 
1204, 1134, 1105, 1029, 1003, 940, 874, 840, 819, 765, 689. 
MS (EI, 70 eV): m/z (%) = 332 (23), 331 (100), 330 (10), 227 (12), 226 (65), 77 (14). 
HRMS (EI): m/z calcd. for [C21H21N3O]: 331.1685; found 331.1681 (M+). 
M.p. (°C): 105.6 – 108.1. 
(E)-Ethyl 2'-methoxy-5'-(phenyldiazene)-[1,1'-biphenyl]-4-carboxylate (5g) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.24 M, 1.0 equiv., 1 mL) and TMPLi (0.59 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask at 0 °C containing ZnCl2 (0.26 mL of a 
1.0 M in THF, 0.26 mmol, 1.1 equiv.) and stirred for 15 min. Then ethyl 4-bromo-benzoate (4e, 44 mg, 
0.19 mmol, 0.8 equiv.), Pd(dba)2 (5.5 mg, 4 mol%) and DavePhos (7.6 mg, 8 mol%) dissolved in THF 
(1 mL). The reaction mixture was stirred overnight at 25 °C before it was quenched with sat. aq. NH4Cl 
solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions 
were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by 
flash column chromatography (silica gel, i-hex:DCM = 9:1) afforded 5g as an orange solid (56 mg, 
0.16 mmol, 83%). 1H-NMR analysis indicated that the sample contains a 11:1.0 mixture of trans- and 
cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.15 – 8.10 (m, 2H), 8.02 – 7.97 (m, 2H), 7.92 – 7.87 (m, 2H), 
7.70 – 7.64 (m, 2H), 7.54 – 7.48 (m, 2H), 7.48 – 7.44 (m, 1H), 7.14 – 7.10 (m, 1H), 4.42 (q, J = 7.1 Hz, 
2H), 3.91 (s, 3H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.7, 159.0, 152.8, 147.0, 142.6, 130.7, 130.4, 129.7, 129.4, 
129.4, 129.2, 125.4, 124.9, 122.8, 111.4, 61.1, 56.1, 14.5. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3058, 2964, 2837, 1708, 1597, 1575, 1490, 1481, 1459, 1452, 
1367, 1336, 1271, 1260, 1240, 1224, 1178, 1099, 1017, 930, 863, 824, 766, 689, 662. 
MS (EI, 70 eV): m/z (%) = 360 (100), 283 (96), 255 (49), 165 (32), 100 (22). 
HRMS (EI): m/z calcd. for [C22H20N2O3]: 360.1474; found 360.1479 (M+). 
M.p. (°C): 135.3 – 136.7. 
The structure was confirmed by Single-Crystal X-Ray diffraction studies. For detailed information see 
Crystallographic Data section. 
(E)-(2-Methoxy-5-(phenyldiazenyl)phenyl)(phenyl)methanol (5h) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(4-methoxyphenyl)-2-
phenyldiazene (2a, 0.24 M, 1.0 equiv., 1 mL) and TMPLi (0.60 M, 2.5 equiv., 1 mL). After injection 
and metalation the combined streams were collected in a flask at 0 °C containing benzaldehyde (4f, 
20 mg, 0.19 mmol, 0.8 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 
5 h at 0 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was extracted 
with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, 
and the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, 
i-hex:EtOAc = 7:3) afforded 5h as an orange solid (35 mg, 0.11 mmol, 58%). 1H-NMR analysis 
indicated that the sample contains a 7.4:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 (d, J = 2.4 Hz, 1H), 7.93 – 7.86 (m, 3H), 7.52 – 7.43 (m, 
5H), 7.38 – 7.32 (m, 3H), 7.30 – 7.24 (m, 1H), 6.99 (d, J = 8.8 Hz, 1H), 6.14 (s, 1H), 4.69 (s, 1H), 3.87 
(s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.0, 152.9, 147.0, 143.1, 132.9, 130.5, 129.1, 128.4, 127.5, 
126.8, 124.3, 122.7, 122.3, 110.9, 72.0, 55.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3064, 3031, 2939, 2837, 1597, 1486, 1453, 1439, 1419, 1303, 
1250, 1180, 1154, 1098, 1072, 1021, 965, 923, 832, 816, 759, 751, 736, 688, 668, 660. 
MS (EI, 70 eV): m/z (%) = 319 (23). 318 (100), 316 (10), 213 (22), 211 (11), 197 (12), 196 (13), 195 
(86), 180 (15), 165 (31), 153 (12), 152 (16), 107 (18), 105 (16), 79 (11), 77 (55), 44 (11). 
HRMS (EI): m/z calcd. for [C20H18N2O2]: 318.1368; found 318.1362 (M+). 
M.p. (°C): 54.5 – 56.8. 
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(E)-1-(4-Allyl-3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)diazene (5i) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(3,5-dimethoxyphenyl)-
2-(4-methoxyphenyl)diazene (2b, 0.25 M, 1.0 equiv., 1 mL) and TMPLi (0.63 M, 2.5 equiv., 1 mL). 
After injection and metalation the combined streams were collected in a flask containing containing 
allyl bromide (4g, 24 mg, 0.2 mmol, 0.8 equiv.) and CuCN·2LiCl solution (0.03 mL, 1.0 M in THF, 
10 mol%) dissolved in THF (1 mL). The reaction mixture was stirred 1 h at 25 °C before it was 
quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), 
the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was 
removed in vacuo. Purification by flash column chromatography (silica gel, i-hex: DCM = 19:1) 
afforded 5i as an orange solid (57 mg, 0.18 mmol, 90%). 1H-NMR analysis indicated that the sample 
contains a 34:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.92 (d, J = 9.0 Hz, 2H), 7.16 (s, 2H), 7.02 (d, J = 9.0 Hz, 2H), 
6.05 – 5.89 (m, 1H), 5.03 – 4.91 (m, 2H), 3.92 (s, 6H), 3.90 (s, 3H), 3.51 – 3.42 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.1, 158.6, 152.5, 147.1, 136.4, 124.8, 119.4, 114.4, 114.4, 
98.9, 56.1, 55.7, 27.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3078, 2996, 2963, 2926, 2835, 1634, 1597, 1581, 1500, 1461, 
1404, 1343, 1292, 1253, 1209, 1136, 1078, 1029, 1001, 910, 840, 832, 818, 799, 788, 723. 
MS (EI, 70 eV): m/z (%) = 312 (27), 177 (18), 135 (41), 108 (10), 107 (100), 92 (15), 77 (28). 
HRMS (EI): m/z calcd. for [C18H20N2O3]: 312.1474; found 312.1461 (M+). 
M.p. (°C): 89.2 – 91.0. 
(E)-1-(2,6-Dimethoxy-4-((4-methoxyphenyl)diazenyl)phenyl)propan-2-ol (5j) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(3,5-dimethoxyphenyl)-
2-(4-methoxyphenyl)diazene (2b, 0.24 M, 1.0 equiv., 1 mL) and TMPLi (0.59 M, 2.5 equiv., 1 mL). 
After injection and metalation the combined streams were collected in a flask at 0 °C containing 
propylene oxide (4h, 11 mg, 0.19 mmol, 0.8 equiv.) and CuI (4.6 mg, 10 mol%) dissolved in THF 
(1 mL). The reaction mixture was stirred overnight at 25 °C before it was quenched with sat. aq. NH4Cl 
solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions 
were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by 
flash column chromatography (silica gel, i-hex:EtOAc:MeOH = 8:1.5:0.5) afforded 5j as a red solid 
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(49 mg, 0.15 mmol, 78%). 1H-NMR analysis indicated that the sample contains a 5.1:1.0 mixture of 
trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.92 (d, J = 8.8 Hz, 2H), 7.17 (s, 2H), 7.02 (d, J = 8.8 Hz, 2H), 
4.06 (sept, J = 6.7 Hz, 1H), 3.92 (s, 6H), 3.90 (s, 3H), 3.00 – 2.83 (m, 2H), 1.23 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.2, 158.9, 152.6, 147.0, 124.8, 118.2, 114.4, 98.8, 68.6, 
56.0, 55.7, 33.0, 23.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3328, 3068, 3042, 2931, 2886, 2835, 1712, 1610, 1598, 1592, 
1485, 1463, 1441, 1406, 1251, 1322, 1260, 1241, 1202, 1123, 1039, 1022, 940, 923, 840, 818, 765, 
689. 
MS (EI, 70 eV): m/z (%) = 330 (43), 287 (10), 286 (57), 285 (100), 135 (26), 107 (54), 77 (18). 
HRMS (EI): m/z calcd. for [C18H22N2O4]: 330.1568; found 330.1568 (M+). 
M.p. (°C): 108.1 – 108.5. 
(E)-1-(4-Methoxyphenyl)-2-(2,4',6-trimethoxy-[1,1'-biphenyl]-4-yl)diazene (5k) 
 
According to TP 1, injection loop A and B were loaded with solutions of (E)-1-(3,5-dimethoxyphenyl)-
2-(4-methoxyphenyl)diazene (2b, 0.25 M, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 2.5 equiv., 1 mL). 
After injection and metalation the combined streams were collected in a flask containing ZnCl2 
(0.28 mL, 1.0 M in THF, 0.28 mmol, 1.1 equiv.), 4-bromoanisole (4c, 37 mg, 0.20 mmol, 0.8 equiv.), 
Pd(dba)2 (5.8 mg, 4 mol%) and DavePhos (7.9 mg, 8 mol%) dissolved in THF (1 mL). The reaction 
mixture was stirred overnight at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). 
The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were dried over 
anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash column 
chromatography (silica gel, i-hex) afforded 5k as an orange solid (68 mg, 0.18 mmol, 90%). 1H-NMR 
analysis indicated that the sample contains only the trans-isomer. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.98 – 7.92 (m, 2H), 7.38 – 7.32 (m, 2H), 7.25 (s, 2H), 
7.05 – 7.01 (m, 2H), 7.00 – 6.96 (m, 2H), 3.90 (s, 3H), 3.85 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.2, 158.7, 158.2, 153.1, 147.1, 132.1, 125.8, 124.9, 121.3, 
114.4, 113.4, 99.2, 56.2, 55.7, 55.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3000, 2934, 2837, 1595, 1582, 1500, 1460, 1396, 1322, 1295, 
1243, 1141, 1123, 1106, 1030, 998, 830, 790, 757, 725, 698, 659. 
MS (EI, 70 eV): m/z (%) = 379 (33), 378 (100), 282 (15), 244 (13), 243 (19), 207 (21), 135 (35), 107 
(80), 77 (24), 73 (28), 44 (23), 43 (26). 
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HRMS (EI): m/z calcd. for [C22H22N2O4]: 378.1580; found 378.1573 (M+). 
M.p. (°C): 152.4 – 153.9. 
(E)-1-(4-Fluoro-3-iodophenyl)-2-phenyldiazene (8a) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.40 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.60 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing iodine (4a, 203 mg, 0.80 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction 
mixture was stirred for further 10 min at 25 °C before it was quenched with sat. aq. Na2S2O3 solution 
(15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were 
dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash 
column chromatography (silica gel, i-hex) afforded 8a as an orange solid (111 mg, 0.34 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.37 – 8.32 (m, 1H), 7.97 – 7.92 (m, 1H), 7.92 – 7.89 (m, 2H), 
7.55 – 7.48 (m, 3H), 7.23 – 7.19 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.2 (d, J = 250.9 Hz), 152.4, 150.0 (d, J = 3.3 Hz), 133.1 
(d, J = 2.5 Hz), 131.6, 129.3, 126.0 (d, J = 8.0 Hz), 123.1, 116.0 (d, J = 25.5 Hz), 82.0 (d, J = 27.5 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3062, 1700, 1654, 1577, 1507, 1474, 1463, 1445, 1386, 1241, 
1166, 1116, 1030, 922, 893, 823, 766, 686, 668. 
MS (EI, 70 eV): m/z (%) = 326 (43), 249 (12), 221 (41), 105 (50), 94 (64), 78 (11), 77 (100), 51 (40), 
50 (16). 
HRMS (EI): m/z calcd. for [C12H8FIN2]: 325.9716; found 325.9711 (M+). 
M.p. (°C): 59.6 – 60.7. 
(E)-1-(3-Bromo-4-fluoro-5-iodophenyl)-2-phenyldiazene (8b) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(3-bromo-4-
fluorophenyl)-2-phenyldiazene (6b, 0.40 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi 
(0.60 M, 1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were 
collected in a flask containing iodine (4a, 203 mg, 0.80 mmol, 2.0 equiv.) dissolved in THF (1 mL). 
The reaction mixture was stirred for further 10 min at 25 °C before it was quenched with sat. aq. 
Na2S2O3 solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. 
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Purification by flash column chromatography (silica gel, i-hex) afforded 8b as a light orange solid 
(121 mg, 0.30 mmol, 75%). 1H-NMR analysis indicated that the sample contains a 25:1.0 mixture of 
trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.28 (dd, J = 5.3, 2.3 Hz, 1H), 8.13 (dd, J = 6.0, 2.3 Hz, 1H), 
7.92 – 7.88 (m, 2H), 7.55  –  7.50 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.4 (d, J = 249.5 Hz), 152.1, 149.8 (d, J = 4.0 Hz), 133.3 
(d, J = 1.7 Hz), 132.0, 129.4, 128.2, 123.3, 109.3 (d, J = 25.5 Hz), 82.0 (d, J = 28.9 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3074, 3055, 1562, 1470, 1449, 1437, 1387, 1306, 1253, 1166, 
1158, 1144, 1022, 887, 874, 785, 767, 726, 696, 684, 661. 
MS (EI, 70 eV): m/z (%) = 406 (25), 404 (21), 301 (13), 299 (15), 105 (47), 42 (100). 
HRMS (EI): m/z calcd. for [C12H7FBrIN2]: 403.8821; found 403.8818 (M+). 
M.p. (°C): 108.2 – 109.2. 
(E)-1-(2-Fluoro-3-iodophenyl)-2-phenyldiazene (8c) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(2-fluorophenyl)-2-
phenyldiazene (6c, 0.38 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.56 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation, which for this case was carried out at 
−20 °C for 60 seconds, the combined streams were collected in a flask containing iodine (4a, 203 mg, 
0.80 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min at 
25 °C before it was quenched with sat. aq. Na2S2O3 solution (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex) 
afforded 8c as an orange solid (81 mg, 0.25 mmol, 66%). 1H-NMR analysis indicated that the sample a 
67:1.0 mixture of trans- and cis-isomers.  
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00 – 7.92 (m, 2H), 7.89 – 7.81 (m, 1H), 7.75 – 7.68 (m, 1H), 
7.57 – 7.50 (m, 3H), 7.00 (td, J = 8.0, 1.1 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.1 (d, J = 256.3 Hz), 152.8, 141.5 (d, J = 1.8 Hz), 141.1 
(d, J = 9.1 Hz), 132.0, 129.3, 126.0 (d, J = 4.5 Hz), 123.4, 118.3, 83.0 (d, J = 24.4 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3062, 1888, 1694, 1586, 1574, 1487, 1449, 1301, 1291, 1231, 
1149, 1070, 1018, 926, 852, 782, 718, 685. 
MS (EI, 70 eV): m/z (%) = 327 (10), 326 (78), 249 (11), 221 (34), 105 (61), 94 (28), 77 (100), 44 (10), 
43 (10). 
HRMS (EI): m/z calcd. for [C12H8FIN2]: 325.9716; found 325.9710 (M+). 
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M.p. (°C): 70.8 – 71.9. 
(E)-2-Iodo-4-(phenyldiazenyl)benzonitrile (8d) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-(4-
phenyldiazenyl)benzonitrile (6d, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi 
(0.61 M, 1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were 
collected in a flask containing iodine (4a, 208 mg, 0.82 mmol, 2.0 equiv.) dissolved in THF (1 mL). 
The reaction mixture was stirred for further 10 min at 25 °C before it was quenched with sat. aq. 
Na2S2O3 solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. 
Purification by flash column chromatography (silica gel, i-hex:DCM = 9:1) afforded 8d as an orange 
solid (113 mg, 0.34 mmol, 83%). 1H-NMR analysis indicated that the sample contains a 14:1.0 mixture 
of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.39 (d, J = 1.8 Hz, 1H), 7.96 (dd, J = 8.2, 1.8 Hz, 1H), 
7.95 – 7.92 (m, 2H), 7.74 (d, J = 8.2 Hz, 1H), 7.56 – 7.53 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.4, 152.3, 135.0, 132.9, 132.8, 129.5, 123.6, 123.5, 121.9, 
119.2, 99.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3083, 2230, 1584, 1558, 1458, 1440, 1374, 1310, 1283, 1254, 
1156, 1145, 1070, 1029, 1020, 926, 892, 836, 769, 685, 668, 652. 
MS (EI, 70 eV): m/z (%) = 333 (40), 228 (19), 105 (33), 101 (15), 77 (100). 
HRMS (EI): m/z calcd. for [C13H8IN2]: 332.9763; found 332.9759 (M+). 
M.p. (°C): 123.1 – 123.9. 
The structure was confirmed by Single-Crystal X-Ray diffraction studies. For detailed information see 
Crystallographic Data section. 
(E)-1-(3-Bromo-4-fluorophenyl)-2-phenyldiazene (8e) 
 
According to TP 4, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.39 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 6 mL) and TMPLi (0.58 M, 
1.5 equiv., 6 mL). After injection and in situ trapping metalation the combined streams were collected 
at 0 °C in a flask containing bromine (4i, 1.79 mL, 35 mmol, 3 equiv.) dissolved in THF (12 mL). This 
procedure was repeated 5 times for a total amount of 11.7 mmol. The reaction mixture was stirred for 
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further 1 h at 0 °C before it was quenched with sat. aq. Na2S2O3 solution (100 mL). The aq. layer was 
extracted with EtOAc (3×150 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex) afforded 8e as an orange solid (2.428 g, 8.7 mmol, 74%). 1H-NMR analysis indicated that 
the sample contains a 13:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.16 (dd, J = 6.5, 2.4 Hz, 1H), 7.91 (m, 3H), 7.56 – 7.49 (m, 
3H), 7.27 (t, J = 8.0 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.6 (d, J = 252.8 Hz), 152.4, 150.0 (d, J = 3.5 Hz), 131.7, 
129.32, 127.1 (d, J = 1.1 Hz), 125.1 (d, J = 7.8 Hz), 123.2 , 117.0 (d, J = 23.7 Hz), 110.2 (d, 
J = 22.6 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3088, 3054, 1590, 1580, 1492, 1476, 1462, 1442, 1388, 1305, 
1252, 1241, 1162, 1156, 1113, 1032, 887, 783, 772, 704, 684. 
MS (EI, 70 eV): m/z (%) = 280 (27), 278 (32), 175 (33), 172 (35), 105 (29), 94 (28), 77 (100), 71 (15), 
57 (23), 43 (13). 
HRMS (EI): m/z calcd. for [C12H8FBrN2]: 277.9855; found 277.9852 (M+). 
M.p. (°C): 80.1 – 81.3. 
(E)-1-(3-Allyl-4-fluorophenyl)-2-phenyldiazene (8f) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask at 0 °C containing allyl bromide (4g, 54 mg, 0.45 mmol, 1.1 equiv.) and CuCN·2LiCl solution 
(0.04 mL, 1.0 M in THF, 10 mol%) dissolved in THF (1 mL). The reaction mixture was stirred for 
further 1 h at 0 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex:Et2O = 100:1) afforded 8f as an orange liquid (84 mg, 0.35 mmol, 85%). 1H-NMR analysis 
indicated that the sample contains a 6.2:1.0 mixture of trans- and cis-isomers.  
scale-up: 
According to TP 4, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.40 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 6 mL) and TMPLi (0.60 M, 
1.5 equiv., 6 mL). After injection and in situ trapping metalation the combined streams were collected 
at 0 °C in a flask containing allyl bromide (4g, 2.904 g, 24 mmol, 2 equiv.) and CuCN·2LiCl solution 
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(1.20 mL, 1.0 M in THF, 10 mol%) dissolved in THF (12 mL). This procedure was repeated 5 times for 
a total amount of 12.0 mmol. The reaction mixture was stirred for further 1 h at 0 °C before it was 
quenched with sat. aq. NH4Cl solution (100 mL). The aq. layer was extracted with EtOAc (3×150 mL), 
the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was 
removed in vacuo. Purification by flash column chromatography (silica gel, i-hex) afforded 8f as an 
orange liquid (2.381 g, 9.91 mmol, 83%).  
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.94 – 7.89 (m, 2H), 7.88 – 7.78 (m, 2H), 7.54 – 7.50 (m, 2H), 
7.49 – 7.46 (m, 1H), 7.17 (t, J = 8.8 Hz, 1H), 6.07 – 5.99 (m, 1H), 5.22 – 5.12 (m, 2H), 3.51 (d, 
J = 7.0 Hz, 2H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 162.7 (d, J = 251.9 Hz), 152.7, 149.2, 135.3, 131.1, 129.2, 
128.1 (d, J = 17.5 Hz),125.4 (d, J = 6.2 Hz), 123.0, 122.9, 117.0, 116.0 (d, J = 23.8 Hz), 33.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3079, 2981, 2915, 1641, 1584, 1485, 1557, 1434, 1266, 1243, 
1108, 1084, 1071, 994, 920, 824, 766, 688, 661. 
MS (EI, 70 eV): m/z (%) = 326 (43), 249 (12), 221 (41), 105 (50), 94 (64), 78 (11), 77 (100), 51 (40), 
50 (16). 
HRMS (EI): m/z calcd. for [C12H8FIN2]: 325.9716; found 325.9711 (M+). 
(E)-1-(6-Fluoro-3',4'-dimethyl-[1,1'biphenyl]-3-yl)-2-phenyldiazene (8g) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing 4-iodo-1,2-dimethylbenzene (4j, 105 mg, 0.45 mmol, 1.1 equiv.), Pd(OAc)2 
(1.8 mg, 2 mol%) and SPhos (6.7 mg, 4 mol%) dissolved in THF (1 mL). The reaction mixture was 
stirred for further 3 h at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. 
layer was extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous 
Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography 
(silica gel, i-hex) afforded 8g as a light orange solid (91 mg, 0.30 mmol, 73%). 1H-NMR analysis 
indicated that the sample contains a 12:1.0 mixture of trans- and cis-isomers. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.07 (dd, J = 7.4, 2.5 Hz, 1H), 7.95 – 7.92 (m, 2H), 7.92 – 7.88 
(m, 1H), 7.56 – 7.52 (m, 2H), 7.51 – 7.47 (m, 1H), 7.43 (s, 1H), 7.39 (d, J = 7.7 Hz, 1H), 7.31 – 7.25 
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13C-NMR (151 MHz, CDCl3): δ / ppm = 161.26 (d, J = 253.6 Hz), 152.46 , 149.13 , 137.83 – 135.26 
(d, J = 19.8 Hz), 132.53 , 130.95 , 130.09 , 129.76 , 129.04 , 126.37 , 125.57 , 122.88 (d, J = 8.9 Hz), 
122.75 , 116.69 (d, J = 24.8 Hz), 19.82 , 19.50. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3061, 3023, 2940, 2920, 2859, 1583, 1481, 1447, 1384, 1248, 
1226, 1156, 1107, 1020, 922, 886, 826, 766, 688, 668. 
MS (EI, 70 eV): m/z (%) = 305 (15), 304 (78), 303 (70), 293 (10), 288 (17), 200 (15), 199 (100), 188 
(11), 184 (46), 183(52), 105(28), 77 (91). 
HRMS (EI): m/z calcd. for [C20H17FN2]: 304.1376; found 304.1368 (M+). 
M.p. (°C): 89.5 – 90.9. 
(E)-1-(6-Fluoro-4’-methoxy-[1,1'-biphenyl]-3-yl)-2-phenyldiazene (8h) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing 4-iodoanisole (4k, 106 mg, 0.45 mmol, 1.1 equiv.), Pd(OAc)2 (1.8 mg, 2 mol%) 
and SPhos (6.7 mg, 4 mol%) dissolved in THF (1 mL). The reaction mixture was stirred for further 3 h 
at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex) 
afforded 8h as an orange solid (95 mg, 0.31 mmol, 76%). 1H-NMR analysis indicated that the sample 
contains a 20:1.0 mixture of trans- and cis-isomers. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.06 (dd, J = 7.4, 2.5 Hz, 1H), 7.96 – 7.92 (m, 2H), 7.90 – 7.87 
(m, 1H), 7.62 – 7.58 (m, 2H), 7.56 – 7.51 (m, 2H), 7.51 – 7.47 (m, 1H), 7.31 – 7.26 (m, 1H), 7.05 – 7.01 
(m, 2H), 3.88 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 161.2 (d, J = 253.2 Hz), 159.5, 152.4, 149.1, 131.0, 130.1, 
129.3 (d, J = 15.6 Hz), 129.0, 127.4, 125.2, 122.9, 122.8, 122.7, 116.7 (d, J = 24.8 Hz), 114.0, 55.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3062, 3002, 2935, 2836, 1609, 1518, 1481, 1464, 1442, 1399, 
1296, 1246, 1180, 1107, 1040, 1026, 922, 902, 832, 766, 688. 
MS (EI, 70 eV): m/z (%) = 307 (18), 306 (100), 303 (13), 217 (10), 202 (15), 201 (97), 186 (27), 170 
(21), 158 (42), 157 (19), 105 (22), 78 (10), 57 (12), 44 (63), 43 (21). 
HRMS (EI): m/z calcd. for [C19H15FN2O]: 306.1168; found 306.1158 (M+). 
M.p. (°C): 78.2 – 79.5. 
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(E)-1-(6-Fluoro-4'-nitro-[1,1'-biphenyl]-3-yl]-2-phenyldiazene (8i) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing 1-iodo-4-nitrobenzene (4l, 112 mg, 0.45 mmol, 1.1 equiv.), Pd(OAc)2 (1.8 mg, 
2 mol%) and SPhos (6.7 mg, 4 mol%) dissolved in THF (1 mL). The reaction mixture was stirred for 
further 3 h at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex) afforded 8i as an orange solid (90 mg, 0.28 mmol, 69%). 1H-NMR analysis indicated that 
the sample contains a 14:1.0 mixture of trans- and cis-isomers. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.33 (d, J = 8.8 Hz, 2H), 8.07 (dd, J = 7.3, 2.4 Hz, 1H), 
8.03 – 7.99 (m, 1H), 7.93 (d, J = 7.1 Hz, 2H), 7.80 (d, J = 7.6 Hz, 2H), 7.52 (d, J = 282.9 Hz, 3H), 7.35 
(d, J = 9.3 Hz, 1H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 161.1 (d, J = 255.4 Hz), 152.4, 149.4, 147.6, 141.7, 131.6, 
130.0, 129.3, 127.6 (d, J = 14.2 Hz), 125.3 (d, J = 9.6 Hz), 125.2, 123.9, 123.1, 117.4 (d, J = 24.3 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3073, 2942, 2852, 1599, 1515, 1478, 1394, 1342, 1310, 1249, 
1215, 1157, 1106, 1071, 1014, 1001, 906, 851, 767, 756, 688. 
MS (EI, 70 eV): m/z (%) = 322 (14), 321 (42), 291 (42), 244 (16), 216 (34), 187 (14), 186 (54), 185 
(25), 171 (10), 170 (61), 169 (30), 105 (42), 78 (12), 77 (100), 57 (18), 44 (68), 43 (28).  
HRMS (EI): m/z calcd. for [C18H12FN3O2]: 321.0914; found 321.0904 (M+). 
M.p. (°C): 126.9 – 130.3. 
(E)-Ethyl 2'-fluoro-5'-(phenyldiazene)-[1,1'-biphenyl]-4-carboxylate (8j) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.41 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.61 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing ethyl 4-iodobenzoate (4m, 124 mg, 0.45 mmol, 1.1 equiv.), Pd(OAc)2 (1.8 mg, 
2 mol%) and SPhos (6.7 mg, 4 mol%) dissolved in THF (1 mL). The reaction mixture was stirred for 
further 3 h at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
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filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex) afforded 8j as a light orange solid (118 mg, 0.34 mmol, 83%). 1H-NMR analysis indicated 
that the sample contains only the trans-isomers. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.19 – 8.14 (m, 2H), 8.08 (dd, J = 7.3, 2.5 Hz, 1H), 7.98 – 7.94 
(m, 1H), 7.94 – 7.91 (m, 2H), 7.74 – 7.70 (m, 2H), 7.55 – 7.51 (m, 2H), 7.51 – 7.47 (m, 1H), 7.33 – 7.29 
(m, 1H), 4.43 (q, J = 7.1 Hz, 2H), 1.43 (t, J = 7.2 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 166.4, 161.3 (d, J = 254.8 Hz), 152.5, 149.4, 139.6, 131.4, 
130.1, 129.9, 129.3, 129.1, 128.9 (d, J = 14.2 Hz), 125.5, 124.3 (d, J = 8.6 Hz), 123.0, 117.2 (d, 
J = 24.5 Hz), 61.2, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3065, 2982, 1714, 1684, 1611, 1582, 1481, 1396, 1367, 1272, 
1248, 1215, 1184, 1101, 1019, 905, 859, 771, 688, 668. 
MS (EI, 70 eV): m/z (%) = 349 (23), 348 (82), 303 (19), 244 (18), 243 (87), 198 (20), 171 (33), 170 
(82), 105 (31), 77 (100), 44 (13). 
HRMS (EI): m/z calcd. for [C21H17FN2O2]: 348.1274; found 348.1264. 
M.p. (°C): 112.0 – 115.0. 
(E)-Ethyl 2'-cyano-5'-(phenyldiazene)-[1,1'-biphenyl]-4-carboxylate (8k) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.33 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 1 mL) and TMPLi (0.50 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask containing ethyl 4-iodobenzoate (4m, 73 mg, 0.26 mmol, 0.8 equiv.), Pd(OAc)2 (1.5 mg, 
2 mol%) and SPhos (5.8 mg, 4 mol%) dissolved in THF (1 mL). The reaction mixture was stirred for 
further 3 h at 25 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). The aq. layer was 
extracted with EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated, and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex:EtOAc = 98:2) afforded 8k as an orange solid (57 mg, 0.16 mmol, 67%). 1H-NMR analysis 
indicated that the sample contains only the trans-isomer. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.24 – 8.18 (m, 2H), 8.04 (d, J = 1.8 Hz, 1H), 8.00 – 7.92 (m, 
4H), 7.75 – 7.69 (m, 2H), 7.56 – 7.53 (m, 3H), 4.43 (q, J = 7.1 Hz, 2H), 1.43 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.2, 154.6, 152.5, 145.7, 141.9, 135.0, 132.5, 131.1, 130.2, 
129.4, 129.0, 124.3, 123.5, 122.2, 118.2, 112.8, 61.4, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2983, 2224, 1715, 1682, 1602, 1474, 1462, 1441, 1417, 1311, 
1283, 1274, 1183, 1126, 1102, 1016, 1000, 856, 850, 774, 704, 682, 666. 
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MS (EI, 70 eV): m/z (%) = 356 (24), 355 (88), 310 (18), 250 (34), 205 (20), 178 (23), 177 (36), 151 
(10), 105 (33), 77 (100). 
HRMS (EI): m/z calcd. for [C22H17N3O2]: 355.1321; found 355.1318 (M+). 
M.p. (°C): 151.9 – 153.9. 
(E)-1-(3-Bromo-4-fluoro-5-(trimethylsilyl)phenyl)-2-phenyldiazene (8l) 
 
According to TP 3, injection loop A and B were loaded with solutions of (E)-1-(3-bromo-4-
fluorophenyl)-2-phenyldiazene (8e, 0.35 M containing 0.5 equiv. MgCl2·LiCl, 1.0 equiv., 1 mL) and 
TMPLi (0.52 M, 1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams 
were collected in a flask at 0 °C containing TMSCl (34 mg, 0.31 mmol, 0.9 equiv.) dissolved in THF 
(1 mL). The reaction mixture was stirred for further 3 h at 0 °C before it was quenched with sat. aq. 
NH4Cl solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. 
Purification by flash column chromatography (silica gel, i-hex) afforded 8l as a red oil (102 mg, 
0.29 mmol, 92%). 1H-NMR analysis indicated that the sample contains a 9:1 mixture of trans- and cis-
isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.12 (dd, J = 6.7, 2.4 Hz, 1H), 7.97 – 7.93 (m, 1H), 7.92 – 7.89 
(m, 2H), 7.54 – 7.49 (m, 3H), 0.41 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.2 (d, J = 246.9 Hz), 152.5, 149.3, 131.5, 131.2 (d, 
J = 11.8 Hz), 129.3, 129.0, 128.6, 126.9, 123.1, 110.3 (d, J = 27.5 Hz), −1.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3070, 2956, 2900, 1589, 1560, 1487, 1445, 1424, 1387, 1286, 
1265, 1250, 1238, 1200, 1272, 1065, 1036, 957, 838, 763, 686, 662. 
MS (EI, 70 eV): m/z (%) = 352 (20), 350 (15), 335 (11), 333 (14), 247 (13), 245 (10), 165 (13), 105 
(18), 85 (11), 77 (56), 74 (12), 73 (100), 71 (38), 57 (28), 44 (12), 43 (25). 
HRMS (EI): m/z calcd. for [C15H16FBrN2Si]: 350.0250; found 350.0253 (M+). 
(E)-(2-Fluoro-5-(phenyldiazenyl)phenyl)(phenyl)methanol (8m) 
 
According to TP 3, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.35 M containing 0.5 equiv. MgCl2·LiCl, 1.0 equiv., 1 mL) and TMPLi (0.52 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask at 0 °C containing benzaldehyde (4f, 33 mg, 0.31 mmol, 0.9 equiv.) dissolved in THF (1 mL). 
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The reaction mixture was stirred for further 5 h at 0 °C before it was quenched with sat. aq. NH4Cl 
solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions 
were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by 
flash column chromatography (silica gel, i-hex: DCM = 2:1  1:2) afforded 8m as an orange-red solid 
(83 mg, 0.27 mmol, 77%). 1H-NMR analysis indicated that the sample contains only the trans-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.22 (dd, J = 7.0, 2.4 Hz, 1H), 7.95 – 7.89 (m, 2H), 7.89 – 7.83 
(m, 1H), 7.56 – 7.44 (m, 5H), 7.40 – 7.33 (m, 2H), 7.33 – 7.27 (m, 1H), 7.19 – 7.11 (m, 1H), 6.19 (d, 
J = 2.8 Hz, 1H), 2.50 (d, J = 2.8 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.4 (d, J = 252.5 Hz), 152.6 , 149.4 (d, J = 3.1 Hz), 132.1 
(d, J = 14.7 Hz), 131.2, 129.2, 128.8, 128.1, 126.6 (d, J = 0.8 Hz), 123.6 (d, J = 9.1 Hz), 123.0, 122.9 
(d, J = 5.1 Hz), 116.3 (d, J = 23.4 Hz), 70.3 (d, J = 2.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3379, 3062, 1584, 1481, 1449, 1418, 1302, 1239, 1187, 1136, 
1138, 1092, 1018, 924, 834, 766, 695, 686, 659. 
MS (EI, 70 eV): m/z (%) = 307 (21), 306 (91), 229 (12), 201 (13), 184 (20), 183 (98), 152 (15), 107 
(16), 105 (29), 95 (16), 79 (19), 77 (100), 51 (10), 43 (20). 
HRMS (EI): m/z calcd. for [C19H15FN2O]: 306.1168; found 306.1167 (M+). 
M.p. (°C): 96.0 – 96.9. 
(E)-(2-Fluoro-5-(phenyldiazenyl)phenyl)(4-fluorophenyl)methanol (8n) 
 
According to TP 3, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.39 M containing 0.5 equiv. MgCl2·LiCl, 1.0 equiv., 1 mL) and TMPLi (0.59 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask at 0 °C containing 4-fluoro-benzaldehyde (4o, 53 mg, 0.43 mmol, 1.1 equiv.) dissolved in 
THF (1 mL). The reaction mixture was stirred for further 3 h at 0 °C before it was quenched with sat. 
aq. NH4Cl solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. 
Purification by flash column chromatography (silica gel, i-hex: DCM = (8:2  1:2) afforded 8n as an 
orange solid (94 mg, 0.29 mmol, 74%).1H-NMR analysis indicated that the sample contains only the 
trans-isomer. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.18 (dd, J = 6.9, 2.5 Hz, 1H), 7.94 – 7.83 (m, 3H), 7.56 – 7.47 
(m, 3H), 7.46 – 7.39 (m, 2H), 7.19 – 7.11 (m, 1H), 7.08 – 7.00 (m, 2H), 6.17 (d, J = 3.8 Hz, 1H), 2.47 
(d, J = 3.8 Hz, 1H). 
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13C-NMR (101 MHz, CDCl3): δ / ppm = 162.5 (d, J = 246.5 Hz), 160.0 (d, J = 252.8 Hz), 152.6, 149.4 
(d, J = 3.0 Hz), 138.3 (d, J = 3.1 Hz), 132.0 (d, J = 14.7 Hz), 131.3, 129.3, 128.4 (d, J = 9.0 Hz), 123.8 
(d, J = 9.6 Hz), 123.0, 122.6 (d, J = 5.1 Hz), 116.4 (d, J = 23.3 Hz), 115.7 (d, J = 21.5 Hz), 69.7 (d, 
J = 2.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3238, 3068, 1603, 1584, 1509, 1480, 1464, 1444, 1414, 1341, 
1304, 1237, 1223, 1162, 1136, 1037, 1020, 911, 861, 839, 825, 766, 683. 
MS (EI, 70 eV): m/z (%) = 325 (17), 324 (88), 219 (14), 202 (11), 201 (83), 171 (13), 125 (29), 123 
(12), 105 (25), 97 (17), 95 (35), 77 (100), 57 (12). 
HRMS (EI): m/z calcd. for [C19H14F2N2O]: 306.1168; found 324.1072 (M+). 
M.p. (°C): 110.3 – 110.6. 
(E)-(3-Chlorophenyl)(2-fluoro-5-(phenyldiazenyl)phenyl)methanone (8o) 
 
According to TP 3, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.33 M containing 0.5 equiv. MgCl2·LiCl, 1.0 equiv., 1 mL) and TMPLi (0.50 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask at 0 °C containing 3-chlorobenzoyl chloride (4p, 52 mg, 0.30 mmol, 0.9 equiv.) and 
CuCN·2LiCl solution (0.36 mL, 1.0 M in THF, 1.1 equiv.) dissolved in THF (1 mL). The reaction 
mixture was stirred for further 3 h at 0 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). 
The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were dried over 
anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash column 
chromatography (silica gel, i-hex:EtOAc = 49:1) afforded 8o as an orange solid (81 mg, 0.24 mmol, 
81%). 1H-NMR analysis indicated that the sample contains a 50:1 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.17 – 8.12 (m, 2H), 7.95 – 7.90 (m, 2H), 7.88 (s, 1H), 
7.77 – 7.72 (m, 1H), 7.63 – 7.58 (m, 1H), 7.55 – 7.49 (m, 3H), 7.45 (t, J = 7.9 Hz, 1H), 7.36 – 7.30 (m, 
1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 191.5, 161.4 (d, J = 258.2 Hz), 152.4, 149.0 (d, J = 3.3 Hz), 
138.8, 135.1, 133.7, 131.7, 130.1, 129.7 (d, J = 1.0 Hz), 129.3, 128.1 (d, J = 1.0 Hz), 127.8 (d, 
J = 9.2 Hz), 127.1 (d, J = 16.4 Hz), 125.5 (d, J = 3.7 Hz), 123.2, 117.4 (d, J = 23.4 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3070, 1668, 1589, 1577, 1573, 1480, 1426, 1307, 1281, 1270, 
1227, 1209, 1174, 1088, 1069, 905, 828, 754, 682, 671. 
MS (EI, 70 eV): m/z (%) = 340 (19), 339 (19), 338 (67), 235 (14), 233 (51), 198 (17), 141 (16), 139 
(47), 111 (27), 105 (39), 77 (100), 75 (10), 57 (16). 
HRMS (EI): m/z calcd. for [C19H12FClN2O]: 338.0622; found 338.0616 (M+). 
M.p. (°C): 105.2 – 107.1. 
C. EXPERIMENTAL PART    85 
(E)-Cyclopropyl-(2-fluoro-5-(phenyldiazenyl)phenyl)methanone (8p) 
 
According to TP 3, injection loop A and B were loaded with solutions of (E)-1-(4-fluorophenyl)-2-
phenyldiazene (6a, 0.33 M containing 0.5 equiv. MgCl2·LiCl, 1.0 equiv., 1 mL) and TMPLi (0.50 M, 
1.5 equiv., 1 mL). After injection and in situ trapping metalation the combined streams were collected 
in a flask at 0 °C containing cyclopropanecarbonyl chloride (4q, 31 mg, 0.30 mmol, 0.9 equiv.) and 
CuCN·2LiCl solution (0.36 mL, 1.0 M in THF, 1.1 equiv.) dissolved in THF (1 mL). The reaction 
mixture was stirred for further 3 h at 0 °C before it was quenched with sat. aq. NH4Cl solution (15 mL). 
The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were dried over 
anhydrous Mg2SO4, filtrated, and the solvent was removed in vacuo. Purification by flash column 
chromatography (silica gel, i-hex:EtOAc = 49:1) afforded 8p as an orange solid (62 mg, 0.23 mmol, 
78%). 1H-NMR analysis indicated that the sample contains a 8.7:1.0 mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.35 (dd, J = 6.7, 2.4 Hz, 1H), 8.12 – 8.06 (m, 1H), 7.95 – 7.90 
(m, 2H), 7.55 – 7.49 (m, 3H), 7.33 – 7.27 (m, 1H), 2.81 – 2.61 (m, 1H), 1.38 – 1.33 (m, 2H), 1.16 – 1.09 
(m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 199.1, 162.8 (d, J = 259.2 Hz), 152.4, 149.0 (d, J = 3.1 Hz), 
131.6, 129.3, 127.9 (d, J = 14.5 Hz), 127.6 (d, J = 9.8 Hz), 125.7 , 123.1, 117.7 (d, J = 25.1 Hz), 21.6, 
12.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3070, 3005, 2958, 2920, 1755, 1664, 1610, 1578, 1480, 1413, 
1375, 1269, 1256, 1230, 1197, 1142, 1091, 1037, 1013, 970, 919, 883, 828, 766, 685, 656. 
MS (EI, 70 eV): m/z (%) = 269 (19), 268 (99), 163 (59), 105 (29), 94 (15), 77 (100), 69 (42), 41 (11). 
HRMS (EI): m/z calcd. for [C16H13FN2O]: 268.1012; found 268.1001 (M+). 
M.p. (°C): 63.1 – 64.4. 
(E)-1-(4-Butyl-2,6-dichlorophenyl)-2-(2,6-dichloro-3-iodophenyl)diazene (10) 
 
According to TP 2, injection loop A and B were loaded with solutions of (E)-1-(4-butyl-2,6-
dichlorophenyl)-2-(2,6-dichlorophenyl)diazene (9, 0.20 M containing 0.5 equiv. ZnCl2, 1.0 equiv., 
1 mL) and TMPLi (0.30 M, 1.5 equiv., 1 mL). After injection and in situ trapping metalation the 
combined streams were collected in a flask containing iodine (4a, 102 mg, 0.40 mmol, 2.0 equiv.) 
dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min at 25 °C before it was 
quenched with sat. aq. Na2S2O3 solution (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), 
the combined organic fractions were dried over anhydrous Mg2SO4, filtrated, and the solvent was 
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removed in vacuo. Purification by flash column chromatography (silica gel, i-hex) afforded 10 as an 
orange solid (65 mg, 0.13 mmol, 65%). 1H-NMR analysis indicated that the sample contains a 3.3:1.0 
mixture of trans- and cis-isomers. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99 (d, J = 8.6 Hz, 1H), 7.48 (s, 2H), 7.38 (d, J = 8.6 Hz, 1H), 
2.83 (d, J = 7.2 Hz, 2H), 1.83 (p, J = 7.6 Hz, 2H), 1.58 (h, J = 7.5 Hz, 2H), 1.15 (t, J = 7.4 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 149.2, 146.5, 144.6, 139.2, 130.3, 129.7, 129.3, 128.1, 126.2, 
98.4, 35.1, 33.1, 22.3, 14.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2955, 2932, 2858, 1592, 1551, 1542, 1491, 1464, 1447, 1435, 
1424, 1401, 1362, 1274, 1239, 1208, 1184, 1170, 1117, 1096, 1080, 1004, 932, 912, 898, 870, 859, 
801, 746, 726, 711, 691, 680, 668, 658, 651. 
MS (EI, 70 eV): m/z (%) = 504 (18), 502 (39), 500 (30), 299 (14), 273 (18), 271 (29), 233 (10), 231 
(65), 230 (13), 229 (100), 203 (21), 201 (34), 161 (40), 159 (61), 146 (13), 144 (19), 123 (15). 
HRMS (EI): m/z calcd. for [C16H13Cl4IN2]: 499.8878; found 499.8872 (M+). 
M.p. (°C): 68.2 – 69.3. 
The structure was confirmed by Single-Crystal X-Ray diffraction studies. For detailed information see 
Crystallographic Data Section.  
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3 Selective Zincation of 1,2-Dicyanobenzene and Related Benzonitriles in 
Continuous Flow Using In Situ Trapping Metalations 
3.1 Typical Procedures (TP) 
 
Scheme 46: General flow setup for the selective zincation of 1,2-dicyanobenzene and related benzonitriles.  
Typical procedure for the in situ trapping metalation of 1,2-dicyanobenzene in flow followed by 
the reaction with an electrophile in batch (TP 5): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.60 – 0.64 M in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.40 – 0.43 M in dry THF containing 0.5 equiv. ZnCl2 additive). The solutions were 
simultaneously injected into separate THF streams (pump A and B, flow rates: 1.50 mL min−1), which 
passed a pre-cooling loop (vol.pre = 1 mL, residence time: 40 s, 0 °C) respectively, before they were 
mixed in a coiled reactor (vol.R = 1 mL, residence time: t1 = 20 s, T1 = 0 °C). The combined streams 
were collected in a flame-dried, argon flushed 25 mL flask equipped with a magnetic stirrer and a 
septum containing the electrophile (1.1 equiv.) dissolved in dry THF (1 mL). Then, the reaction mixture 
was further stirred for the indicated time (t2) at the indicated temperature (T2). The completion of the 
reaction was checked by GC analysis of reaction aliquots quenched with sat. aq. NH4Cl solution and 
using dodecane or hexadecane as an internal standard. 
Typical procedure for the in situ trapping metalation in flow of 1,3-dicyanobenzene followed by 
the reaction with an electrophile in batch (TP 6): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.51 – 0.66 M in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.34 – 0.38 M in dry THF containing 0.5 equiv. ZnCl2 additive). The solutions were 
simultaneously injected into separate THF streams (pump A and B, flow rates: 2.50 mL min−1), which 
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passed a pre-cooling loop (vol.pre = 1 mL, residence time: 24 s, −78 °C) respectively, before they were 
mixed in a coiled reactor (vol.R = 1 mL, residence time: t1 = 36 s, T1 = −78 °C). The combined streams 
were collected in a flame-dried, argon flushed 25 mL flask equipped with a magnetic stirrer and a 
septum containing the electrophile (0.8 – 1.2 equiv.) dissolved in dry THF (1 mL). Then, the reaction 
mixture was further stirred for the indicated time (t2) at the indicated temperature (T2). The completion 
of the reaction was checked by GC analysis of reaction aliquots quenched with sat. aq. NH4Cl solution 
and using dodecane or hexadecane as an internal standard. 
Typical procedure for the in situ trapping metalation in flow of 3-methoxybenzonitrile followed 
by the reaction with an electrophile in batch (TP 7): 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (vol.inj = 1.0 mL) was loaded with TMPLi 
(0.52 – 0.56 M in dry THF, 1.5 equiv.) and injection loop B (vol.inj = 1.0 mL) was loaded with the 
reactant solution (0.34 – 0.38 M in dry THF containing 0.5 equiv. ZnCl2 additive). The solutions were 
simultaneously injected into separate THF streams (pump A and B, flow rates: 2.0 mL min−1), which 
passed a pre-cooling loop (vol.pre = 1 mL, residence time: 30 s, 0 °C) respectively, before they were 
mixed in a coiled reactor (vol.R = 3 mL, residence time: t1 = 45 s, T1 = 0 °C). The combined streams 
were collected in a flame-dried, argon flushed 25 mL flask equipped with a magnetic stirrer and a 
septum containing the electrophile (0.8 – 1.2 equiv.) dissolved in dry THF (1 mL). Then the reaction 
mixture was further stirred for the indicated time (t2) at the indicated temperature (T2). The completion 
of the reaction was checked by GC-analysis of reaction aliquots quenched with sat. aq. NH4Cl solution 
and using dodecane or hexadecane as an internal standard. 
3.2 Preparation of the Products 
3-Iodophthalonitrile (14a) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing I2 (16a, 197 mg, 
0.84 mmol, 2.0 equiv.) dissolved in THF (1 mL). The reaction mixture was stirred for further 2 h at 
0 °C before it was quenched with sat. aq. Na2S2O3 (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 8:2) 
afforded 14a as a white powder (93 mg, 0.37 mmol, 88%). 
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scale-up: 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (6.0 mL) was loaded with TMPLi (0.63 M in dry 
THF, 1.5 equiv.) and injection loop B (6.0 mL) was loaded with 1,2-dicyanobenzene solution (11a, 
0.42 M in dry THF containing 0.5 equiv. ZnCl2 additive). The solutions were simultaneously injected 
into separate THF streams (pump A and B, flow rates: 1.50 mL min−1), which passed a pre-cooling loop 
(1 mL, residence time: 40 s, 0 °C) respectively, before they were mixed in a coiled reactor (1 mL, 
residence time: 20 s, 0 °C). The combined streams were collected in a flame-dried, argon flushed 
250 mL flask equipped with a magnetic stirrer and a septum containing I2 (16a, 10.15 g, 40.00 mmol, 
4.0 equiv.) dissolved in THF (20 mL) at 25 °C. After 4 min, the injection loops were reloaded with the 
reactant solution and TMPLi, injected into the separate THF streams again and collected in the same 
flask as well. This procedure was repeated 4 times for a total amount of 10.08 mmol. The reaction 
mixture was stirred overnight before it was quenched with sat. aq. NH4Cl (60 mL). The aq. layer was 
extracted with EtOAc (3×100 mL), the combined organic fractions were dried over anhydrous Mg2SO4, 
filtrated and the solvent was removed in vacuo. Purification by flash column chromatography (silica 
gel, i-hex:EtOAc = (8:2) afforded 14a as a light brown solid (2.228 g, 8.77 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.19 (dd, J = 8.2, 1.1 Hz, 1H), 7.80 (dd, J = 7.8, 1.1 Hz, 1H), 
7.42 (t, J = 8.0 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.6, 133.5, 132.8, 123.7, 118.0, 116.5, 114.8, 100.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3072, 2230, 1570, 1552, 1448, 1426, 1206, 1126, 820, 804, 726. 
MS (EI, 70 eV): m/z (%) = 253 (100), 155 (34), 127 (13), 100 (14). 
HRMS (EI): m/z calcd. for [C8H3IN2]: 253.9341; found: 253.9335. 
M.p. (°C): 156.0 – 160.0. 
1',2',3',4'-Tetrahydro-[1,1'-biphenyl]-2,3-dicarbonitrile (14b) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 3-bromocyclohexene 
(16b, 74 mg, 0.46 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.04 mL, 1.0 M in THF, 10 mol%) 
dissolved in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 2 h at 0 °C before it was 
quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the 
combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed 
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in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 1:4) afforded 14b as 
a white powder (71 mg, 0.34 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.65 (s, 2H), 6.09 – 6.04 (m, 1H), 5.61 – 5.59 (m, 1H), 
3.96 – 3.89 (m, 1H), 2.21 – 2.11, 3H), 1.75 – 1.67 (m, 2H), 1.55 – 1.47 (m, 1H). 
 13C-NMR (151 MHz, CDCl3): δ / ppm = 152.6, 132.9, 132.7, 131.4, 131.3, 126.8, 116.6, 116.0, 115.4, 
114.7, 40.4, 31.6, 24.8, 20.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3028, 2936, 2863, 2233, 2224, 1585, 1466, 1446, 1433, 1257, 
1232, 1184, 1137, 1047, 945, 892, 807, 746, 732, 724. 
MS (EI, 70 eV): m/z (%) = 209 (10), 208 (69), 207 (100), 193 (34), 192 (17), 191 (18), 190 (19), 181 
(11), 180 (26), 179 (28), 167 (10), 165 (12), 153 (19), 152 (13), 141 (11), 140 (19), 54 (16), 43 (13). 
HRMS (EI): m/z calcd. for [C14H12N2]: 208.1000; found: 207.0917 (M+). 
M.p. (°C): 117.3 – 118.4. 
Ethyl 2-(2,3-dicyanobenzyl)acrylate (14c) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing ethyl 
2-(bromomethyl)acrylate (16c, 89 mg, 0.46 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.04 mL, 
1.0 M in THF, 10 mol%) dissolved in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 
2 h at 0 °C before it was quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 9:1) 
afforded 14c as a colorless liquid (77 mg, 0.32 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.69 – 7.62 (m, 3H), 6.57 (s, 1H), 5.72 (s, 1H), 4.18 – 4.13 (q, 
J = 8 Hz, 2H) 3.9 (s, 2H), 1.26 – 1.22 (t, J = 8 Hz, 3H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 165.8, 145.0, 137.0, 134.5, 132.9, 131.7, 128.8, 116.5, 116.1, 
115.7, 114.7, 61.3, 37.0, 14.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3085, 2984, 2930, 2854, 2362, 2236, 1711, 1632, 1586, 1465, 
1447, 1408, 1369, 1329, 1300, 1255, 1200, 1175, 1139, 1096, 1024, 959, 858, 809, 792, 753, 733, 715. 
MS (EI, 70 eV): m/z (%) = 212 (37), 195 (20), 194 (12), 168 (14), 167 (31), 166 (100), 165 (12), 141 
(13), 140 (21). 
HRMS (EI): m/z calcd. for [C14H12N2O2]: 240.0899; found: 240.0883 (M+). 
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3-(3-Chlorobenzoyl)phthalonitrile (14d) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.44 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.66 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 3-chlorobenzoyl chloride 
(16d, 84 mg, 0.48 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.48 mL, 1.0 M in THF, 0.48 mmol, 
1.1 equiv.) dissolved in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 8 h at 0 °C 
before it was quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 9:1) 
afforded 14d as a pale brown solid (66 mg, 0.25 mmol, 57%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 – 7.97 (m, 1H), 7.93 – 7.86 (m, 2H), 7.76 (t, J = 1.7 Hz, 
1H), 7.69 – 7.59 (m, 2H), 7.48 (t, J = 7.9 Hz, 1H). 
 13C-NMR (151 MHz, CDCl3): δ / ppm = 190.7, 142.6, 136.6, 135.6, 135.5, 134.7, 133.7, 133.3, 133.3, 
133.0, 130.5, 130.1, 128.6, 118.3, 115.3, 114.9, 113.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3086, 2925, 2242, 2234, 1667, 1590, 1570, 1468, 1441, 1422, 
1401, 1292, 1276, 1207, 1166, 1074, 1015, 998, 896, 833, 799, 758, 727, 702, 672, 658. 
MS (EI, 70 eV): m/z (%) = 268 (17), 266 (39), 231 (50), 155 (26), 141 (34), 139 (100), 127 (19), 111 
(29), 75 (18), 44 (10). 
HRMS (EI): m/z calcd. for [C16H12N2]: 266.0247; found: 266.0240 (M+). 
M.p. (°C): 115.9 – 120.1. 
1-(2,4-Dichlorobenzoyl)phthalonitrile (14) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 2,4-dichlorobenzoyl 
chloride (16e, 97 mg, 0.46 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.46 mL, 1.0 M in THF, 
0.46 mmol, 1.1 equiv.) dissolved in THF (1.0 mL) at 0 °C. The reaction mixture was stirred for further 
8 h at −20 °C before it was quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, 
i-hex:EtOAc = 8:2) afforded 14e as a light yellow powder (93 mg, 0.31 mmol, 74%). 
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1H-NMR (4599 MHz, CDCl3): δ / ppm = 8.01 (s, 1H), 7.86 (s, 2H), 7.58 – 7.38 (m, 3H). 
 13C-NMR (151 MHz, CDCl3): δ / ppm = 190.4, 141.6, 139.6, 136.5, 134.2, 133.4, 133.3, 132.1, 130.7, 
128.2, 118.7, 115.0, 113.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3096, 2234, 1680, 1579, 1553, 1467, 1444, 1375, 1309, 1286, 
1244, 1205, 1180, 1171, 1148, 1103, 1078, 1062, 1008, 991, 962, 940, 860, 832, 819, 800, 767, 729, 
703, 670. 
MS (EI, 70 eV): m/z (%) = 300 (11), 264 (78), 173 (100). 
HRMS (EI): m/z calcd. for [C15H6ON2Cl2]: 299.9857; found: 299.9849 (M+). 
M.p. (°C): 145.0. 
3-(Cyclopropanecarbonyl)phthalonitrile (14f) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing cyclopropanecarbonyl 
chloride (16f, 48 mg, 0.46 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.46 mL, 1.0 M in THF, 
0.46 mmol, 1.1 equiv.) dissolved in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 
2 h at 0 °C before it was quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 8:2) 
afforded 14f as a light yellow powder (64 mg, 0.33 mmol, 78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.20 – 8.14 (m, 1H), 7.96 (dd, J = 7.8, 1.2 Hz, 1H), 7.85 (td, 
J = 7.9, 0.9 Hz, 1H), 2.57 (tt, J = 7.7, 4.5, 1H), 1.45 (m, J = 3.6 Hz, 2H), 1.27 (dq, J = 7.6, 3.7 Hz, 2H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 198.4, 143.5, 135.8, 133.1, 132.7, 118.6, 115.1, 114.5, 114.3, 
20.3, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3083, 2235, 2229, 1668, 1632, 1570, 1444, 1413, 1383, 1293, 
1249, 1237, 1188, 1174, 1114, 1076, 1059, 1033, 954, 891, 821, 801, 773, 757, 718, 695. 
MS (EI, 70 eV): m/z (%) = 196 (32), 156 (33), 127 (100). 
HRMS (EI): m/z calcd. for [C12H8N2O]: 196.0637; found: 196.0627 (M+). 
M.p. (°C): 173.0 – 175.0. 
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3-(Thiophene-2-carbonyl)phthalonitrile (14) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.42 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.63 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing thiophene-2-carbonyl 
chloride (16g, 67 mg, 0.46 mmol, 1.1 equiv.) and CuCN∙2LiCl solution (0.46 mL, 1.0 M in THF, 
0.46 mmol, 1.1 equiv.) dissolved in THF (1.0 mL) at 0 °C. The reaction mixture was stirred for further 
8 h at −20 °C before it was quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with 
EtOAc (3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and 
the solvent was removed in vacuo. Purification by flash column chromatography (silica gel, 
i-hex:EtOAc = 8:2) afforded 14g as a light yellow powder (76 mg, 0.32 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99 (d, J = 8.0 Hz, 2H), 7.91 – 7.82 (m, 2H), 7.50 (dd, 
J = 3.9, 1.1 Hz, 1H), 7.21 (dd, J = 4.9, 3.9 Hz, 1H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 183.5, 143.6, 141.8, 137.5, 136.6, 135.2, 132.8, 132.6, 128.9, 
118.2, 115.1, 115.0, 113.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3079, 2237, 2230, 1635, 1574, 1511, 1438, 1405, 1352, 1302, 
1289, 1231, 1203, 1164, 1075, 1063, 1034, 1000, 954, 946, 918, 866, 822, 799, 762, 752, 720, 676. 
MS (EI, 70 eV): m/z (%) = 238 (51), 210 (35), 111 (100), 83 (11). 
HRMS (EI): m/z calcd. for [C13H6N2OS]: 238.0201; found: 238.0194 (M+). 
M.p. (°C): 160.0 – 163.0. 
4'-Methoxy-[1,1'-biphenyl],-2,3-dicarbonitrile (14h) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.44 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.66 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 4-iodoanisole (16h, 
113 mg, 0.49 mmol, 1.1 equiv.), Pd(OAc)2 (2.0 mg, 2 mol%) and SPhos (7.2 mg, 4 mol%) dissolved in 
THF (1 mL) at 25 °C. The reaction mixture was stirred overnight before it was quenched with sat. aq. 
NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions 
were dried over anhydrous Mg2SO4, filtrated and the solvent was removed in vacuo. Purification by 
flash column chromatography (silica gel, i-hex:EtOAc = 9:1) afforded 14h as a pale brown solid 
(89 mg, 0.38 mmol, 87%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.76 – 7.72 (m, 3H), 7.55 – 7.49 (m, 2H), 7.06 – 7.02 (m, 2H), 
3.88 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.8, 147.1, 134.0, 132.8, 131.5, 130.1, 128.7, 117.3, 115.8, 
115.5, 114.6, 114.1, 55.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2225, 1608, 1580, 1523, 1514, 1460, 1442, 1308, 1298, 1249, 
1178, 1117, 1082, 1026, 991, 861, 840, 820, 802, 783, 769, 743, 725, 683. 
MS (EI, 70 eV): m/z (%) = 235 (18), 234 (100), 219 (6), 191 (28), 165 (10), 164 (10), 138 (5), 43 (6). 
HRMS (EI): m/z calcd. for [C15H10N2O]: 234.0793; found: 234.0783 (M+). 
M.p. (°C): 200.3 – 201.5. 
Ethyl 2',3'-dicyano-[1,1'-biphenyl]-4-carboxylate (14) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.44 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.66 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing ethyl 4-iodobenzoate 
(16i, 134 mg, 0.48 mmol, 1.1 equiv.), Pd(OAc)2 (2.0 mg, 2 mol%) and SPhos (7.2 mg, 4 mol%) 
dissolved in THF (1 mL) at 25 °C. The reaction mixture was stirred overnight before it was quenched 
with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed in vacuo. 
Purification by flash column chromatography (silica gel, i-hex:EtOAc = 9:1 → 7:3) afforded 14i as a 
light brown solid (99 mg, 0.36 mmol, 82%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.21 – 8.18 (d, J = 8.4 Hz, 2H), 7.86 – 7.77 (m, 3H), 
7.63 – 7.61 (d, J = 8.4 Hz, 2H), 4.44 – 4.39 (q, J = 7 Hz, 2H), 1.44 – 1.40 (t, J = 7 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.9, 146.4, 140.6, 134.1, 133.3, 132.7, 131.8, 130.4, 128.9, 
117.6, 115.6, 115.0, 114.7, 61.5, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2230, 1716, 1613, 1582, 1456, 1400, 1370, 1312, 1296, 1282, 
1188, 1128, 1102, 1024, 1016, 863, 845, 814, 768, 743, 704. 
MS (EI, 70 eV): m/z (%) = 276 (21), 248 (45), 232 (20), 230 (100), 204 (24), 203 (32), 202 (12), 176 
(28). 
HRMS (EI): m/z calcd. for [C17H12N2O2]: 276.0899; found: 276.0893 (M+). 
M.p. (°C): 168.4 – 171.6. 
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3’,4'-Dimethyl-[1,1'-biphenyl]-2,3-dicarbonitrile (14j) 
 
According to TP 5, injection loop A and B were loaded with solutions of 1,2-dicyanobenzene (11a, 
0.37 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.56 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 4-iodo-1,2-
dimethylbenzene (16l, 95 mg, 0.41 mmol, 1.1 equiv.), Pd(OAc)2 (1.7 mg, 2 mol%) and SPhos (6.1 mg, 
4 mol%) dissolved in THF (1 mL) at 25 °C. The reaction mixture was stirred overnight before it was 
quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the 
combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed 
in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 7:3) afforded 14j as 
a light brown solid (65 mg, 0.28 mmol, 76%). 
scale-up: 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (4.0 mL) was loaded with TMPLi (0.6 M in dry 
THF, 1.5 equiv.) and injection loop B (4.0 mL) was loaded with the reactant solution (11a, 0.40 M in 
dry THF containing 0.5 equiv. ZnCl2 additive). The solutions were simultaneously injected into separate 
THF streams (pump A and B, flow rates: 1.50 mL min−1), which passed a pre-cooling loop (1 mL, 
residence time: 40 s, 0 °C) respectively, before they were mixed in a coiled reactor (1 mL, residence 
time: 20 s, 0 °C). The combined streams were collected in a flame-dried, argon flushed 250 mL flask 
equipped with a magnetic stirrer and a septum containing 4-iodo-1,2-dimethylbenzene (16m, 2.04 g, 
8.80 mmol, 1.1 equiv.), Pd(OAc)2 (36 mg, 2 mol%) and SPhos (131 mg, 4 mol%) dissolved in THF 
(20 mL) at 25 °C. After 3 min, the injection loops were reloaded with the reactant solution and TMPLi, 
injected into the separate THF streams again and collected in the same flask as well. This procedure 
was repeated 5 times for a total amount of 8 mmol. The reaction mixture was stirred overnight before 
it was quenched with sat. aq. NH4Cl (60 mL). The aq. layer was extracted with EtOAc (3×100 mL), the 
combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed 
in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 9:1) afforded 14j as 
a light brown solid (1.43 g, 6.16 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.77 – 7.72 (m, 3H), 7.31 – 7.29 (m, 3H), 2.35 (s, 3H), 2.34 
(s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 147.7, 138.7, 137.6, 134.2, 134.1, 132.9, 131.8, 130.4, 129.9, 
126.2, 117.4, 116.0, 115.6, 114.4, 20.0, 19.8. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3067, 2968, 2918, 2856, 1612, 1584, 1506, 1459, 1394, 1379, 
1276, 1198, 1028, 995, 909, 838, 816, 800, 772, 744, 740, 716. 
MS (EI, 70 eV): m/z (%) = 233 (17), 232 (100), 231 (69), 218 (10), 217 (66), 204 (11), 190 (29). 
HRMS (EI): m/z calcd. for [C16H12N2]: 232.1000; found: 232.0996 (M+). 
M.p. (°C): 185.6 – 286.1. 
2-Iodoisophthalonitrile (15a) 
 
According to TP 6, injection loop A and B were loaded with solutions of 1,3-dicyanobenzene (11b, 
0.34 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.51 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing I2 (16a, 104 mg, 
0.41 mmol, 1.2 equiv. dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min 
before it was quenched with sat. aq. Na2S2O3 (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 19:1) 
afforded 15a as a light brown solid (68 mg, 0.27 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.80 – 7.78 (d, J = 8 Hz, 2H), 7.64 – 7.60 (t, J = 8 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 137.3, 129.2, 123.6, 118.3, 103.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3133, 3092, 3055, 3002, 2925, 2854, 2238, 2232, 1743, 1569, 
1451, 1404, 1271, 1237, 1106, 1024, 879, 804, 704. 
MS (EI, 70 eV): m/z (%) = 255 (9), 254 (100), 127 (9). 
HRMS (EI): m/z calcd. for [C8H3IN2]: 253.9341; found: 253.9351 (M+). 
M.p. (°C): 208.4 – 211.4. 
1',2',3',4'-Tetrahydro-[1,1'-biphenyl]-2,6-dicarbonitrile (15b) 
 
According to TP 6, injection loop A and B were loaded with solutions of 1,3-dicyanobenzene (11b, 
0.38 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.56 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 3-bromocyclohexene 
(16b, 48 mg, 0.30 mmol, 0.8 equiv.) and CuCN∙2LiCl solution (0.04 mL, 1.0 M in THF, 10 mol%) 
dissolved in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 2 h at 0 °C before it was 
quenched with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the 
combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed 
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in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 19:1) afforded 15b 
as a white solid (56 mg, 0.27 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.86 – 7.84 (d, J = 8 Hz, 2H), 7.46 – 7.42 (t, J = 8 Hz, 1H), 
6.10 – 6.05 (m, 1H), 5.58 – 5.55 (m, 1H), 4.18 – 4.11 (m, 1H), 2.33 – 2.22 (m, 1H), 2.19 – 2.04 (m, 
2H), 1.99 – 1.89 (m, 2H), 1.81 – 1.70 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 153.2, 138.0, 131.9, 127.6, 125.3, 116.4, 114.2, 41.8, 29.9, 
24.4, 22.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3077, 3025, 2933, 2861, 2836, 2230, 1580, 1457, 1442, 1265, 
1222, 1136, 982, 916, 898, 847, 806, 748, 723, 709. 
MS (EI, 70 eV): m/z (%) = 209 (11), 208 (92), 207 (100), 192 (23), 191 (44), 190 (33), 180 (22), 179 
(27), 167 (11), 153 (13), 140 (11). 
HRMS (EI): m/z calcd. for [C14H12N2]: 208.1000; found: 207.0925 (M+). 
M.p. (°C): 106.2 – 106.9. 
4'-Methoxy-[1,1'-biphenyl]-2,6-dicarbonitrile (15c) 
 
According to TP 6, injection loop A and B were loaded with solutions of 1,3-dicyanobenzene (11b, 
0.38 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.56 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 4-iodoanisole (16h, 
70 mg, 0.30 mmol, 0.8 equiv.), Pd(OAc)2 (1.7 mg, 2 mol%) and SPhos (6.1 mg, 4 mol%) dissolved in 
THF (1 mL). The reaction mixture was stirred overnight before it was quenched with sat. aq. NH4Cl 
(15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were 
dried over anhydrous Mg2SO4, filtrated and the solvent was removed in vacuo. Purification by flash 
column chromatography (silica gel, i-hex:EtOAc = 9:1) afforded 15c as colorless crystals (56 mg, 
0.24 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.96 – 7.94 (d, J = 8 Hz, 2H), 7.57 – 7.53 (t, J = 8 Hz, 1H), 
7.50 – 7.47 (m, 2H), 7.09 – 7.05 (m, 2H), 3.89 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.2, 148.9, 137.3, 130.9, 128.0, 126.4, 117.1, 114.6, 114.5, 
55.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3076, 3007, 2932, 2840, 2233, 1729, 1608, 1582, 1517, 1449, 
1440, 1299, 1252, 1180, 1153, 1033, 1017, 911, 834, 807, 755. 
MS (EI, 70 eV): m/z (%) = 235 (18), 234 (100), 203 (8), 191 (23), 165 (9), 164 (10). 
HRMS (EI): m/z calcd. for [C15H10N2O]: 234.0793; found: 234.0800 (M+). 
M.p. (°C): 174.4 – 176.1. 
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2-Iodo-3-methoxybenzonitrile (15d) 
 
According to the TP 7, injection loop A and B were loaded with solutions of 3-methoxybenzonitrile 
(11c, 0.34 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.52 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing I2 (16a, 104 mg, 
0.41 mmol, 1.2 equiv. dissolved in THF (1 mL). The reaction mixture was stirred for further 10 min 
before it was quenched with sat. aq. Na2S2O3 (15 mL). The aq. layer was extracted with EtOAc 
(3×15 mL), the combined organic fractions were dried over anhydrous Mg2SO4, filtrated and the solvent 
was removed in vacuo. Purification by flash column chromatography (silica gel, i-hex:EtOAc = 19:1) 
afforded 15d as colorless crystals (72 mg, 0.28 mmol, 82%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.42 – 7.38 (t, J = 8 Hz, 1H), 7.23 – 7.20 (dd, J = 8.0, 1.4 Hz, 
1H), 7.00 – 6.98 (dd, J = 8.0, 1.4 Hz, 1H), 3.92 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.3, 130.1, 126.5, 122.3, 119.5, 114.6, 91.2, 56.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3131, 3080, 2969, 2941, 1926, 1836, 2228, 1579, 1562, 1462, 
1420, 1408, 1290, 1269, 1190, 1063, 1024, 1013, 896, 798, 791, 704. 
MS (EI, 70 eV): m/z (%) = 260 (7), 259 (100), 244 (15), 216 (6), 117 (13), 102 (5). 
HRMS (EI): m/z calcd. for [C8H6INO]: 258.9494; found: 258.9495 (M+). 
M.p. (°C): 127.1 – 127.9. 
2-Allyl-3-methoxybenzonitrile (15e) 
 
According to TP 7, injection loop A and B were loaded with solutions of 3-methoxybenzonitrile (11c, 
0.38 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.56 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing allylbromide (16c, 
36 mg, 0.30 mmol, 0.8 equiv.) and CuCN∙2LiCl solution (0.04 mL, 1.0 M in THF, 10 mol%) dissolved 
in THF (1 mL) at 0 °C. The reaction mixture was stirred for further 2 h at 0 °C before it was quenched 
with sat. aq. NH4Cl (15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic 
fractions were dried over anhydrous Mg2SO4, filtrated and the solvent was removed in vacuo. 
Purification by flash column chromatography (silica gel, i-hex:EtOAc = 19:1) afforded 15e as a 
colorless liquid (30 mg, 0.17 mmol, 58%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.24 – 7.22 (m, 1H), 7.19 – 7.17 (m, 1H), 7.05 – 7.02 (m, 1H), 
5.93 – 5.85 (m, 1H), 5.07 – 4.99 (m, 2H), 3.83 (s, 3H), 3.59 – 3.56 (d, 2H). 
C. EXPERIMENTAL PART    99 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.6, 134.6, 132.8, 128.2, 124.6, 118.0, 116.3, 114.9, 113.8, 
56.0, 33.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3081, 3010, 2943, 2840, 2227, 1638, 1580, 1469, 1439, 1321, 
1289, 1268, 1238, 1211, 1112, 1059, 993, 863, 786, 740, 690, 683. 
MS (EI, 70 eV): m/z (%) = 173 (52), 159 (20), 158 (29), 140 (29), 130 (100), 116 (80), 115 (20), 103 
(35), 89 (25). 
HRMS (EI): m/z calcd. for [C11H11NO]: 173.0841; found: 173.0841 (M+). 
4'-6-Dimethoxy-[1,1'-biphenyl]-2-carbonitrile (15f) 
 
According to TP 7, injection loop A and B were loaded with solutions of 3-methoxybenzonitrile (11c, 
0.38 M containing 0.5 equiv. ZnCl2, 1 mL) and TMPLi (0.56 M, 1 mL). After injection and in situ 
trapping metalation the combined streams were collected in a flask containing 4-iodoanisole (16h, 
70 mg, 0.30 mmol, 0.8 equiv.), Pd(OAc)2 (1.7 mg, 2 mol%) and SPhos (6.1 mg, 4 mol%) dissolved in 
THF (1 mL). The reaction mixture was stirred overnight before it was quenched with sat. aq. NH4Cl 
(15 mL). The aq. layer was extracted with EtOAc (3×15 mL), the combined organic fractions were 
dried over anhydrous Mg2SO4, filtrated and the solvent was removed in vacuo. Purification by flash 
column chromatography (silica gel, i-hex:EtOAc = 9:1) afforded 15f as a light brown solid (57 mg, 
0.24 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.40 – 7.35 (m, 3H), 7.34 – 7.32 (m, 1H), 7.18 – 7.16 (m, 1H), 
7.02 – 6.99 (m, 1H), 3.86 (s, 3H), 3.79 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.7, 157.1, 134.6, 131.4, 128.8, 126.4, 125.2, 118.6, 115.4, 
114.0, 113.8, 56.1, 55.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3004, 2937, 2838, 2226, 1609, 1579, 1516, 1464, 1456, 1437, 
1412, 1298, 1262, 1245, 1178, 1110, 1067, 1035, 1018, 1000, 907, 831, 792, 745. 
MS (EI, 70 eV): m/z (%) = 240 (15), 239 (100), 224 (17), 209 (9), 193 (7), 153 (7). 
HRMS (EI): m/z calcd. for [C15H13NO2]: 239.0946; found: 239.0942 (M+). 
M.p. (°C): 99.5 – 100.3. 
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3,3'-(Ethane-1,2-diylbis(dimethylsilanediyl))diphthalonitrile (17) 
 
The flow system (FlowSyn, Uniqsis) was dried by flushing it with dry THF (flow rate of all pumps: 
1.00 mL min−1, run-time: 30 min). Injection loop A (4.0 mL) was loaded with i-PrMgCl∙LiCl (0.45 M 
in dry THF, 0.9 equiv.) and injection loop B (4.0 mL) was loaded with 3-iodophthalonitrile (14a, 0.5 M 
in dry THF, 1.0 equiv.). The solutions were simultaneously injected into separate THF streams (pump 
A and B, flow rates: 0.75 mL min−1) and mixed in a coiled reactor (1 mL, residence time: 30 s, 25 °C). 
The combined streams were collected in a flame-dried, argon flushed 25 mL flask equipped with a 
magnetic stirrer and a septum containing 1,2-bis(chlorodimethylsilyl)ethane (16k, 1.935 g, 9 mmol, 
0.6 equiv.) in THF (20 mL) at room temperature. After 8 min, the injection loops were reloaded with 
the reactant solution and i-PrMgCl∙LiCl, injected into the separate THF streams again and collected in 
the same flask as well. This reload was repeated 5 times to reach a total volume of 30 mL reactant 
solution (15 mmol). After collection in the flask containing the electrophile the mixture was stirred for 
another hour at room temperature before it was quenched with sat. aq. NH4Cl (200 mL). The aq. layer 
was extracted with EtOAc (3×300 mL), the combined organic fractions were dried over anhydrous 
Mg2SO4, filtrated and the solvent was removed in vacuo. Purification by flash column chromatography 
(silica gel, i-hex:EtOAc = 10:1) afforded 17 as a white solid (1.605 g, 4.03 mmol, 60%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.84 – 7.82 (dd, J = 8.0 Hz, J = 1.4 Hz, 1H), 7.80 – 7.78 (dd, 
J = 8.0, 1.4 Hz, 1H), 7.71 – 7.68 (t, J = 8.0 Hz, 1H), 0.84 (s, 2H), 0.45 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 146.3, 139.0, 133.7, 131.9, 120.4, 117.2, 116.5, 116.0, 6.8, 
−3.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3074, 2965, 2922, 2891, 2234, 2226, 1568, 1560, 1407, 1274, 
1252, 1209, 1147, 1137, 1066, 942, 853, 842, 808, 782, 759, 716, 702. 
MS (EI, 70 eV): m/z (%) = 399 (19), 398 (54), 397 (38), 385 (11), 384 (29), 383 (83), 371 (18), 370 
(45), 369 (35), 362 (15), 361 (42), 348 (11), 186 (18), 185 (100), 170 (10), 144 (22), 130 (14), 117 (12), 
116 (11), 43 (16). 
HRMS (EI): m/z calcd. for [C22H22N4Si2]: 398.1383; found: 398.1376 (M+). 
M.p. (°C): 142.4 – 143.4. 
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4 Preparation of Polyfunctional Diorgano-Magnesium and –Zinc 
Reagents Using In Situ Trapping Halogen-Lithium Exchange of Highly 
Functionalized (Hetero)aryl Halides in Continuos Flow 
4.1 Typical Procedure (TP 8) 
Typical procedure using a Vapourtec E-series flow setup 
 
Scheme 47: General flow setup for the in situ trapping halogen-lithium exchange using a Vapourtec E-series flow 
setup.  
A n-BuLi or PhLi solution in hexane (0.3 M, 1.5 equiv.) and a solution of the aryl halide substrate 
(R – X, 0.20 M, 1.0 equiv.) and metallic salt (M – Y, 0.1 M, 0.5 equiv.) in THF were prepared. The 
solutions were pumped from their flasks through a suction needle at flow rate A = 3.0 – 10.0 mL min−1 
and flow rate B = flow rate A. After passing a PTFE tubing (volpre = 1.0 – 2.0 mL, T1 = −78 – 0°C, 
residence time: 6 – 20 s) for precooling, the solutions were mixed in a T-mixer (PFA or PTFE, 
I.D. = 0.5 mm). The combined stream passed a PTFE reactor tube (volR = 0.02 – 5.3 mL, residence 
time: t1 = 0.06 – 53.0 s, T1 = −78 – 25 °C) and was subsequently injected in a flask containing a stirred, 
cooled (T1 = −40 – 25°C) solution of an electrophile E+ (1.2 – 2.5 equiv.) and catalyst, if applicable, in 
1 mL THF per mmol of substrate. The reaction mixture was stirred further for the indicated times and 
temperatures (T2, reaction time: t2) and quenched with sat. aq. NH4Cl solution. The aq. phase was 
extracted with EtOAc and the organic phases were dried and filtrated. After removal of the solvent in 
vacuo, flash column chromatographical purification with suited i-hex:EtOAc mixtures afforded the pure 
products R – E. 
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Typical procedure using a Uniqsis flow setup  
 
Scheme 48: General flow setup for the in situ trapping halogen-lithium exchange using a Uniqsis flow setup.  
A n-BuLi or PhLi solution in hexane (0.3 M, 1.5 equiv.) and a solution of the aryl halide substrate 
(R – X, 0.20 M, 1.0 equiv.) and metallic salt (M – Y, 0.1 M, 0.5 equiv.) in THF were prepared. Injection 
loop A (volinj  = 1.0 – 2.0 mL) was loaded with the exchange reagent (n-BuLi or PhLi) and injection 
loop B (volinj  = 1.0 – 2.0 mL) was loaded with the solution of the substrate (R – X) and the metallic salt 
M – Y The solutions were simultaneously injected into separate streams of hexane and THF, 
respectively (pump A: THF, pump B: THF, flow rates: 3.0 – 10.0 mL min−1), which each passed a pre-
cooling loop (volpre = 1.0 – 2.0 mL, T1 = −78 – 0°C, residence time: 6 – 20 s), before they were mixed 
in a T-mixer (PFA or PTFE, I.D. = 0.5 mm). The combined stream passed a PTFE reactor tube 
(volR = 0.02 – 5.3 mL, residence time: t1 = 0.06 – 53.0 s, T1 = −78 – 25 °C) and was subsequently 
injected in a flask containing a stirred, cooled (T1 = −40 – 25°C) solution of an electrophile E+ 
(1.1 – 2.5 equiv.) and catalyst, if applicable, in 1 mL THF per mmol of substrate. The reaction mixture 
was stirred further further for the indicated times and temperatures (T2, reaction time: t2) and quenched 
with sat. aq. NH4Cl solution. The aq. phase was extracted with EtOAc and the organic phases were 
dried and filtrated. After removal of the solvent in vacuo, flash column chromatographical purification 
with suited i-hex:EtOAc mixtures afforded the pure products R – E. 
4.2 Preparation of the products 
4-Allylbenzonitrile (20a) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of allyl bromide 
(21a, 121 mg, 1.0 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 1.0 M in THF, 0.1 equiv.) in 
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THF. Stirring was continued for 10 min at 25 °C before sat. aq. NH4Cl solution was added to quench 
the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, 
purification via HPLC afforded the title compound 20a as a pale yellow oil (40 mg, 0.28 mmol, 70% 
yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.58 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 5.92 (ddt, 
J = 16.9, 10.1, 6.7 Hz, 0H), 5.17 – 5.04 (m, 1H), 3.44 (d, J = 6.7 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 145.8, 135.8, 132.4 (2C), 129.5 (2C), 119.2, 117.4, 110.2, 
40.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2964, 2922, 2854, 2228, 1608, 1458, 1374, 1260, 1176, 1096, 
994, 918, 814, 702. 
MS (EI, 70 eV): m/z (%) = 144 (11), 143 (98), 142 (100), 140 (20), 116 (37), 115 (75), 89 (15). 
HRMS (EI): m/z calcd. for [C10H8N]: 142.0657, found 142.0650 (M+ − H). 
4-Iodobenzonitrile (20b) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred solution of iodine (21b, 254 mg, 
1.00 mmol, 2.5 equiv.) in THF. Stirring was continued for 10 min at 25 °C before sat. aq. Na2S2O3 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 49:1) 
afforded the title compound 20b as a pale yellow powder (75 mg, 0.33 mmol, 83% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 – 7.73 (m, 2H), 7.46 – 7.30 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 138.7 (2C), 133.3 (2C), 118.3, 111.9, 100.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3078, 2958, 2926, 2870, 2226, 1910, 1684, 1644, 1588, 1578, 
1474, 1390, 1370, 1342, 1302, 1274, 1244, 1222, 1204, 1112, 1056, 1010, 962, 816, 766, 732, 700. 
MS (EI, 70 eV): m/z (%) = 229 (100), 130 (12). 
HRMS (EI): m/z calcd. for [C7H4IN]: 228.9388; found 228.9382 (M+). 
M.p. (°C): 170.2 – 170.8. 
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4-(Hydroxy(phenyl)methyl)benzonitrile (20c) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of benzaldehyde 
(21c, 64 mg, 0.60 mmol, 1.5 equiv.) in THF. Stirring was continued for 1 h at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 4:1) 
afforded the title compound 20c as colorless crystals (58 mg, 0.28 mmol, 70% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.67 – 7.55 (m, 2H), 7.56 – 7.45 (m, 2H), 7.45 – 7.27 (m, 5H), 
5.84 (s, 1H), 2.65 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.0, 142.9, 132.3 (2C), 129.0 (2C), 128.4, 127.1 (2C), 126.8 
(2C), 118.9, 111.2, 75.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3462, 3418, 2926, 2882, 2870, 2232, 2226, 1663, 1608, 1599, 
1513, 1503, 1491, 1450, 1404, 1339, 1320, 1276, 1230, 1187, 1172, 1114, 1079, 1044, 1027, 1018, 
862, 846, 802, 770, 732, 723, 702, 675. 
MS (EI, 70 eV): m/z (%) = 209 (53), 208 (16), 190 (11), 130 (24), 107 (13), 105 (34), 104 (27), 103 
(10), 102 (14), 79 (28), 78 (14), 77 (29), 61 (12), 45 (13), 42 (100). 
HRMS (EI): m/z calcd. for [C14H11NO]: 209.0841; found 209.0835 (M+). 
M.p. (°C): 80.7 – 81.0. 
4-(3-Chlorobenzoyl)benzonitrile (20d) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 3-chlorobenzoyl 
chloride (21d, 105 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.44 mL, 1.0 M in THF, 
1.1 equiv.) in THF. Stirring was continued for 1 h at 0 °C before sat. aq. NH4Cl solution was added to 
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quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined 
organic phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, 
flash chromatographical purification (silica gel, i-hex:EtOAc = 49:1) afforded the title compound 20d 
as a white solid (81 mg, 0.34 mmol, 85% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.90 – 7.84 (m, 2H), 7.84 – 7.78 (m, 2H), 7.76 (t, J = 1.8 Hz, 
1H), 7.66 – 7.58 (m, 2H), 7.46 (t, J = 7.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 193.7, 140.6, 138.1, 135.1, 133.4, 132.4 (2C), 130.3 (2C), 
130.1, 130.0, 128.2, 118.0, 116.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3091, 3076, 3064, 2923, 2854, 2228, 1728, 1646, 1606, 1588, 
1567, 1463, 1416, 1403, 1312, 1292, 1279, 1268, 1247, 1180, 1149, 1120, 1074, 1019, 999, 969, 961, 
929, 900, 853, 817, 789, 753, 730, 707, 672, 663. 
MS (EI, 70 eV): m/z (%) = 241 (35), 226 (11), 225 (14), 191 (10), 190 (45), 140 (22), 139 (100), 130 
(45), 111 (37), 102 (36), 75 (13), 50 (10), 44 (30), 43 (17). 
HRMS (EI): m/z calcd. for [C14H8ClNO]: 241.0294; found 241.0286 (M+). 
M.p. (°C): 95.4 – 95.8. 
4-Pivaloylbenzonitrile (20e) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of pivaloyl chloride 
(21e, 72 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.44 mL, 1.0 M in THF, 1.1 equiv.) in 
THF. Stirring was continued for 1 h at 0 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 49:1) afforded the title compound 20e as a 
colorless oil (58 mg, 0.31 mmol, 78% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.69 (s, 4H), 1.31 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 208.5, 142.9, 132.1 (2C), 128.1 (2C), 118.2, 114.3, 44.5, 27.7 
(3C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2972, 2933, 2896, 2872, 2231, 2168, 1678m 1478, 1465, 1400, 
1367, 1275, 1220, 1192, 1170, 1118, 1034, 1018, 965, 953, 844, 766, 697. 
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MS (EI, 70 eV): m/z (%) = 131 (17), 130 (21), 103 (15), 102 (18), 57 (100), 41 (27). 
HRMS (EI): m/z calcd. for [C12H13NO]: 187.0997; found 187.0999 (M+). 
4-Benzoylbenzonitrile (20f) 
 
According to TP 8, a solution of 4-bromobenzonitrile (18a, 0.20 M, 0.40 mmol) and CuCN2LiCl 
(0.22 M, 0.22 mmol, 1.1 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of benzoyl chloride 
(21f, 84 mg, 0.60 mmol, 1.5 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 19:1) 
afforded the title compound 20f as a white solid (66 mg, 0.32 mmol, 80% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 – 7.85 (m, 2H), 7.82 – 7.76 (m, 4H), 7.67 – 7.61 (m, 1H), 
7.55 – 7.48 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 195.1, 141.4, 136.5, 133.5, 132.3 (2C), 130.4 (2C), 130.2 
(2C), 128.8 (2C), 118.1, 115.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3064, 2924, 2226, 1648, 1594, 1578, 1556, 1544, 1446, 1404, 
1308, 1276, 1210, 1174, 1144, 1114, 1072, 1018, 1000, 966, 940, 928, 856, 794, 734, 692, 676. 
MS (EI, 70 eV): m/z (%) = 207 (48), 206 (10), 130 (26), 105 (100), 77 (25). 
HRMS (EI): m/z calcd. for [C14H9NO]: 207.0684; found 207.0679 (M+). 
M.p. (°C): 113.8 – 114.1. 
2-(4-(tert-Butyl)-1-hydroxycyclohexyl)benzonitrile (20g) 
 
According to TP 8, a solution of 2-bromobenzonitrile (18b, 0.20 M, 0.50 mmol) and MgCl2·LiCl 
(0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 4-(tert-
butyl)cyclohexan-1-one (21g, 85 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
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times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 7:3) afforded the title compound 20g as a white solid (99 mg, 0.36 mmol, 73% yield, 
d.r. 84:16). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.81 (dt, J = 7.7, 0.9 Hz, 1H), 7.52 (td, J = 7.5, 1.1 Hz, 1H), 
7.43 (td, J = 7.5, 1.0 Hz, 1H), 7.24 (dt, J = 7.6, 0.9 Hz, 1H), 1.86 – 1.73 (m, 5H), 1.65 – 1.50 (m, 2H), 
1.24 – 1.11 (m, 1H), 0.92 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 152.2, 132.1 (2C), 128.7 (2C), 124.1, 120.7, 88.2, 47.2, 37.4 
(2), 32.7, 27.7 (3C), 23.6 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3286, 2942, 2868, 2224, 1744, 1676, 1660, 1466, 1438, 1364, 
1310, 1240, 1148, 1062, 1008, 924, 904, 854, 840, 756, 694, 656. 
MS (EI, 70 eV): m/z (%) = 201 (10), 200 (12), 160 (14), 160 (14), 159 (100), 158 (52), 146 (10), 145 
(13), 130 (17). 
HRMS (EI): m/z calcd. for [C17H23NO]: 257.1780; found 257.1773 (M+). 
M.p. (°C): 73.4 – 74.6. 
2-(Cyclopropyl(4-fluorophenyl)(hydroxy)methyl)benzonitrile (20h) 
 
According to TP 8, a solution of 2-bromobenzonitrile (18b, 0.20 M, 0.50 mmol) and MgCl2·LiCl 
(0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of cyclopropyl(4-
fluorophenyl)methanone (21h, 90 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 7:3) afforded the title compound 20h as a colorless crystals (93 mg, 0.35 mmol, 70% 
yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.85 (d, J = 7.7 Hz, 1H), 7.54 – 7.41 (m, 4H), 7.27 – 7.21 (m, 
1H), 7.05 – 6.95 (m, 2H), 1.71 (tt, J = 8.3, 5.4 Hz, 1H), 0.72 – 0.63 (m, 1H), 0.58 – 0.50 (m, 1H), 
0.50 – 0.38 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.5 (d, J = 247.4 Hz), 149.8, 137.7, 137.7, 132.3 (2C), 129.0, 
128.1 (d, J = 8.2 Hz, 2C), 124.0, 122.3, 115.4 (d, J = 21.5 Hz, 2C), 89.8, 19.8, 2.3, 1.7. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3296, 3012, 1764, 1676, 1604, 1508, 1466, 1368, 1336, 1304, 
1226, 1160, 1046, 1004, 966, 950, 898, 830, 752, 714, 662. 
MS (EI, 70 eV): m/z (%) = 239 (21), 227 (14), 226 (100), 130 (31). 
HRMS (EI): m/z calcd. for [C17H14FNO]: 267.1059; found 268.1136 (M+). 
M.p. (°C): 112.7 – 114.0. 
Ethyl 2-(2-cyanobenzyl)acrylate (20i) 
 
According to TP 8, a solution of 2-bromobenzonitrile (18b, 0.20 M, 0.50 mmol) and MgCl2·LiCl 
(0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of ethyl 
2-(bromomethyl)acrylate (21i, 138 µL, 1.0 mmol, 2.0 equiv.) and CuCN2LiCl solution (0.05 mL, 
1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 30 min at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) 
afforded the title compound 20i as a colorless oil (73 mg, 0.34 mmol, 68% yield). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.62 (ddd, J = 7.6, 1.3, 0.5 Hz, 1H), 7.51 (td, J = 7.7, 1.4 Hz, 
1H), 7.36 (ddd, J = 7.8, 1.3, 0.7 Hz, 1H), 7.31 (td, J = 7.6, 1.2 Hz, 1H), 6.32 (q, J = 0.9 Hz, 1H), 5.56 
(q, J = 1.3 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.86 (s, 2H), 1.25 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 166.3, 142.7, 138.2, 133.0, 132.8, 130.3, 127.6, 127.1, 118.0, 
113.1, 61.1, 36.6, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2984, 2226, 1712, 1634, 1600, 1486, 1448, 1368, 1302, 1254, 
1198, 1138, 1094, 1024, 952, 930, 858, 816, 760, 680. 
MS (EI, 70 eV): m/z (%) = 355 (12), 341 (11), 299 (20), 281 (31), 225 (21), 221 (14), 215 (15), 214 
(19), 207 (14), 207 (19), 171 (15), 149 (38), 147 (21), 141 (11), 131 (11), 130 (17), 129 (13), 128 (15), 
119 (13), 117 (19), 115 (23), 105 (19), 104 (14), 103 (27), 91 (39), 79 (13), 78 (16), 77 (11), 76 (11), 
73 (25), 45 (25), 44 (30), 43 (100), 42 (11), 41 (17). 
HRMS (EI): m/z calcd. for [C13H13NO2]: 215.0946; found 215.0939 (M+). 
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2-(4-Bromobenzoyl)benzonitrile (20j) 
 
According to TP 8, a solution of 2-bromobenzonitrile (18b, 0.20 M, 0.50 mmol) and MgCl2·LiCl 
(0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 4-bromobenzoyl 
chloride (21j, 165 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 1.0 M in THF, 
1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution was added to 
quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined 
organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the solvent in vacuo, 
flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) afforded the title compound 20j as 
colorless crystals (111 mg, 0.39 mmol, 78% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.88 – 7.83 (m, 1H), 7.75 – 7.60 (m, 7H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 192.9, 141.1, 134.9, 134.4, 132.4, 132.2 (2C), 131.8 (2C), 
131.7, 130.0, 129.5, 117.0, 112.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2924, 2854, 2226, 1732, 1662, 1580, 1476, 1428, 1306, 1292, 
1272, 1192, 1180, 1068, 1010, 926, 840, 766, 754, 730, 716, 678. 
MS (EI, 70 eV): m/z (%) = 207 (15), 206 (100), 185 (10), 185 (50), 183 (11), 183 (51), 130 (13). 
HRMS (EI): m/z calcd. for [C14H8BrNO]: 284.9789; found 284.9785 (M+). 
M.p. (°C): 148.1 – 150.2. 
4-(Cyclopropyl(4-fluorophenyl)(hydroxy)methyl)-2-fluorobenzonitrile (20k) 
 
According to TP 8, a solution of 4-bromo-2-fluorobenzonitrile (18c, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
cyclopropyl(4-fluorophenyl)methanone (21h, 90 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was 
continued for 2 h at 0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase 
was extracted three times with EtOAc (3×30 mL) and the combined organic phases were dried over 
anhydrous Na2SO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
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purification (silica gel, i-hex:EtOAc = 92:8) afforded the title compound 20k as colorless crystals 
(105 mg, 0.37 mmol, 74% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.53 (dd, J = 8.1, 6.5 Hz, 1H), 7.47 – 7.39 (m, 2H), 7.34 (dd, 
J = 10.4, 1.6 Hz, 1H), 7.24 (dd, J = 8.2, 1.6 Hz, 1H), 7.07 – 6.97 (m, 2H), 2.08 (s, 1H), 1.63 – 1.50 (m, 
1H), 0.82 – 0.68 (m, 1H), 0.60 – 0.40 (m, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.0 (d, J = 78.8 Hz), 161.5 (d, J = 67.7 Hz), 156.2 (d, 
J = 6.9 Hz), 141.4 (d, J = 3.3 Hz), 133.0, 128.9 (d, J = 8.2 Hz, 2C), 123.2, 123.1, 115.4 (d, J = 21.4 Hz, 
2C), 114.7 (d, J = 20.8 Hz), 114.1, 99.7 (d, J = 15.6 Hz), 21.5, 2.7, 1.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3418, 2244, 1618, 1602, 1568, 1504, 1496, 1422, 1342, 1220, 
1158, 1106, 1044, 996, 874, 824, 800, 736. 
MS (EI, 70 eV): m/z (%) = 258 (16), 259 (100), 244 (12), 161 (11), 148 (18), 148 (59), 123 (25), 109 
(26). 
HRMS (EI): m/z calcd. for [C17H13F2NO]: 285.0965; found 285.0961 (M+). 
M.p. (°C): 78.4 – 78.9. 
4-(4-Bromobenzoyl)-2-fluorobenzonitrile (20l) 
 
According to TP 8, a solution of 4-bromo-2-fluorobenzonitrile (18c, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.7 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
4-bromobenzoyl chloride (21j, 165 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 97:3) afforded the title 
compound 20l as a colorless crystals (112 mg, 0.37 mmol, 74% yield). 
scale-up: 
In addition, a sufficient scale-up of the reaction was demonstrated according to TP 8. A solution of 
4-bromo-2-fluorobenzonitrile (18c, 0.20 M, 10 mmol) and MgCl2·LiCl (0.1 M, 5 mmol, 0.5 equiv.) in 
THF (total volume: 50 mL) and a solution of n-BuLi (0.30 M in hexane, 15 mmol, 1.5 equiv.) were 
prepared. The precooled solutions were mixed with an overall 9 mL min−1 flow rate in a T-mixer. The 
flow rates were constant over a total runtime of 660 sec. The combined stream passed a 0.25 mL reactor 
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tube (1.7 s, 0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution 
of 4-bromobenzoyl chloride (21j, 3.30 g, 11 mmol, 1.1 equiv.) in THF. Stirring was continued for 3 h 
at 0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted 
three times with EtOAc (3×100 mL) and the combined organic phases were dried over anhydrous 
Na2SO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica 
gel, i-hex:EtOAc = 92:8) afforded the title compound 20l as colorless crystals (2.31 g, 7.6 mmol, 76%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.78 (dd, J = 7.8, 6.4 Hz, 1H), 7.71 – 7.56 (m, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 192.6 (d, J = 1.7 Hz), 163.0 (d, J = 261.9 Hz), 143.4 (d, 
J = 6.5 Hz), 134.6, 133.9, 132.3 (2C), 131.5 (2C), 129.2, 125.8 (d, J = 3.9 Hz), 117.5 (d, J = 20.9 Hz), 
113.2, 105.2 (d, J = 15.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2236, 1660, 1584, 1564, 1494, 1418, 1396, 1298, 1274, 1216, 
1104, 1068, 1010, 896, 872, 858, 840, 826, 754, 686. 
MS (EI, 70 eV): m/z (%) = 185 (13), 185 (97, 183 (13), 183 (100), 157 (19), 155 (19), 148 (15), 148 
(10), 100 (11), 76 (10), 75 (10). 
HRMS (EI): m/z calcd. for [C14H7BrFNO]: 302.9695; found 302.9687 (M+). 
M.p. (°C): 114.0 – 115.4. 
1',2',3',4'-Tetrahydro-[1,1'-biphenyl]-2-carbonitrile (20m) 
 
According to TP 8, a solution of 2-iodobenzonitrile (18d, 0.20 M, 0.40 mmol) and ZnCl2 (0.1 M, 
0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 6 mL min−1 
flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (2.5 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 3-bromocyclohexene 
(21k, 161 mg, 1.00 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 1.0 M in THF, 0.1 equiv.) in 
THF. Stirring was continued for 10 min at 0 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 99:1) afforded the title compound 20m as 
pale yellow oil (59 mg, 0.32 mmol, 80% yield). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.62 (dd, J = 7.7, 1.4 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.39 – 7.35 
(m, 1H), 7.29 (td, J = 7.6, 1.2 Hz, 1H), 6.02 – 5.97 (m, 1H), 5.67 – 5.62 (m, 1H), 3.89 – 3.84 (m, 1H), 
2.18 – 2.09 (m, 3H), 1.77 – 1.64 (m, 2H), 1.57 – 1.50 (m, 1H). 
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13C-NMR (151 MHz, CDCl3): δ / ppm = 150.4, 133.0, 132.9, 130.1, 128.4, 128.1, 126.7, 118.2, 112.1, 
40.2, 31.7, 25.0, 21.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3024, 2932, 2860, 2838, 2222, 1684, 1652, 1598, 1480, 1446, 
1432, 1346, 1322, 1296, 1284, 1248, 1206, 1164, 1136, 1094, 1046, 1038, 984, 956, 902, 884, 876, 
848, 702, 760, 746, 722, 686, 662. 
MS (EI, 70 eV): m/z (%) = 183 (79), 182 (100), 168 (37), 167 (19), 166 (21), 165 (21), 156 (11), 154 
(43), 142 (14), 141 (10), 140 (30), 129 (30), 128 (18), 127 (18), 116 (22), 115 (25), 89 (14), 77 (20), 76 
(11), 63 (16), 54 (14), 43 (13), 42 (11), 41 (31). 
HRMS (EI): m/z calcd. for [C13H12N]: 182.0970; found 182.0960 (M+ − H). 
(2-Bromophenyl)(4-methoxyphenyl)methanone (20n) 
 
According to TP 8, a solution of 1-bromo-4-methoxybenzene (18e, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 5 mL reactor tube (12 s, 0 °C) 
and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 2-bromobenzoyl 
chloride (21l, 165 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 1.0 M in THF, 
1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution was added to 
quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined 
organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the solvent in vacuo, 
flash chromatographical purification (silica gel, i-hex:EtOAc = 95:5) afforded the title compound 20n 
as colorless crystals (98 mg, 0.34 mmol, 68% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.81 – 7.76 (m, 2H), 7.63 (ddd, J = 8.0, 1.1, 0.5 Hz, 1H), 7.40 
(td, J = 7.4, 1.1 Hz, 1H), 7.35 – 7.30 (m, 2H), 6.95 – 6.91 (m, 2H), 3.87 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 194.6, 164.3, 141.2, 133.2, 132.8 (2C), 131.0, 129.2, 128.9, 
127.3, 119.5, 114.0 (2C), 55.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3056, 2972, 2840, 1654, 1596, 1572, 1510, 1486, 1428, 1308, 
1292, 1246, 1178, 1150, 1112, 1020, 926, 860, 822, 760, 734, 692, 654. 
MS (EI, 70 eV): m/z (%) = 292 (16), 290 (16), 135 (100). 
HRMS (EI): m/z calcd. for [C14H11BrO2]: 289.9942; found 289.9937 (M+). 
M.p. (°C): 92.2 – 93.5. 
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(3-Chlorophenyl)(4-methoxyphenyl)methanone (20o) 
 
According to TP 8, a solution of 1-bromo-4-methoxybenzene (18e, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 5 mL reactor tube (12 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
3-chlorobenzoyl chloride (21d, 131 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 95:5) afforded the title 
compound 20o as colorless crystals (71 mg, 0.28 mmol, 56% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.82 – 7.78 (m, 2H), 7.72 (dd, J = 2.1, 1.5 Hz, 1H), 7.61 (dt, 
J = 7.6, 1.4 Hz, 1H), 7.52 (ddd, J = 8.0, 2.2, 1.1 Hz, 1H), 7.40 (t, J = 7.8 Hz, 1H), 6.98 – 6.95 (m, 2H), 
3.88 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 194.1, 163.6, 140.1, 134.5, 132.7 (2C), 131.9, 129.7, 129.6, 
129.6, 127.9, 113.8 (2C), 55.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3062, 2844, 1644, 1602, 1566, 1506, 1456, 1418, 1302, 1282, 
1252, 1170, 1152, 1114, 1028, 962, 896, 838, 756, 706, 668. 
MS (EI, 70 eV): m/z (%) = 246 (22), 135 (100). 
HRMS (EI): m/z calcd. for [C14H11ClO2]: 246.0448; found 246.0441 (M+). 
M.p. (°C): 71.4 – 72.3. 
(4-Fluorophenyl)(4-methoxyphenyl)methanone (20p) 
 
According to TP 8, a solution of 1-bromo-4-methoxybenzene (18e, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 5 mL reactor tube (12 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
4-fluorobenzoyl chloride (21m, 119 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
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the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 95:5) afforded the title 
compound 20p as a white solid (87 mg, 0.34 mmol, 67% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.79 (dt, J = 8.8, 2.7 Hz, 4H), 7.14 (t, J = 8.6 Hz, 2H), 6.96 
(d, J = 8.8 Hz, 2H), 3.88 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 194.2, 165.2 (d, J = 253.2 Hz), 163.4, 134.6, 132.5 (2C), 
132.4 (d, J = 8.9 Hz, 2C), 130.1, 115.4 (d, J = 21.8 Hz, 2C), 113.8 (2C), 55.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3070, 1644, 1592, 1570, 1500, 1460, 1418, 1406, 1304, 1286, 
1258, 1224, 1146, 1110, 1098, 1020, 960, 928, 852, 840, 764, 676. 
MS (EI, 70 eV): m/z (%) = 230 (46), 199 (14), 135 (100), 123 (15). 
HRMS (EI): m/z calcd. for [C14H11FO2]: 230.0743; found 230.0738 (M+). 
M.p. (°C): 86.8 – 88.0. 
(2,6-Difluorophenyl)(4-methoxyphenyl)methanone (20q) 
 
According to TP 8, a solution of 1-bromo-4-methoxybenzene (18e, 0.20 M, 0.50 mmol) and 
MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 5.0 mL reactor tube (12 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
2,5-difluorobenzoyl chloride (21n, 132 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 95:5) afforded the title 
compound 20q as colorless crystals (90 mg, 0.31 mmol, 61% yield). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.87 – 7.81 (m, 2H), 7.41 (tt, J = 8.4, 6.3 Hz, 1H), 7.00 – 6.96 
(m, 2H), 6.96 – 6.93 (m, 2H), 3.86 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 187.4, 164.6, 159.8 (dd, J = 250.9, 7.7 Hz, 2C), 132.2 (2C), 
131.7 (t, J = 9.9 Hz), 130.1 , 117.4 (t, J = 22.3 Hz), 114.1 (2C) , 111.9 (d, J = 22.3 Hz, 2C), 55.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3090, 2940, 2844, 1736, 1650, 1622, 1598, 1574, 1464, 1456, 
1424, 1284, 1264, 1236, 1188, 1142, 1120, 1024, 1000, 928, 844, 790, 766, 724, 688, 654. 
MS (EI, 70 eV): m/z (%) = 248 (42), 141 (11), 135 (100), 77 (10). 
HRMS (EI): m/z calcd. for [C14H10F2O2]: 248.0649; found 248.0643 (M+). 
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M.p. (°C): 89.9 – 91.1. 
4'-Methoxy-[1,1'-biphenyl]-4-carbonitrile (20r) 
 
According to TP 8, a solution of 4-bromoanisole (18e, 0.20 M, 0.40 mmol) and MgCl2·LiCl (0.1 M, 
0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 12 mL min−1 
flow rate in a T-mixer. The combined stream passed a 5.0 mL reactor tube (25 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of ZnCl2 (0.44 mL, 1.0 M in 
THF, 1.1 equiv.) in THF. The mixture was stirred for 15 min and then PEPPSI-i-Pr (5.4 mg, 
0.008 mmol, 2 mol%) and 4-iodobenzonitrile (20b, 137 mg, 0.6 mmol, 1.5 equiv.) were added. Stirring 
was continued overnight at 25 °C before sat. aq. NH4Cl solution was added to quench the reaction. The 
aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic phases were dried 
over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
purification (silica gel, i-hex:EtOAc = 19:1) afforded the title compound 20r as colorless crystals 
(73 mg, 0.35 mmol, 88% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.69 (d, J = 8.3 Hz, 2H), 7.64 (d, J = 8.3 Hz, 2H), 7.54 (d, 
J = 8.6 Hz, 2H), 7.01 (d, J = 8.6 Hz, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.3, 145.3, 132.7 (2C), 131.6, 128.5 (2C), 127.2 (2C), 
119.2, 114.6 (2C), 110.2, 55.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2222, 1604, 1576, 1514, 1492, 1470, 1446, 1420, 1396, 1312, 
1306, 1294, 1266, 1240, 1188, 1176, 1110, 1036, 1020, 1000 970, 936, 854, 822, 812, 768, 738, 718, 
698, 666. 
MS (EI, 70 eV): m/z (%) = 210 (15), 209 (100), 194 (50), 166 (61), 140 (35), 139 (13). 
HRMS (EI): m/z calcd. for [C14H11NO]: 209.0841; found 209.0834 (M+). 
M.p. (°C): 96.9 – 101.2. 
5-(4-Nitrophenyl)benzo[d][1,3]dioxole (20s) 
 
According to TP 8, a solution of 5-bromobenzo[d][1,3]dioxole (18f, 0.20 M, 0.40 mmol) and 
MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 18 mL min−1 flow rate in a T-mixer. The combined stream passed a 5.0 mL reactor tube (16.7 s, 
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0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of ZnCl2 
(0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. The mixture was stirred for 15 min and then PEPPSI-i-Pr 
(5.4 mg, 0.008 mmol, 2 mol%) and 1-iodo-4-nitrobenzene (21o, 149 mg, 0.6 mmol, 1.5 equiv.) were 
added. Stirring was continued overnight at 25 °C before sat. aq. NH4Cl solution was added to quench 
the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 99:1) afforded the title compound 20s as a 
yellow solid (82 mg, 0.34 mmol, 85% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.26 (dt, J = 9.0, 2.6, 2.0 Hz, 2H), 7.65 (dt, J = 9.0, 2.5, 2.0 Hz, 
2H), 7.15 – 7.06 (m, 2H), 6.92 (d, J = 8.0 Hz, 1H), 6.04 (s, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.7, 148.6, 147.4, 146.9, 133.1, 127.5 (2C), 124.3 (2C), 
121.6, 109.0, 107.7, 101.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2922, 2854, 1594, 1506, 1494, 1478, 1440, 1410, 1334, 1294, 
1280, 1258, 1232, 1202, 1186, 1154, 1110, 1032, 1012, 974, 962, 926, 876, 846, 810, 752, 740, 720, 
692, 658. 
MS (EI, 70 eV): m/z (%) = 243 (100), 242 (11), 213 (24), 185 (15), 167 (11), 139 (76). 
HRMS (EI): m/z calcd. for [C13H9NO4]: 243.0532; found 243.0527 (M+). 
M.p. (°C): 124.0 – 124.9. 
Ethyl 4-(benzo[d][1,3]dioxol-5-yl)benzoate (20t) 
 
According to TP 8, a solution of 5-bromobenzo[d][1,3]dioxole (18f, 0.20 M, 0.40 mmol) and 
MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 18 mL min−1 flow rate in a T-mixer. The combined stream passed a 5.0 mL reactor tube (16.7 s, 
0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of ZnCl2 
(0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. The mixture was stirred for 15 min and then PEPPSI-i-Pr 
(5.4 mg, 0.008 mmol, 2 mol%) and ethyl 4-iodobenzoate (21p, 166 mg, 0.6 mmol, 1.5 equiv.) were 
added. Stirring was continued overnight at 25 °C before sat. aq. NH4Cl solution was added to quench 
the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 24:1) afforded the title compound 20t as 
colorless crystals (75 mg, 0.28 mmol, 70% yield). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.07 (dt, J = 8.6, 2.2 Hz, 2H), 7.57 (dt, J = 8.6, 1.9 Hz, 2H), 
7.13 – 7.05 (m, 2H), 6.95 – 6.81 (m, 1H), 6.01 (s, 2H), 4.40 (q, J = 7.1 Hz, 2H), 1.41 (t, J = 7.1 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.6, 148.4, 147.9, 145.3, 134.4, 130.2 (2C), 129.0, 126.7 
(2C), 121.1, 108.8, 107.8, 101.4, 61.1, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2986, 2942, 2902, 2788, 1704, 1604, 1522, 1502, 1484, 1440, 
1410, 1368, 1314, 1288, 1270, 1254, 1234, 1180, 1148, 1102, 1034, 1020, 1010, 932, 890, 856, 848, 
812, 768, 738, 700, 656. 
MS (EI, 70 eV): m/z (%) = 271 (18), 270(100), 242 (51), 241 (28), 226 (11), 225 (75), 197 (11), 
139(61). 
HRMS (EI): m/z calcd. for [C16H14O4]: 270.0892; found 270.0887 (M+). 
M.p. (°C): 92.9 – 93.2. 
1-Allyl-4-azidobenzene (24a) 
 
According to TP 8, a solution of 1-azido-4-iodobenzene (22a, 0.20 M, 1.00 mmol) and ZnCl2 (0.1 M, 
0.50 mmol, 0.5 equiv.) in THF (total volume: 5.00 mL) and a solution of n-BuLi (0.30 M in hexane, 
1.50 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 12 mL min−1 
flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.25 s, −40 °C) and was 
subsequently injected in a flask containing a stirred, cooled (−40 °C) solution of allyl bromide (21a, 
0.22 mL, 2.5 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.05 mL, 1.0 M in THF, 0.1 equiv.) in THF. 
Stirring was continued for 1.5 h at −40 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×60 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex) afforded the title compound 24a as a pale yellow oil 
(114 mg, 0.72 mmol, 72% yield). 
scale-up: 
Scale-up of the reaction was achieved according to TP 8. A solution of azido-4-iodobenzene (22a, 
0.20 M, 4.90 mmol) and ZnCl2 (0.1 M, 2.45 mmol, 0.5 equiv.) in THF (total volume: 24.50 mL) and a 
solution of n-BuLi (0.30 M in hexane, 7.35 mmol, 1.5 equiv.) were prepared. The precooled solutions 
were mixed with an overall 12 mL min−1 flow rate in a T-mixer over a total runtime of 250 sec. The 
combined stream passed a 0.25 mL reactor tube (1.25 s, −40 °C) and was subsequently injected in a 
flask containing a stirred, cooled (−40 °C) solution of allyl bromide (21a, 1.06 mL, 12.25 mmol, 
2.5 equiv.) and CuCN2LiCl solution (0.49 mL, 1.0 M in THF, 0.1 equiv.) in THF. Stirring was 
continued for 1 h at −40 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. 
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phase was extracted three times with EtOAc (3×150 mL) and the combined organic phases were dried 
over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
purification (silica gel, i-hex) afforded 24a as a pale yellow oil (464 mg, 2.91 mmol, 60%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.17 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 8.3 Hz, 2H), 6.02 – 5.87 
(m, 1H), 5.12 – 5.06 (m, 1H), 5.10 – 5.02 (m, 1H), 3.40 – 3.33 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 138.0, 137.3, 137.0, 130.1 (2C), 119.2 (2C), 116.2, 39.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2923, 2108, 1611, 1510, 1505, 1434, 1357, 1284, 1184, 1120, 
1082, 994, 805, 735. 
MS (EI, 70 eV): m/z (%) = 159(20), 132(15), 131(100), 130(82), 128(17), 127(12), 116(18), 104(23), 
103(28), 97(13), 95(14), 91(15), 85(13), 83(14), 81(14), 78(23), 77(20), 71(17), 69(21), 63(11), 57(21), 
55(13), 41(28), 40(15). 
HRMS (EI): m/z calcd. for [C9H9N3]: 159.0796; found 159.0788 (M+). 
3-Allyl-4-azidobenzene (24b) 
 
According to TP 8, a solution of 1-azido-3-iodobenzene (22b, 0.20 M, 1.00 mmol) and ZnCl2 (0.1 M, 
0.50 mmol, 0.5 equiv.) in THF (total volume: 5.00 mL) and a solution of n-BuLi (0.30 M in hexane, 
1.50 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 12 mL min−1 
flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.25 s, −40 °C) and was 
subsequently injected in a flask containing a stirred, cooled (−40 °C) solution of allyl bromide (21a, 
0.22 mL, 2.5 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.05 mL, 1.0 M in THF, 0.1 equiv.) in THF. 
Stirring was continued for 1.5 h at −40 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×60 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex) afforded the title compound 24b as a pale yellow oil 
(132 mg, 0.83 mmol, 83%). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.28 (t, J = 7.8 Hz, 1H), 6.98 (d, J = 7.7 Hz, 1H), 6.88 (d, 
J = 7.9 Hz, 1H), 6.86 (s, 1H), 5.95 (ddt, J = 18.8, 9.5, 6.7 Hz, 1H), 5.12 (s, 1H), 5.14 – 5.06 (m, 1H), 
3.38 (d, J = 6.7 Hz, 2H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 142.2, 140.2, 136.8, 129.9, 125.4, 119.3, 116.9, 116.6, 40.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3047, 2924, 2108, 1603, 1558, 1483, 1444, 1356, 1288, 1203, 
1168, 1101, 1073, 1021, 994, 941, 914, 885, 775, 695. 
MS (EI, 70 eV): m/z (%) = 133(17), 132(27), 131(100), 116(24), 115(17), 111(17), 106(19), 104(26), 
103(23), 97(23), 91(30), 85(23), 83(28), 78(23), 77(50), 71(27), 69(32), 65(16), 57(43), 55(26), 51(16), 
44(59), 43(27), 41(36). 
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HRMS (EI): m/z calcd. for [C9H9N3]: 159.0796; found 159.0791 (M+). 
2'-Nitro-1,2,3,4-tetrahydro-1,1'-biphenyl (24c) 
 
According to TP 8, a solution of 1-bromo-2-nitrobenzene (22c, 0.20 M, 0.40 mmol) and ZnCl2 (0.1 M, 
0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M in 
hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with 
an overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube 
(1.25 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
3-bromocyclohexene (21k, 161 mg, 1.0 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 1.0 M 
in THF, 0.1 equiv.) in THF. Stirring was continued for 10 min at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous MgSO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the title compound 
24c as pale yellow oil (76 mg, 0.37 mmol, 93% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.77 (dd, J = 8.1, 1.3 Hz, 1H), 7.52 (td, J = 7.6, 1.3 Hz, 1H), 
7.45 (dd, J = 7.9, 1.5 Hz, 1H), 7.36 – 7.29 (m, 1H), 6.02 – 5.93 (m, 1H), 5.63 – 5.55 (m, 1H), 
4.00 – 3.89 (m, 1H), 2.26 – 2.15 (m, 1H), 2.16 – 2.05 (m, 2H), 1.81 – 1.61 (m, 2H), 1.61 – 1.49 (m, 
1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.9, 140.7, 132.6, 130.4, 129.8, 129.0, 127.0, 124.2, 36.9, 
31.8, 25.0, 21.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3022, 2928, 2860, 2838, 1650, 1606, 1576, 1520, 1478, 1444, 
1348, 1294, 1252, 1222, 1190, 1164, 1144, 1134, 1078, 1060, 1036, 984, 956, 932, 902, 884, 854, 840, 
784, 744, 726, 698, 660. 
MS (EI, 70 eV): m/z (%) = 186 (54), 169 (11), 168 (80), 167 (48), 158 (33), 156 (21), 153 (15), 152 
(15), 147 (14), 146 (61), 143 (37), 141 (18), 132 (17), 131 (10), 130 (100), 129 (13), 128 (40), 127 (11), 
118 (11), 117 (21), 115 (57), 105 (13), 103 (10) 102 (10), 92 (11), 91 (20), 89 (11), 77 (23). 
HRMS (EI): m/z calcd. for [C12H12NO2]: 202.0868; found 202.0861 (M+ − H). 
Ethyl 5-(2-nitrophenyl)cyclopent-1-ene-1-carboxylate (24d) 
 
According to TP 8, a solution of 1-bromo-2-nitrobenzene (22c, 0.20 M, 0.40 mmol) and ZnCl2 (0.1 M, 
0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M in 
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hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with 
an overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube 
(1.25 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
ethyl 5-bromocyclopent-1-ene-1-carboxylate (21q, 131 mg, 0.6 mmol, 1.5 equiv.) and CuCN2LiCl 
solution (0.04 mL, 1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 1 h at 0 °C before sat. 
aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three times with 
EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 19:1) afforded the title compound 24d as a brown-red oil (81 mg, 0.31 mmol, 78% 
yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.83 (d, J = 8.1 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 7.31 (t, 
J = 7.7 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 7.12 – 7.06 (m, 1H), 4.72 – 4.54 (m, 1H), 4.07 – 3.91 (m, 
2H), 2.82 – 2.53 (m, 2H), 1.98 – 1.88 (m, 1H), 1.33 – 1.17 (m, 1H), 1.03 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.3, 149.5, 146.6, 140.1, 138.3, 133.0, 128.2, 127.0, 124.3, 
60.3, 45.4, 33.8, 32.1, 14.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2980, 2936, 2906, 2872, 1758, 1710, 1634, 1608, 1578, 1522, 
1478, 1446, 1352, 1292, 1266, 1204, 1188, 1140, 1098, 1032, 1018, 956, 930, 902, 852, 824, 784, 746, 
708, 684, 662. 
MS (EI, 70 eV): m/z (%) = 216 (79), 205 (15), 198 (20), 188 (26), 187 (24), 185 (30), 172 (80), 171 
(49), 170 (100), 169 (15), 168 (21), 161 (16), 160 (37), 159 (16), 157 (21), 155 (18), 154 (53), 146 (16), 
145 (89), 144 (22), 143 (38), 142 (40), 141 (59), 140 (18), 139 (34), 130 (30), 129 (37), 128 (52), 127 
(32), 117 (21), 116 (22), 115 (98), 77 (17), 55 (32). 
HRMS (EI): m/z calcd. for [C12H10NO3]: 216.0661; found 216.0669 (M+ − C2H5O). 
1-Allyl-4-methoxy-2-nitrobenzene (24e) 
 
According to TP 8, a solution of 1-bromo-4-methoxy-2-nitrobenzene (22d, 0.20 M, 0.40 mmol) and 
ZnCl2 (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium 
(0.30 M in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were 
mixed with an overall 12 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL 
reactor tube (0.10 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of allyl bromide (21a, 121 mg, 1.0 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 
1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 10 min at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
C. EXPERIMENTAL PART    121 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 49:1) 
afforded the title compound 24e as a red-brown oil (56 mg, 0.29 mmol, 73% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.44 (d, J = 2.7 Hz, 1H), 7.26 (d, J = 8.5 Hz, 2H), 7.09 (dd, 
J = 8.6, 2.7 Hz, 1H), 6.04 – 5.79 (m, 1H), 5.22 – 4.92 (m, 2H), 3.85 (s, 3H), 3.61 (dt, J = 6.4, 1.5 Hz, 
2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.5, 149.7, 135.6, 132.9, 126.9, 119.9, 116.8, 109.4, 55.9, 
36.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3082, 2942, 2840, 1640, 1622, 1572, 1524, 1498, 1462, 1440, 
1410, 1348, 1322, 1286, 1248, 1186, 1146, 1066, 1034, 996, 916, 856, 832, 810, 792, 760, 738, 676. 
MS (EI, 70 eV): m/z (%) = 192 (11), 176 (70), 175 (19), 164 (41), 163 (15), 161 (15), 160 (10), 159 
(100), 148 (15), 147 (11), 146 (35), 133 (56), 132 (15), 131 (29), 130 (10), 129 (28), 117 (14), 115 (24), 
105 (18), 103 (57), 102 (11), 91 (16), 89 (11), 78 (10), 88 (26). 
HRMS (EI): m/z calcd. for [C10H11NO3]: 193.0739; found 193.0732 (M+). 
(1-Methyl-1H-indol-2-yl)(3-nitrophenyl)methanol (24f) 
 
According to TP 8, a solution of 1-iodo-3-nitrobenzene (22e, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 20 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL reactor 
tube (0.06 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of 1-methyl-1H-indole-3-carbaldehyde (21r, 96 mg, 0.60 mmol, 1.5 equiv.) in THF. Stirring 
was continued for 1.5 h at 0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The 
aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic phases were dried 
over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
purification (silica gel, i-hex:EtOAc = 4:1) afforded the title compound 24f as a red gel (67 mg, 
0.24 mmol, 60% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.44 – 8.28 (m, 1H), 8.14 – 7.99 (m, 1H), 7.92 – 7.73 (m, 1H), 
7.59 – 7.43 (m, 2H), 7.40 – 7.20 (m, 2H), 7.17 – 7.04 (m, 1H), 6.85 (s, 1H), 6.19 (s, 1H), 3.74 (s, 3H), 
2.62 – 2.49 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.4, 146.1, 137.6, 132.5, 129.2, 127.7, 125.9, 122.5, 122.3, 
121.4, 119.9, 119.5, 117.2, 109.7, 69.2, 32.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3056, 2932, 2826, 1702, 1614, 1582, 1524, 1474, 1446, 1424, 
1370, 1346, 1330, 1252, 1234, 1200, 1156, 1130, 1090, 1062, 1036, 1012, 906, 806, 788, 730, 684. 
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MS (EI, 70 eV): m/z (%) = 283 (20), 282 (100), 266 (16), 265 (64), 219 (16), 218 (18), 160 (38), 158 
(16), 132 (39), 129 (10), 117 (15). 
HRMS (EI): m/z calcd. for [C16H14N2O3]: 282.1004; found 282.0997 (M+). 
Cyclopropyl(3-nitrophenyl)methanone (24g) 
 
According to TP 8, a solution of 1-iodo-3-nitrobenzene (22e, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 20 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL reactor 
tube (0.06 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of cyclopropanecarbonyl chloride (21h, 63 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl 
solution (0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 1.5 h at 0 °C before 
sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three times with 
EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, purification via HPLC afforded the title compound 24g as a white 
solid (48 mg, 0.25 mmol, 63% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.84 (t, J = 1.9 Hz, 1H), 8.42 (dq, J = 8.2, 2.3, 1.1 Hz, 1H), 
8.32 (dq, J = 7.8, 1.6, 1.1 Hz, 1H), 7.68 (t, J = 7.8 Hz, 1H), 2.81 – 2.58 (m, 1H), 1.37 – 1.26 (m, 2H), 
1.20 – 1.08 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 198.5, 148.5, 139.3, 133.7, 129.9, 127.2, 123.1, 17.7, 12.7 
(2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3094, 1662, 1614, 1580, 1526, 1476, 1440, 1418, 1384, 1350, 
1316, 1282, 1222, 1172, 1110, 1080, 1046, 1016, 1000, 922, 894, 878, 850, 822, 802, 752, 716, 686, 
664. 
MS (EI, 70 eV): m/z (%) = 150 (150), 104 (19), 76 (12). 
HRMS (EI): m/z calcd. for [C10H8NO3]: 190.0504; found 190.0497 (M+ − H). 
M.p. (°C): 73.9 – 75.0. 
Cyclopropyl(4-fluorophenyl)(4-nitrophenyl)methanol (24h) 
 
According to TP 8, a solution of 1-iodo-4-nitrobenzene (22f, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
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with an overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL reactor 
tube (0.08 s, −60 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of cyclopropyl(4-fluorophenyl)methanone (21h, 99 mg, 0.60 mmol, 1.5 equiv.) in THF. 
Stirring was continued for 1.5 h at 0 °C before sat. aq. NH4Cl solution was added to quench the reaction. 
The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic phases were 
dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 9:1) afforded the title compound 24h as an 
orange oil (82 mg, 0.29 mmol, 73% yield). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.15 (dt, J = 9.0, 2.0 Hz, 2H), 7.57 (dt, J = 9.0, 2.1 Hz, 2H), 
7.46 – 7.41 (m, 2H), 7.05 – 6.98 (m, 2H), 1.98 (s, 1H), 1.63 – 1.57 (m, 1H), 0.77 – 0.69 (m, 1H), 
0.59 – 0.50 (m, 2H), 0.50 – 0.45 (m, 1H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 162.3 (d, J = 247.3 Hz), 154.5, 147.0, 141.2, 129.0 (d, 
J = 8.1 Hz, 2C), 127.6 (2C), 123.3 (2C), 115.3 (d, J = 21.3 Hz, 2C), 76.6, 21.7, 2.6, 1.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3538, 3082, 3010, 1602, 1506, 1424, 1408, 1346, 1316, 1224, 
1160, 1108, 1098, 1026, 1014, 988, 964, 930, 906, 878, 852, 830, 804, 750, 708, 696. 
MS (EI, 70 eV): m/z (%) = 260 (15), 259 (100), 246 (14), 183 (11), 165 (11), 150 (37), 123 (37), 109 
(13). 
HRMS (EI): m/z calcd. for [C16H13FNO3]: 286.0879; found 286.0868 (M+ − H). 
2-Benzoyl-3-fluoro-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-4-carbonitrile (24i) 
 
According to TP 8, a solution of 3-benzoyl-4-bromo-2-fluorobenzonitrile (22g, 0.20 M, 0.40 mmol) and 
ZnCl2 (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium 
(0.30 M in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were 
mixed with an overall 20 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL 
reactor tube (0.06 s, 0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of 3-bromocyclohexene (21k, 161 mg, 1.00 mmol, 2.5 equiv.) and CuCN2LiCl solution 
(0.04 mL, 1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 30 min at 0 °C before sat. aq. 
NH4Cl solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 19:1) 
afforded the title compound 24i as a colorless oil (94 mg, 0.31 mmol, 78% yield). 
C. EXPERIMENTAL PART    124 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.80 (dd, J = 8.2, 1.1 Hz, 2H), 7.68 – 7.64 (m, 2H), 7.52 – 7.49 
(m, 2H), 7.31 (d, J = 8.2 Hz, 1H), 5.95 – 5.90 (m, 1H), 5.52 (dd, J = 10.5, 2.1 Hz, 1H), 3.41 – 3.34 (m, 
1H), 2.10 – 1.99 (m, 2H), 1.96 – 1.90 (m, 1H), 1.71 – 1.65 (m, 1H), 1.52 – 1.41 (m, 2H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 192.4, 160.2, 158.9, 153.3, 136.7, 134.8, 133.9, 130.6, 129.6 
(2C), 129.2 (2C), 127.8, 125.0, 113.7, 99.4, 39.2, 32.0, 24.7, 21.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3026, 2934, 2862, 2838, 2236, 1672, 1614, 1596, 1562, 1476, 
1448, 1428, 1392, 1344, 1316, 1284, 1248, 1174, 1160, 1136, 1074, 1056, 1012, 1002, 984, 954, 910, 
896, 868, 834, 772, 760, 728, 714, 686, 676. 
MS (EI, 70 eV): m/z (%) = 305 (11), 287 (40), 272 (16), 258 (13), 250 (21), 210 (14), 209 (100), 208 
(48), 207 (13), 91 (18), 77 (10). 
HRMS (EI): m/z calcd. for [C20H16FNO]: 305.1216; found 305.1210 (M+). 
4-Allyl-3-benzoyl-2-fluorobenzonitrile (24j) 
 
According to TP 8, a solution of 3-benzoyl-4-bromo-2-fluorobenzonitrile (22g, 0.20 M, 0.40 mmol) and 
ZnCl2 (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium 
(0.30 M in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were 
mixed with an overall 20 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.02 mL 
reactor tube (0.06 s, 0 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) 
solution of allyl bromide (21a, 122 mg, 1.00 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 
1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 10 min at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 19:1) 
afforded the title compound 24j as a colorless oil (68 mg, 0.26 mmol, 65% yield). 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.79 (d, J = 7.3 Hz, 2H), 7.69 – 7.63 (m, 2H), 7.52 – 7.48 (m, 
2H), 7.26 (d, J = 8.4 Hz, 1H), 5.80 – 5.71 (m, 1H), 5.04 (dq, J = 10.3, 1.3 Hz, 1H), 4.98 (dq, J = 17.0, 
1.5 Hz, 1H), 3.34 (d, J = 6.8 Hz, 2H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 192.1, 160.4, 159.1, 146.7, 136.5, 134.8, 134.1, 134.0, 129.6 
(2C), 129.1 (2C), 126.4, 118.6, 113.5, 99.9, 37.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3084, 3066, 2236, 1670ß, 1640, 1613, 1596, 1564, 1480, 1450, 
1428, 1316, 1278, 1252, 1202, 1174, 1160, 1100, 1028, 1012, 992, 918, 832, 770, 742, 706, 686, 674. 
MS (EI, 70 eV): m/z (%) = 265 (14), 264 (19), 251 (17), 250 (100), 247 (11), 246 (20), 244 (11), 221 
(14), 208 (13), 188 (44), 187 (31), 159 (10), 158 (24), 105 (17), 91 (18), 77 (25). 
HRMS (EI): m/z calcd. for [C17H12FNO]: 265.0903; found 265.0903 (M+). 
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Ethyl 4-((1s,3s)-adamantane-1-carbonyl)benzoate (24k) 
 
According to TP 8, a solution of ethyl 4-iodobenzoate (22h, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor 
tube (0.94 s, −40 °C) and was subsequently injected in a flask containing a stirred, cooled (−40 °C) 
solution of 1-adamantanecarbonyl chloride (21t, 119 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl 
solution (0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at −40 °C before 
sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three times with 
EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 99:1) afforded the title compound 24k as a colorless oil (86 mg, 0.28 mmol, 70% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05 (d, J = 8.2 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H), 4.39 (q, 
J = 7.1 Hz, 2H), 2.09 – 2.04 (m, 3H), 2.00 – 1.92 (m, 6H), 1.79 – 1.66 (m, 6H), 1.40 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 210.3, 166.1, 144.0, 131.7, 129.3 (2C), 126.8 (2C), 61.4, 47.1, 
39.0 (3C), 36.6 (3C), 28.1 (3C), 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2904, 2850, 2167, 1717, 1674, 1608, 1569, 1503, 1475, 1452, 
1400, 1367, 1345, 1269, 1231, 1198, 1179, 1161, 1021, 988, 951, 931, 860, 829, 776, 767, 716, 696, 
662. 
MS (EI, 70 eV): m/z (%) = 312 (13), 136 (25), 135 (100), 93 (18), 79 (21). 
HRMS (EI): m/z calcd. for [C20H24O3]: 312.1725; found 312.1721 (M+). 
Ethyl 4-pivaloylbenzoate (24l) 
 
According to TP 8, a solution of ethyl 4-iodobenzoate (22h, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor 
tube (0.94 s, −40 °C) and was subsequently injected in a flask containing a stirred, cooled (−40 °C) 
solution of pivaloyl chloride (21e, 72 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.44 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at −40 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
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(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 99:1) 
afforded the title compound 24l as a colorless oil (72 mg, 0.31 mmol, 78% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 (d, J = 8.6 Hz, 2H), 7.64 (d, J = 8.6 Hz, 2H), 4.39 (q, 
J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H), 1.32 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 209.6, 166.0, 143.0, 132.2, 129.4 (2C), 127.4 (2C), 61.4, 44.5, 
27.8 (3C), 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2971, 2933, 2872, 2168, 1718, 1680, 1569, 1502, 1477, 1463, 
1448, 1402, 1367, 1310, 1271, 1187, 1104, 1020, 956, 862, 853, 816, 789, 734, 717, 703. 
MS (EI, 70 eV): m/z (%) = 178 (21), 177 (100), 149 (12), 57 (16), 43 (32). 
HRMS (EI): m/z calcd. for [C14H18O3]: 234.1256; found 234.1254 (M+). 
Ethyl 4-(furan-2-yl(hydroxy)methyl)benzoate (24m) 
 
According to TP 8, a solution of ethyl 4-iodobenzoate (22h, 0.20 M, 0.40 mmol) and MgCl2·LiCl 
(0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of phenyllithium (0.30 M 
in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor 
tube (0.94 s, −40 °C) and was subsequently injected in a flask containing a stirred, cooled (−40 °C) 
solution of furfural (21u, 58 mg, 0.60 mmol, 1.5 equiv.) in THF. Stirring was continued for 3 h at 
−40 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted 
three times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 8:2) afforded the title compound 24m as a light orange oil (73 mg, 0.30 mmol, 75% 
yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.02 (dt, J = 8.1, 1.8 Hz, 2H), 7.49 (d, J = 8.1 Hz, 2H), 7.37 
(dd, J = 1.8, 0.8 Hz, 1H), 6.30 (dd, J = 3.3, 1.8 Hz, 1H), 6.10 (d, J = 3.3 Hz, 1H), 5.86 (s, 1H), 4.36 (q, 
J = 7.1 Hz, 2H), 2.88 (s, 1H), 1.38 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.6, 155.4, 145.8, 142.9, 130.1, 129.8 (2C), 126.5 (2C), 
110.4, 107.8, 69.7, 61.1, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3436, 2982, 2938, 2906, 1712, 1696, 1652, 1612, 1578, 1504, 
1464, 1414, 1392, 1368, 1310, 1272, 1174, 1142, 1102, 1074, 1010, 940, 928, 884, 866, 828, 812, 792, 
736, 706, 678. 
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MS (EI, 70 eV): m/z (%) = 246 (21) 229 (27), 219 (14), 218 (100), 217 (11), 201 (68), 189 (12), 178 
(10), 177 (89), 175 (15), 173 (24), 155 (14), 151 (45), 149 (44), 145 (48), 129 (21), 128 (25), 127 (17), 
123 (37), 117 (29), 115 (32), 105 (20), 97 (15), 95 (65), 79 (13), 77 (14). 
HRMS (EI): m/z calcd. for [C14H14O4]: 246.0892; found 246.0886 (M+). 
1-Isothiocyanato-2-(non-1-en-3-yl)benzene (24n) 
 
According to TP 8, a solution of 1-bromo-2-isothiocyanatobenzene (22i, 0.20 M, 0.40 mmol) and 
MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (0.94 s, 
−20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of (E)-1-
bromonon-2-ene (21v, 123 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.04 mL, 1.0 M in 
THF, 1.1 equiv.) in THF. Stirring was continued for 1 h at 0 °C before sat. aq. NH4Cl solution was 
added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the 
combined organic phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent 
in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the title compound 24n as a 
pale yellow oil (70 mg, 0.27 mmol, 68% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.25 – 7.18 (m, 4H), 5.60 – 5.45 (m, 2H), 3.40 (d, J = 5.6 Hz, 
2H), 2.03 (q, J = 6.4 Hz, 2H), 1.38 – 1.21 (m, 8H), 0.91 – 0.83 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 137.7, 133.6, 130.1, 127.6, 127.6, 127.3, 126.5, 126.4, 35.6, 
32.7, 31.9, 29.5, 29.0, 22.8, 22.8, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2956, 2924, 2870, 2854, 2176, 2076, 1598, 1578, 1484, 1450, 
1378, 966, 934, 904, 752, 724, 672. 
MS (EI, 70 eV): m/z (%) = 258 (61), 226 (92), 216 (23), 202 (32), 188 (30), 174 (33), 170 (17), 168 
(22), 163 (48), 162 (100), 161 (45), 156 (42), 155 (30), 154 (34), 149 (64), 148 (60), 130 (54), 129 (26), 
128 (33), 121 (15), 118 (20), 117 (31), 116 (26), 115 (32). 
HRMS (EI): m/z calcd. for [C16H20NS]: 258.1316; found 258.1312 (M+ − H). 
1-Allyl-3-isothiocyanatobenzene (24o) 
 
According to TP 8, a solution of 1-bromo-3-isothiocyanatobenzene (22j, 0.20 M, 0.50 mmol) and ZnCl2 
(0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
18 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.022 mL reactor tube (0.07 s, 
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−60 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of allyl 
bromide (21a, 151 mg, 1.25 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.05 mL, 1.0 M in THF, 
0.1 equiv.) in THF. Stirring was continued for 30 min at 0 °C before sat. aq. NH4Cl solution was added 
to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the 
combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the solvent 
in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the title compound 24o as a 
colorless oil (57 mg, 0.33 mmol, 65% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.27 (dd, J = 8.5, 7.7 Hz, 1H), 7.11 (dddd, J = 7.7, 1.5, 1.0, 
0.4 Hz, 1H), 7.09 – 7.04 (m, 2H), 5.93 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.15 – 5.06 (m, 2H), 3.37 (dtd, 
J = 6.8, 1.4, 0.7 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 142.1, 136.4, 136.4, 131.4, 129.6, 127.8, 126.0, 123.5, 116.9, 
39.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3078, 2978, 2906, 2246, 2050, 2042, 1640, 1600, 1580, 1482, 
1438, 1410, 1292, 1164, 1080, 992, 916, 898, 822, 780, 702, 680, 654. 
MS (EI, 70 eV): m/z (%) = 175 (74), 174 (12), 118 (10), 117 (100), 116 (22), 115 (70). 
HRMS (EI): m/z calcd. for [C10H9NS]: 175.0456; found 175.0448 (M+). 
1-Allyl-4-isothiocyanatobenzene (24p) 
 
According to TP 8, a solution of 1-bromo-4-isothiocyanatobenzene (22k, 0.20 M, 0.50 mmol) and 
ZnCl2 (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M 
in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.022 mL reactor tube (0.15 s, 
−60 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of allyl 
bromide (21a, 151 mg, 1.25 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.05 mL, 1.0 M in THF, 
0.1 equiv.) in THF. Stirring was continued for 30 min at 0 °C before sat. aq. NH4Cl solution was added 
to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the 
combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the solvent 
in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the title compound 24p as a 
colorless oil (59 mg, 0.34 mmol, 67% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.16 (d, J = 0.7 Hz, 4H), 5.93 (ddt, J = 16.8, 10.2, 6.7 Hz, 1H), 
5.13 – 5.04 (m, 2H), 3.38 (dt, J = 6.7, 1.5 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 139.7, 136.6 (2C), 129.9 (3C), 125.9 (2C), 116.7, 39.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3080, 2978, 2902, 2180, 2050, 2042, 1638, 1604, 1502, 1432, 
1418, 1294, 1248, 1196, 1106, 992, 916, 838, 800, 722, 676. 
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MS (EI, 70 eV): m/z (%) = 176 (11), 175 (100), 148 (22), 117 (93), 116 (24), 115 (59). 
HRMS (EI): m/z calcd. for [C10H9NS]: 175.0456; found 175.0449 (M+). 
(4-Fluorophenyl)(2-isothiocyanatophenyl)methanone (24q) 
 
According to TP 8, a solution of 1-bromo-2-isothiocyanatobenzene (22i, 0.20 M, 0.40 mmol) and 
MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (0.94 s, 
−20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 4-
fluorobenzoyl chloride (21m, 95 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.44 mL, 1.0 M 
in THF, 1.1 equiv.) in THF. Stirring was continued for 1.5 h at 0 °C before sat. aq. NH4Cl solution was 
added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the 
combined organic phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent 
in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 24:1) afforded the title 
compound 24q as a light yellow oil (64 mg, 0.25 mmol, 63% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.89 – 7.81 (m, 2H), 7.56 – 7.45 (m, 2H), 7.41 – 7.33 (m, 2H), 
7.21 – 7.13 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 193.0, 166.3 (d, J = 256.2 Hz), 135.0, 133.2 (d, J = 3.0 Hz, 
2C), 132.8, 132.9, 132.1, 130.1, 129.8, 127.5, 127.1, 116.1 (d, J = 22.1 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3070, 2926, 2166, 2062, 1662, 1594, 1572, 1532, 1504, 1478, 
1444, 1410, 1378, 1304, 1288, 1262, 1230, 1200, 1148, 1102, 1094, 1042, 1012, 938, 926, 890, 848, 
816, 778, 752, 734, 706, 678, 660. 
MS (EI, 70 eV): m/z (%) = 257 (56), 256 (33), 197 (53), 162 (90), 134 (36), 123 (19), 123 (100), 95 
(17), 75 (12). 
HRMS (EI): m/z calcd. for [C14H8FNOS]: 257.0311; found 257.0304 (M+). 
(2,4-Dichlorophenyl)(2-isothiocyanatophenyl)methanone (24r) 
 
According to TP 8, a solution of 1-bromo-2-isothiocyanatobenzene (22i, 0.20 M, 0.40 mmol) and 
MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi 
(0.30 M in hexane, 0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an 
overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (0.94 s, 
−20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
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2,4-dichlorobenzoyl chloride (21w, 126 mg, 0.60 mmol, 1.5 equiv.) and CuCN2LiCl solution 
(0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 4 h at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 97:3) 
afforded the title compound 24r as a light yellow solid (73 mg, 0.24 mmol, 60% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.61 (ddd, J = 7.8, 1.6, 0.5 Hz, 1H), 7.55 (dd, J = 7.7, 1.6 Hz, 
1H), 7.48 (dd, J = 1.9, 0.3 Hz, 1H), 7.45 (dd, J = 8.2, 0.3 Hz, 1H), 7.39 (dd, J = 8.3, 1.9 Hz, 1H), 
7.37 – 7.31 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 192.3, 138.1, 136.9, 136.7, 133.8, 133.4, 133.0, 131.3, 131.3, 
130.5, 130.5, 128.4, 127.8, 127.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3086, 2924, 2854, 2190. 2172, 2116, 1908, 1740, 1674, 1580, 
1566, 1554, 1478, 1442, 1378, 1302, 1278, 1270, 1242, 1160, 1138, 1104, 1054, 940, 916, 872, 828, 
800, 788, 758, 704, 666. 
MS (EI, 70 eV): m/z (%) = 307 (11) 274 (36), 273 (15), 272 (100), 175 (27), 173 (41), 162 (74), 134 
(32), 109 (10). 
HRMS (EI): m/z calcd. for [C14H7Cl2NOS]: 306.9625; found 306.9618 (M+). 
M.p. (°C): 80.0 – 81.8. 
(2-Bromophenyl)(thiophen-3-yl)methanone (27a) 
 
According to TP 8, a solution of 3-bromothiophene (25a, 0.20 M, 0.50 mmol) and MgCl2·LiCl (0.1 M, 
0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 6 mL min−1 
flow rate in a T-mixer. The combined stream passed a 1 mL reactor tube (10 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 2-bromobenzoyl chloride 
(21l, 165 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 1.0 M in THF, 1.1 equiv.) in 
THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous Na2SO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 95:5) afforded the title compound 27a as 
colorless crystals (96 mg, 0.34 mmol, 72% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.79 (dd, J = 2.9, 1.2 Hz, 1H), 7.64 (ddd, J = 7.9, 1.1, 0.6 Hz, 
1H), 7.56 (dd, J = 5.1, 1.2 Hz, 1H), 7.44 – 7.30 (m, 4H). 
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13C-NMR (100 MHz, CDCl3): δ / ppm = 189.3, 141.6, 141.3, 136.1, 133.5, 131.3, 128.8, 127.8, 127.2, 
126.8, 119.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2974, 2858, 1622, 1562, 1476, 1446, 1432, 1404, 1302, 1274, 
1252, 1156, 1110, 1066, 1012, 996, 914, 842, 804, 738, 668. 
MS (EI, 70 eV): m/z (%) = 188 (11), 187 (100), 185 (11), 183 (11), 111 (56). 
HRMS (EI): m/z calcd. for [C11H7BrOS]: 265.9401; found 265.9396 (M+). 
M.p. (°C): 81.3 – 81.9. 
Cyclopropyl(4-fluorophenyl)(thiophen-3-yl)methanol (27b) 
 
According to TP 8, a solution of 3-bromothiophene (25a, 0.20 M, 0.50 mmol) and MgCl2·LiCl (0.1 M, 
0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 6 mL min−1 
flow rate in a T-mixer. The combined stream passed a 1 mL reactor tube (10 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of cyclopropyl(4-
fluorophenyl)methanone (21h, 90 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 27b as a yellow oil (95 mg, 0.39 mmol, 77% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.45 – 7.38 (m, 2H), 7.32 (ddd, J = 3.0, 1.4, 0.4 Hz, 1H), 7.25 
(ddd, J = 5.0, 3.0, 0.4 Hz, 1H), 7.04 – 6.96 (m, 2H), 6.94 (ddd, J = 5.0, 1.4, 0.4 Hz, 1H), 2.01 (s, 1H), 
1.65 – 1.55 (m, 1H), 0.70 – 0.59 (m, 1H), 0.58 – 0.42 (m, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 168.3, 140.7, 139.7, 135.6, 131.3, 128.8, 128.6 (d, 
J = 11.2 Hz, 2C), 128.7 (d, J = 179.5 Hz, 2C), 126.2, 61.0, 33.3, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3496, 3104, 3006, 1658, 1588, 1506, 1430, 1410, 1394, 1282, 
1222, 1158, 1144, 1046, 1024, 968, 860, 850, 832814, 764, 740, 684. 
MS (EI, 70 eV): m/z (%) = 220 (67), 207 (22), 136 (12), 123 (100), 111 (16). 
HRMS (EI): m/z calcd. for [C14H13FOS]: 248.0671; found 248.0666 (M+). 
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Cyclopropyl(4-fluorophenyl)(pyridin-4-yl)methanol (27c) 
 
According to TP 8, a solution of 4-iodopyridine (25b, 0.20 M, 0.50 mmol) and MgCl2·LiCl (0.1 M, 
0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 18 mL min−1 
flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (0.83 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of cyclopropyl(4-
fluorophenyl)methanone (21h, 90 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 3:7) afforded the title compound 27c as colorless crystals (76 mg, 0.31 mmol, 62% 
yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.47 (s, 2H), 7.47 – 7.39 (m, 2H), 7.33 – 7.28 (m, 2H), 
7.05 – 6.97 (m, 2H), 2.55 (s, 1H), 1.56 (tt, J = 8.0, 5.5 Hz, 1H), 0.72 – 0.64 (m, 1H), 0.58 – 0.44 (m, 
3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 162.1 (d, J = 247.1 Hz), 155.9, 149.4 (2C), 141.7 (d, 
J = 3.3 Hz), 128.8 (d, J = 8.1 Hz, 2C), 121.6 (2C), 115.1 (d, J = 21.3 Hz, 2C), 75.9, 21.2, 2.2, 1.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3186, 3004, 1602, 1506, 1422, 1408, 1358, 1300, 1222, 1194, 
1158, 1148, 1068, 1028, 1016, 994, 968, 878, 840, 816, 802, 730, 686. 
MS (EI, 70 eV): m/z (%) = 216 (15), 215 (100), 202 (14), 123 (32), 109 (13), 106 (17), 95 (15), 78 (13). 
HRMS (EI): m/z calcd. for [C15H14FNO]: 243.1049; found 243.1062 (M+). 
M.p. (°C): 1514.3 – 156.8. 
2-Allyl-5-methylpyridine (27d) 
 
According to TP 8, a solution of 2-bromo-5-methylpyridine (25c, 0.20 M, 1.00 mmol) and ZnCl2 
(0.1 M, 0.50 mmol, 0.5 equiv.) in THF (total volume: 5.00 mL) and a solution of n-BuLi (0.30 M in 
hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 
6 mL min−1 flow rate in a T-mixer. The combined stream passed a 5.0 mL reactor tube (53 s, 0 °C) and 
was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of allyl bromide (21a, 
302 mg, 2.50 mmol, 2.5 equiv.) in THF. Stirring was continued for 1 h at 0 °C before sat. aq. NH4Cl 
solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
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removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 8:2) 
afforded the title compound 27d as pale yellow oil (84 mg, 0.63 mmol, 63% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.34 (d, J = 2.2 Hz, 1H), 7.38 (dd, J = 7.9, 2.3 Hz, 1H), 7.04 
(d, J = 7.9 Hz, 1H), 6.10 – 5.92 (m, 1H), 5.18 – 5.03 (m, 2H), 3.57 – 3.46 (m, 2H), 2.27 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.2, 149.8, 137.1, 136.1, 130.5, 122.3, 116.6, 42.5, 18.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3020, 2927, 2861, 1665, 1602, 1568, 1484, 1448, 1380, 1254, 
1186, 1132, 1029, 886, 830, 745, 723. 
MS (EI, 70 eV): m/z (%) = 134(0.5), 133(10), 132(100), 117(36). 
HRMS (EI): m/z calcd. for [C9H11N]: 133.0891; found 132.0808 (M+ − H). 
5-(Cyclohex-2-en-1-yl)pyrimidine (27e) 
 
According to TP 8, a solution of 5-bromopyrimidine (25d, 0.20 M, 0.40 mmol) and ZnCl2 (0.1 M, 
0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of n-BuLi (0.30 M in hexane, 
0.60 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed with an overall 12 mL min−1 
flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube (1.25 s, 0 °C) and was 
subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 3-bromocyclohexene 
(21k, 161 mg, 1.00 mmol, 2.5 equiv.) and CuCN2LiCl solution (0.04 mL, 1.0 M in THF, 0.1 equiv.) in 
THF. Stirring was continued for 10 min at 0 °C before sat. aq. NH4Cl solution was added to quench the 
reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex) afforded the title compound 27e as a light brown oil 
(43 mg, 0.27 mmol, 68% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.08 (s, 1H), 8.59 (s, 2H), 6.04 – 5.97 (m, 1H), 5.69 – 5.61 
(m, 1H), 3.48 – 3.38 (m, 1H), 2.17 – 2.00 (m, 3H), 1.79 – 1.50 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.0, 156.5 (2C), 139.2, 130.6, 127.3, 37.3, 32.1, 24.9, 20.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3022, 2928, 2858, 2838, 1716, 1672, 1610, 1560, 1432, 1408, 
1370, 1346, 1326, 1302, 1256, 1230, 1184, 1164, 1136, 1110, 1078, 1046, 1036, 984, 958, 910, 890, 
880, 848, 824, 794, 758, 722, 704, 668. 
MS (EI, 70 eV): m/z (%) = 160 (81), 159 (27), 146 (10), 145 (100), 132 (16), 131 (53), 118 (15), 105 
(13), 104 (15), 78 (12). 
HRMS (EI): m/z calcd. for [C10H12N2]: 160.1000; found 160.0994 (M+). 
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Ethyl 4-allyl-2,6-dimethoxypyrimidine-5-carboxylate (27f) 
 
According to TP 8, a solution of ethyl 4-iodo-2,6-dimethoxypyrimidine-5-carboxylate (25e, 0.20 M, 
0.40 mmol) and ZnCl2 (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a solution of 
phenyllithium (0.30 M in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The precooled 
solutions were mixed with an overall 16 mL min−1 flow rate in a T-mixer. The combined stream passed 
a 0.02 mL reactor tube (0.08 s, −40 °C) and was subsequently injected in a flask containing a stirred, 
cooled (0 °C) solution of allyl bromide (21a, 122 mg, 1.00 mmol, 2.5 equiv.) and CuCN2LiCl solution 
(0.04 mL, 1.0 M in THF, 0.1 equiv.) in THF. Stirring was continued for 10 min at 0 °C before sat. aq. 
NH4Cl solution was added to quench the reaction. The aq. phase was extracted three times with EtOAc 
(3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 19:1) 
afforded the title compound 27f as a colorless oil (71 mg, 0.28 mmol, 70% yield). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 6.03 – 5.95 (m, 1H), 5.16 – 5.08 (m, 2H), 4.36 (q, J = 7.1 Hz, 
2H), 4.00 (s, 3H), 4.00 (s, 3H), 3.52 (dt, J = 6.7, 1.5 Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 169.6, 169.3, 165.9, 164.8, 133.9, 117.6, 108.1, 61.6, 55.1, 
54.7, 40.3, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2984, 2960, 1726, 1638, 1560, 1482, 1458, 1374, 1360, 1298, 
1256, 1208, 1194, 1120, 1106, 1078, 1058, 1018, 996, 972, 946, 916, 868, 848, 814, 780, 746, 728, 
686. 
MS (EI, 70 eV): m/z (%) = 251 (30), 224 (10), 223 (100), 207 (19), 205 (73), 19 0(12), 179 (20). 
HRMS (EI): m/z calcd. for [C12H15N2O4]: 252.1110; found 251.1032 (M+ − H). 
Ethyl 2,4-dimethoxy-6-pivaloylpyrimidine-5-carboxylate (27g) 
 
According to TP 8, a solution of ethyl 4-iodo-2,6-dimethoxypyrimidine-5-carboxylate (25e, 0.20 M, 
0.40 mmol) and MgCl2·LiCl (0.1 M, 0.20 mmol, 0.5 equiv.) in THF (total volume: 2.00 mL) and a 
solution of phenyllithium (0.30 M in hexane/dibutyl ether, 0.60 mmol, 1.5 equiv.) were prepared. The 
precooled solutions were mixed with an overall 20 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.06 s, −40 °C) and was subsequently injected in a flask 
containing a stirred, cooled (0 °C) solution of pivaloyl chloride (21e, 72 mg, 0.60 mmol, 1.5 equiv.) and 
CuCN2LiCl solution (0.44 mL, 1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
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times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 19:1) afforded the title compound 27g as a pale yellow oil (79 mg, 0.27 mmol, 68% 
yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 4.29 (q, J = 7.1 Hz, 2H), 4.05 (s, 3H), 4.02 (s, 3H), 1.34 (s, 
9H), 1.31 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 208.2, 170.0, 169.2, 164.8, 163.9, 105.7, 61.8, 55.7, 55.1, 
43.7, 27.2 (3C), 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2978, 2962, 2936, 2874, 1740, 1704, 1568, 1552, 1484, 1460, 
1374, 1360, 1274, 1236, 1200, 1120, 1060, 1032, 986, 946, 872, 860, 824, 786, 768, 726, 680. 
MS (EI, 70 eV): m/z (%) = 251 (16), 239 (67), 211 (89), 185 (14), 167 (100), 140 (25), 139 (40), 109 
(24). 
HRMS (EI): m/z calcd. for [C14H20N2O5]: 296.1372; found 296.1367 (M+). 
(4-Chloro-2,6-dimethoxypyrimidin-5-yl)(3,5-dichlorophenyl)methanone (27h) 
 
According to TP 8, a solution of 4-chloro-5-iodo-2,6-dimethoxypyrimidine (25f, 0.20 M, 0.50 mmol) 
and MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of 
n-BuLi (0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube 
(0.08 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
3,5-dichlorobenzoyl chloride (21x, 157 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) afforded the title 
compound 27h as a white solid (125 mg, 0.36 mmol, 72% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.66 (d, J = 1.9 Hz, 2H), 7.60 (t, J = 1.9 Hz, 1H), 4.09 (s, 3H), 
3.96 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 188.5, 169.6, 164.7, 158.6, 138.9, 136.1 (2C), 133.9, 127.7 
(2C), 111.7, 56.0, 55.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1676, 1564, 1536, 1464, 1390, 1328, 1244, 1202, 1160, 1084, 
1034, 968, 942, 874, 796, 770, 744, 664. 
MS (EI, 70 eV): m/z (%) = 348 (11), 346 (12), 203 (33), 201 (100), 173 (10), 76 (15). 
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HRMS (EI): m/z calcd. for [C13H9Cl3N2O3]: 345.9679; found 345.9671 (M+ − H). 
M.p. (°C): 83.1 – 84.0. 
(2-Bromophenyl)(4-chloro-2,6-dimethoxypyrimidin-5-yl)methanone (27i) 
 
According to TP 8, a solution of 4-chloro-5-iodo-2,6-dimethoxypyrimidine (25f, 0.20 M, 0.50 mmol) 
and MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of 
n-BuLi (0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube 
(0.08 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
2-bromobenzoyl chloride (21l, 165 mg, 0.75 mmol, 1.5 equiv.) and CuCN2LiCl solution (0.55 mL, 
1.0 M in THF, 1.1 equiv.) in THF. Stirring was continued for 2 h at 0 °C before sat. aq. NH4Cl solution 
was added to quench the reaction. The aq. phase was extracted three times with EtOAc (3×30 mL) and 
the combined organic phases were dried over anhydrous Na2SO4 and filtrated. After removal of the 
solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) afforded the title 
compound 27i as white crystals (110 mg, 0.32 mmol, 63% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.64 (d, 1H), 7.62 (dd, J = 2.3, 1.6 Hz, 1H), 7.43 – 7.33 (m, 
2H), 4.06 (s, 3H), 3.92 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 190.4, 169.9, 164.4, 159.4, 138.9, 134.5, 133.3, 131.8, 127.7, 
121.2, 113.9, 55.9, 55.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1682, 1582, 1536, 1460, 1386, 1364, 1286, 1236, 1198, 1154, 
1078, 1020, 938, 918, 866, 792, 752, 724, 654. 
MS (EI, 70 eV): m/z (%) = 358 (13), 356 (10), 277 (11), 203 (33), 201 (100), 185 (17), 183 (18), 76 
(16). 
HRMS (EI): m/z calcd. for [C13H10BrClN2O3]: 355.9563; found 355.9558 (M+ − H). 
M.p. (°C): 111.3 – 113.6. 
2-((4-Chloro-2,6-dimethoxypyrimidin-5-yl)(hydroxy)methyl)benzonitrile (27j) 
 
According to TP 8, a solution of 4-chloro-5-iodo-2,6-dimethoxypyrimidine (25f, 0.20 M, 0.50 mmol) 
and MgCl2·LiCl (0.1 M, 0.25 mmol, 0.5 equiv.) in THF (total volume: 2.50 mL) and a solution of 
n-BuLi (0.30 M in hexane, 0.75 mmol, 1.5 equiv.) were prepared. The precooled solutions were mixed 
with an overall 9 mL min−1 flow rate in a T-mixer. The combined stream passed a 0.25 mL reactor tube 
(0.08 s, −20 °C) and was subsequently injected in a flask containing a stirred, cooled (0 °C) solution of 
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2-formylbenzonitrile (21y, 72 mg, 0.55 mmol, 1.1 equiv.) in THF. Stirring was continued for 2 h at 
0 °C before sat. aq. NH4Cl solution was added to quench the reaction. The aq. phase was extracted three 
times with EtOAc (3×30 mL) and the combined organic phases were dried over anhydrous Na2SO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 6:4) afforded the title compound 27j as colorless crystals (90 mg, 0.30 mmol, 59% 
yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.88 (dd, 1H), 7.55 – 7.42 (m, 2H), 7.17 (dd, J = 7.1, 1.3 Hz, 
1H), 6.85 (d, J = 1.0 Hz, 1H), 3.99 (s, 3H), 3.77 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 170.4 (2C), 164.1, 161.1 (2C) , 145.3, 132.2, 129.0, 123.7, 
121.3, 108.4, 77.7, 55.7, 55.1. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3292, 1770, 1686, 1584, 1544, 1492, 1452, 1398, 1378, 1300, 
1220, 1202, 1176, 1064, 1020, 1008, 964, 956, 886, 858, 852, 782, 748, 708, 658. 
MS (EI, 70 eV): m/z (%) = 271 (15), 270 (100), 242 (31), 200 (20), 185 (24), 132 (12). 
HRMS (EI): m/z calcd. for [C14H12ClN3O3]: 304.0489; found 304.0482 (M+ − H). 
M.p. (°C): 143.5 – 145.2. 
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5 Sodiation of Arenes and Heteroarenes in Continuous Flow 
5.1 Typical Procedure (TP 9) 
 
Typical procedure using a Uniqsis flow setup 
A NaDa solution (0.175 – 0.221 M, 0.90 or 1.05 equiv) in DMEA and a solution of the (hetero)aryl 
substrate (0.156 – 0.230 M, 1.0 equiv) in THF were prepared. Injection loop A (vol.inj  = 1.0 mL) was 
loaded with the NaDA solution and injection loop B (vol.inj  = 1.0 mL) was loaded with the solution of 
the substrate. The solutions were simultaneously injected into separate streams of THF (flow rates: 
5 mL min−1), which each passed a pre-cooling loop (vol.pre = 1.0 mL, T1 = −20 to −78 °C, residence 
time: 12 s), before they were mixed in a T-mixer (PTFE, I.D. = 0.5 mm). The combined stream passed 
a PTFE reactor tube and stainless steel needle (vol.R = 0.08 mL, residence time: t1 = 0.5 s, T1 = −78 to 
−20 °C) changing diameter from 0.25 mm to 0.8 mm and thus achieving better mixing and was 
subsequently injected into a flask containing a stirred, cooled (T2 = 0 °C) solution of an electrophile E+ 
(1.5 – 10.0 equiv) in THF. The reaction mixture was stirred further for the indicated time and 
temperature (T2, reaction time: t2) and quenched with an indicated (sat. aq.) solution. The aq. phase was 
extracted with EtOAc or hexane and the organic phases were dried and filtrated. After removal of the 
solvent in vacuo, flash column chromatographical purification with suited i-hex:EtOAc mixtures 
afforded the pure products R – E. 
5.2 Attempted Batch Sodiation 
Batch sodiation of 2-chloropyrazine (28g) was attempted according to the reported procedure by 
Collum.145 A solution of 2-chloropyrazine (28g, 22 mg, 0.195 mmol, 1.00 equiv) in THF (1 mL) was 
treated with NaDA (0.205 M, 1 M, 1.05 equiv) at −78 °C. After 10 s a solution of iodine in THF (1 M, 
0.975 mL, 5 equiv) was added dropwise at −78 °C under vigorous stirring. The reaction mixture was 
quenched by addition of sat. aq. Na2S2O3. GC-analysis revealed complete decomposition of the starting 
material and no product formation. 
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5.3 Preparation of the Products 
1,3-Dichloro-2-iodobenzene (31a) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.175 M, 0.175 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.184 M in DMEA, 0.184 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of iodine (30a, 222 mg, 0.875 mmol, 5.00 equiv) in THF. The reaction was instantly 
quenched by the addition of sat. aq. Na2S2O3. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the 
title compound 31a as white crystals (40 mg, 0.147 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.34 (d, J = 7.6 Hz, 2H), 7.23 (d, J = 7.3 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 140.8, 129.8 (2C), 127.4 (2C), 103.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3060, 2921, 2850, 1556, 1421, 1392, 1252, 1184, 1147, 1130, 
1080, 1012, 967, 893, 769, 697, 684. 
MS (EI, 70 eV): m/z (%) = 276 (10), 274 (64), 272 (100), 175 (19), 173 (30), 127 (23), 109 (17). 
HRMS (EI): m/z calcd. for [C6H3Cl2I]: 271.8656; found 271.8651 (M+). 
M.p. (°C): 54.7 – 58.7. 
(2,6-Dichlorophenyl)(phenyl)methanol (31b) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.167 M, 0.167 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.175 M in DMEA, 0.175 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred benzaldehyde solution (30b, 26 µL, 0.250 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31b as a colorless liquid (40 mg, 0.16 mmol, 95%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.37 – 7.32 (m, 4H), 7.32 – 7.27 (m, 3H), 7.22 (dd, J = 8.6, 
7.4 Hz, 1H), 6.66 (d, J = 8.7 Hz, 1H), 3.43 (d, J = 10.3 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 141.6, 137.9, 135.3 (2C), 129.6, 129.5 (2C), 128.4 (2C), 127.4 
(2C), 125.5, 72.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3563, 3435, 3060, 3028, 1601, 1579, 1562, 1494, 1449, 1435, 
1400, 1250, 1176, 1148, 1089, 1020, 916, 865, 826, 778, 766, 734, 695, 660. 
MS (EI, 70 eV): m/z (%) = 254 (39), 252 (59), 251 (14), 199 (26), 177 (10), 175 (63), 173 (100), 165 
(10), 152 (14), 79 (21), 78 (27), 77(14). 
HRMS (EI): m/z calcd. for [C13H10Cl2O]: 252.0109; found 252.0105 (M+). 
(2,6-Dichlorophenyl)diphenylphosphine sulphide (31c) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of chlorodiphenylphosphane (30c, 90 µL, 0.500 mmol, 2.50 equiv) in THF. Stirring 
was continued for 30 min at 0 °C before sulfur (513 mg, 2.00 mmol, 10.0 equiv) was added portionwise. 
After stirring the solution for 16 h at 25 °C, 2 M NaOCl was added to quench the reaction. The aq. phase 
was extracted three times with EtOAc (3×10 mL) and the combined organic phases were dried over 
anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
purification (silica gel, i-hex:EtOAc = 4:1) afforded the title compound 31c as a highly viscose yellow 
liquid (53 mg, 0.148 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.98 – 7.91 (m, 4H), 7.49 – 7.37 (m, 6H), 7.34 – 7.31 (m, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 139.5, 139.4, 135.2, 134.4, 132.5, 132.4, 131.3 (4C), 131.2 
(2C), 131.1 (2C), 128.8 (2C), 128.6 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3053, 2977, 1732, 1568, 1552, 1480, 1437, 1416, 1372, 1395, 
1240, 1185, 1146, 1093, 1044, 998, 900, 773, 722, 694, 688. 
MS (EI, 70 eV): m/z (%) = 329 (33), 328 (19), 327 (100), 219 (15), 217 (47), 183 (28), 181 (14). 
HRMS (EI): m/z calcd. for [C18H13Cl2PS]: 361.9850; found 361.9846 (M+). 
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2,6-Dichloro-N-phenylbenzamide (31d) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of isocyanatobenzene (30d, 55 µL, 0.500 mmol, 2.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31d as a white solid (34 mg, 0.128 mmol, 64%). 
1H-NMR (400 MHz, CD3CN): δ / ppm = 8.87 (s, 1H), 7.67 – 7.60 (m, 2H), 7.48 – 7.44 (m, 2H), 
7.43 – 7.36 (m, 3H), 7.21 – 7.15 (m, 1H).  
13C-NMR (101 MHz, CD3CN): δ / ppm = 163.5, 139.3, 137.0, 132.6, 132.2 (2C), 130.0 (2C), 129.1 
(2C), 125.6, 120.7 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3240, 2193, 3131, 3064, 3042, 1653, 1620, 1598, 1579, 1552, 
1534, 1491, 1448, 1430, 1376, 1324, 1268, 1235, 1194, 1177, 1145, 1087, 1026, 915, 887, 798, 778, 
759, 744, 701, 685. 
MS (EI, 70 eV): m/z (%) = 177 (10), 175 (64), 109 (11). 
HRMS (EI): m/z calcd. for [C10H8N]: 265.0061; found 265.0056 (M+). 
M.p. (°C): 175.5 – 177.5. 
(2,6-Dichlorophenyl)(4-fluorophenyl)sulfane (31e) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of (4-fluorophenyl) benzenesulfonothioate (30e, 134 mg, 0.500 mmol, 2.50 equiv) in 
THF. The reaction was instantly quenched by the addition of 2 M NaOCl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex) afforded the title compound 31e as a colorless liquid (41 mg, 0.150 mmol, 75%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.48 – 7.44 (m, 2H), 7.31 – 7.28 (m, 1H), 7.25 – 7.19 (m, 2H), 
7.01 – 6.95 (m, 2H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.9 (d, J = 246.5 Hz), 141.8, 132.3 (2C), 130.9 (d, 
J = 2.1 Hz), 130.8 (2C), 130.6 (d, J = 3.3 Hz, 2C), 129.1, 116.3 (d, J = 22.1 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1589, 1565, 1553, 1487, 1423, 1400, 1292, 1226, 1187, 1155, 
1140, 1106, 1088, 1042, 1012, 821, 773, 734, 711, 698, 676, 667, 659. 
MS (EI, 70 eV): m/z (%) = 274 (21), 272 (30), 203 (12), 202 (100), 157 (12). 
HRMS (EI): m/z calcd. for [C12H7Cl2FS]: 271.9630; found 271.9623 (M+). 
2',6'-Dichloro-1,2,3,4-tetrahydro-1,1'-biphenyl (31f) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.167 M, 0.167 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.175 M in DMEA, 0.175 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of 3-bromocyclohex-1-ene (30f, 49 µL, 0.418 mmol, 2.5 equiv) and CuCN∙2LiCl 
(0.02 mL, 1.0 M in THF, 0.02 mmol, 0.10 equiv) in THF. The reaction was instantly quenched by the 
addition of sat. aq. NH4Cl. The aq. phase was extracted three times with EtOAc (3×10 mL) and the 
combined organic phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent 
in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the title compound 31f as a 
colorless oil (28 mg, 0.125 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33 – 7.26 (m, 2H), 7.08 (t, J = 8.0 Hz, 1H), 5.80 (dddd, 
J = 7.8, 5.0, 2.9, 1.0 Hz, 1H), 5.64 (ddd, J = 10.1, 2.9, 1.5 Hz, 1H), 4.34 (dddd, J = 12.0, 7.0, 4.0, 
2.5 Hz, 1H), 2.20 – 1.67 (m, 6H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 140.4, 129.1 (2C), 127.7 (3C), 126.8 (2C), 40.0, 26.5, 24.6, 
23.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3023, 2931, 2859, 1580, 1559, 1430, 1246, 1182, 1149, 1080, 
1045, 983, 933, 900, 846, 797, 775, 761, 729, 718, 690. 
MS (EI, 70 eV): m/z (%) = 226 (100), 213 (28), 211 (45), 191 (18), 187 (15), 185 (23), 176 (17), 174 
(47), 172 (75), 165 (27), 163 (88), 161 (13), 159 (22), 156 (12), 155 (29), 150 (20), 149 (26), 137 (19), 
128 (65), 127 (19), 115 (25), 76 (14), 67 (13). 
HRMS (EI): m/z calcd. for [C12H12Cl2]: 226.0316; found 226.0311 (M+). 
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1,3-Dichloro-2-methylbenzene (31g) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.190 M, 0.380 mmol) in THF (total 
volume: 2 mL) and a solution of NaDA (0.200 M in DMEA, 0.400 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of iodomethane (30g, 60 µL, 1.900 mmol, 5.00 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
hexane (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, pentane) 
afforded the title compound 31g as a colorless liquid (33 mg, 0.205 mmol, 54%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.27 (d, J = 8.0 Hz, 2H), 7.05 (t, J = 8.0 Hz, 1H), 2.47 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 135.6 (2C), 134.6, 127.9 (2C), 127.3, 17.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2926, 2854, 1561, 1434, 1378, 1269, 1202, 1153, 1086, 1054, 
1000, 804, 769, 759, 692. 
MS (EI, 70 eV): m/z (%) = 162 (31), 160 (49), 127 (33), 125 (100), 89 (28). 
HRMS (EI): m/z calcd. for [C7H6Cl2]: 159.9847; found 159.9840 (M+). 
2-Butyl-1,3-dichlorobenzene (31h) 
 
According to TP 9, a solution of 1,3-dichlorobenzene (28a, 0.190 M, 0.190 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of nbutyl bromide (30h, 0.20 mL, 1.90 mmol, 10.0 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
hexane (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, pentane) 
afforded the title compound 31h as a colorless liquid (20 mg, 0.101 mmol, 53%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.26 (d, J = 8.0 Hz, 2H), 7.06 – 7.01 (m, 1H), 3.08 – 2.79 (m, 
2H), 1.62 – 1.51 (m, 2H), 1.50 – 1.40 (m, 2H), 0.97 (t, J = 7.3 Hz, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 138.9 (2C), 135.4, 128.2 (2C), 127.4, 31.2, 30.5, 22.9, 14.1. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2958, 2928, 2871, 2860, 1582, 1561, 1466, 1456, 1434, 1379, 
1265, 1192, 1182, 1152, 1104, 1086, 1078, 962, 927, 822, 799, 790, 771, 758, 721. 
MS (EI, 70 eV): m/z (%) = 204 (20), 202 (31), 163 (11), 162 (23), 161 (65), 160 (35), 159 (100), 127 
(12), 125 (34), 123 (19), 89 (20). 
HRMS (EI): m/z calcd. for [C10H12Cl2]: 202.0316; found 202.0308 (M+). 
(2,6-Difluorophenyl)(furan-2-yl)methanol (31i) 
 
According to TP 9, a solution of 1,3-difluorobenzene (28b, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask containing 
a stirred solution of furan-2-carbaldehyde (30i, 25 µL, 0.300 mmol, 1.50 equiv) in THF. The reaction 
was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 10:1) afforded the title compound 31i as a highly viscose brown liquid (37 mg, 
0.176 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.40 (d, J = 1.0 Hz, 1H), 7.34 – 7.24 (m, 1H), 6.93 (t, 
J = 8.4 Hz, 2H), 6.33 (dd, J = 3.3, 1.8 Hz, 1H), 6.21 (d, J = 3.3 Hz, 1H), 6.17 (s, 1H), 2.92 (s, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.0 (dd, J = 248.9, 7.9 Hz, 2C), 153.8, 142.8, 130.1 (t, 
J = 10.7 Hz), 116.9 (t, J = 16.5 Hz), 112.0 (d, J = 25.5 Hz, 2C), 110.6, 107.3, 62.3 (t, J = 4.3 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3410, 3115, 2926, 2855, 1758, 1703, 1624, 1593, 1468, 1396, 
1336, 1270, 1233, 1192, 1144, 1086, 994, 940, 898, 886, 783, 740, 722. 
MS (EI, 70 eV): m/z (%) = 210 (20), 193 (26), 183 (10), 182 (100), 173 (11), 164 (21), 153 (15), 141 
(88), 138 (10), 133 (14), 127 (12). 
HRMS (EI): m/z calcd. for [C11H8F2O2]: 210.0492; found 210.0487 (M+). 
(2,6-Difluorophenyl)(phenyl)methanone (31j) 
 
According to TP 9, a solution of 1,3-difluorobenzene (28b, 0.195 M, 0.195 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask containing 
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a stirred solution of benzoyl chloride (30j, 57 µL, 0.488 mmol, 2.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 95:5) afforded the title compound 31j as a colorless liquid (30 mg, 0.138 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 – 7.85 (m, 2H), 7.66 – 7.59 (m, 1H), 7.53 – 7.40 (m, 3H), 
7.06 – 6.96 (m, 2H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 189.1, 160.0 (dd, J = 251.7, 7.6 Hz, 2C), 137.0, 134.4, 132.0 
(t, J = 9.9 Hz), 129.8 (2C), 128.9 (2C), 117.2 (t, J = 21.8 Hz), 112.2 – 111.8 (m, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1672, 1621, 1588, 1583, 1462, 1449, 1316, 1294, 1275, 1266, 
1233, 1180, 1145, 1072, 1026, 1004, 926, 847, 800, 762, 732, 696, 686. 
MS (EI, 70 eV): m/z (%) = 218 (57), 198 (34), 141 (97), 114 (15), 105 (100), 77 (53), 74 (10), 63 (27). 
HRMS (EI): m/z calcd. for [C13H8F2O]: 218.0543; found 218.0538 (M+). 
(2-(2-Fluoro-3-iodophenyl)thio)pyridine (31k) 
 
According to TP 9, a solution of 1-fluoro-2-iodobenzene (28c, 0.190 M, 0.190 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask containing 
a stirred solution of aldrithiol (30k, 105 mg, 0.475 mmol, 2.50 equiv) in THF. The reaction was 
instantly quenched by the addition of 2 M NaOCl. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the 
title compound 31k as a white solid (39 mg, 0.118 mmol, 62%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.41 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.82 (ddd, J = 7.9, 5.7, 
1.6 Hz, 1H), 7.60 – 7.49 (m, 2H), 7.09 – 7.01 (m, 2H), 6.95 (td, J = 7.8, 0.7 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.5 (d, J = 247.0 Hz), 158.4 (d, J = 1.3 Hz), 149.9, 141.0 
(d, J = 1.8 Hz), 137.2, 136.9, 126.5 (d, J = 4.6 Hz), 121.9, 120.7, 119.3 (d, J = 21.1 Hz), 82.3 (d, 
J = 27.5 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1574, 1559, 1556, 1447, 1428, 1418, 1277, 1223, 1152, 1129, 
1087, 1082, 1055, 1046, 990, 882, 819, 776, 770, 760, 741, 724, 711. 
MS (EI, 70 eV): m/z (%) = 312 (19), 205 (12), 204 (100), 203 (11), 185 (16), 127 (47). 
HRMS (EI): m/z calcd. for [C11H7FINS]: 330.9328; found 330.9325 (M+). 
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M.p. (°C): 72.3 – 74.1. 
(5-Bromopyridin-3-yl)(2-chloro-5-(trifluoromethyl)phenyl)methanol (31l) 
 
According to TP 9, a solution of 1-chloro-4-(trifluoromethyl)benzene (28d, 0.200 M, 0.200 mmol) in 
THF (total volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were 
prepared. The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The 
combined stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask 
containing a stirred solution of 5-bromonicotinaldehyde (30l, 93 mg, 0.500 mmol, 1.50 equiv) in THF. 
The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31l as a colorless viscous liquid (62 mg, 0.169 mmol, 
85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.48 (d, J = 17.6 Hz, 2H), 7.99 (d, J = 2.2 Hz, 1H), 7.83 (t, 
J = 2.0 Hz, 1H), 7.54 (dd, J = 8.5, 2.2 Hz, 1H), 7.48 (d, J = 8.4 Hz, 1H), 6.21 (s, 1H), 3.86 (s, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.3, 146.7, 140.9, 139.2, 137.5, 135.9, 135.9, 130.5, 130.3 
(q, J = 33.2 Hz), 126.4 (q, J = 3.7 Hz), 124.9 (q, J = 3.8 Hz), 122.4 (q, J = 272.4 Hz), 69.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3165, 2848, 1611, 1583, 1562, 1478, 1421, 1323, 1275, 1248, 
1202, 1167, 1122, 1099, 1079, 1036, 1021, 916, 886, 873, 826, 768, 737, 708, 695, 661, 654. 
MS (EI, 70 eV): m/z (%) = 209 (26), 207 (24), 184 (11), 179 (28), 163 (25), 161 (82), 160 (32), 159 
(12), 158 (99), 157 (13), 156 (100), 145 (58), 144 (15), 143 (17), 131 (27), 129 (26), 125 (41), 78 (23), 
76 (34), 75 (13), 74 (12), 39 (36), 50 (18). 
HRMS (EI): m/z calcd. for [C13H8BrClF3NO]: 364.9430; found 364.9415 (M+). 
3-(Butylthio)-2-chloropyridine (31m) 
 
According to TP 9, a solution of 2-chloropyridine (28e, 0.167 M, 0.167 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.175 M in DMEA, 0.175 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of iodine (30a, 216 mg, 0.835 mmol, 5.00 equiv) in THF. The reaction was instantly 
quenched by the addition of sat. aq. Na2S2O3. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
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removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) 
afforded the title compound 31m as white crystals (24 mg, 0.09 mmol, 53%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.37 (dd, J = 4.6, 1.7 Hz, 1H), 8.15 (dd, J = 7.8, 1.7 Hz, 1H), 
6.96 (dd, J = 7.8, 4.7 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.6, 148.9, 148.8, 123.2, 94.9. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2920, 2851, 1554, 1546, 1385, 1252, 1208, 1135, 1057, 1011, 
1004, 982, 794, 742, 720. 
MS (EI, 70 eV): m/z (%) = C5H3ClIN]: 241 (32), 239 (100), 127 (20), 114 (11), 112 (31), 76 (15). 
HRMS (EI): m/z calcd. for [C5H3ClIN]: 238.8999; found 238.8993 (M+). 
M.p. (°C): 92.7 – 93.7. 
3-(Butylthio)-2-chloropyridine (31n) 
 
According to TP 9, a solution of 2-chloropyridine (28e, 0.167 M, 0.167 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.175 M in DMEA, 0.175 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of dibutyl disulfid (30m, 94 µL, 0.418 mmol, 2.50 equiv) in THF. The reaction was 
instantly quenched by the addition of 2 M NaOCl. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 9:1) 
afforded the title compound 31n as an orange oil (26 mg, 0.129 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.15 (dd, J = 4.7, 1.7 Hz, 1H), 7.52 (dd, J = 7.8, 1.7 Hz, 1H), 
7.19 (dd, J = 7.8, 4.7 Hz, 1H), 2.93 (t, J = 7.3, 2H), 1.75 – 1.64 (m, 2H), 1.56 – 1.45 (m, 2H), 0.96 (t, 
J = 7.4 Hz, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.1, 145.1, 135.2, 135.1, 122.7, 31.8, 30.5, 22.2, 13.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2958, 2929, 2872, 1547, 1464, 1433, 1379, 1346, 1212, 1143, 
1128, 1064, 1042, 1035, 787, 757, 728, 655. 
MS (EI, 70 eV): m/z (%) = 201 (25), 147 (36), 145 (100), 108 (21). 
HRMS (EI): m/z calcd. for [C9H12ClNS]: 201.0379; found 201.0374 (M+). 
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(2,3-Dichlorophenyl)(2-fluoro-6-(trifluoromethyl)pyridin-3-yl)methanol (31o) 
 
According to TP 9, a solution of 2-fluoro-6-(trifluoromethyl)pyridine (28f, 0.190 M, 0.190 mmol) in 
THF (total volume: 1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were 
prepared. The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The 
combined stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask 
containing a stirred solution of 2,3-dichlorobenzaldehyde (30n, 84 mg, 0.285 mmol, 1.50 equiv) in 
THF. The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31o as a colorless highly viscous liquid (46 mg, 
0.129 mmol, 68%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99 – 7.89 (m, 1H), 7.58 (dd, J = 7.7, 1.4 Hz, 1H), 7.48 (dd, 
J = 8.0, 1.6 Hz, 1H), 7.42 (dd, J = 7.8, 1.6 Hz, 1H), 7.27 (t, J = 8.2 Hz, 1H), 6.44 (s, 1H), 2.82 (s, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.3 (d, J = 246.3 Hz), 145.6 (dd, J = 36.3, 13.8 Hz), 140.7 
(d, J = 4.9 Hz), 140.1, 133.8, 131.0, 130.6, 127.9 (q, J = 120.7 Hz), 127.8, 126.2, 121.4 (q, 
J = 272.8 Hz), 118.5 (dq, J = 6.0, 3.0 Hz), 67.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 1611, 1587, 1568, 1476, 1451, 1410, 1350, 1279, 1193, 1173, 
1141, 1117, 1103, 1051, 1035, 974, 924, 878, 858, 821, 784, 773, 747, 742, 721, 699, 678. 
MS (EI, 70 eV): m/z (%) = 341 (12), 339 (18), 304 (26), 194 (23), 192 (100), 177 (20), 175 (44), 174 
(27), 173 (68), 166 (44), 165 (66), 164 (19), 149 (31), 148 (14), 147 (47), 146 (54), 145 (11), 139 (18), 
138 (11), 126 (10), 114 (10), 111 (19), 109 (12), 75 (15). 
HRMS (EI): m/z calcd. for [C13H7Cl2F4NO]: 338.9841; found 338.9833 (M+). 
2-Chloro-3-iodopyrazine (31p) 
 
According to TP 9, a solution of 2-chloropyrazine (28g, 0.200 M, 0.200 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of iodine (30a, 127 mg, 0.500 mmol, 2.50 equiv) in THF. The reaction was instantly 
quenched by the addition of sat. aq. Na2S2O3. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
C. EXPERIMENTAL PART    149 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 95:5) 
afforded the title compound 31p as light yellow crystals (31 mg, 0.129 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.30 (d, J = 2.4 Hz, 1H), 8.28 (d, J = 2.4 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.8, 142.7, 142.1, 119.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3058, 2920, 2849, 1820, 1721, 1531, 1494, 1463, 1424, 1409, 
1377, 1336, 1311, 1253, 1228, 1181, 1170, 1139, 1056, 1024, 858, 778. 
MS (EI, 70 eV): m/z (%) = 242 (32), 240 (100), 127 (36), 115 (25), 113 (73), 88 (10), 86 (30). 
HRMS (EI): m/z calcd. for [C4H2ClIN2]: 239.8951; found 239.8945. 
M.p. (°C): 77.0 – 78.8. 
(4-Chlorophenyl)(3-chloropyrazin-2-yl)methanol (31q) 
 
According to TP 9, a solution of 2-chloropyrazine (28g, 0.190 M, 0.190 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 4-chlorobenzaldehyde (30o, 40 mg, 0.285 mmol, 1.5 equiv) in THF. The reaction 
was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31q as a yellow liquid (38 mg, 0.154 mmol, 79%). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.56 (d, J = 2.5 Hz, 1H), 8.38 (d, J = 2.5 Hz, 1H), 7.32 – 7.27 
(m, 4H), 6.00 (d, J = 7.3 Hz, 1H), 4.66 (d, J = 7.8 Hz, 1H).  
13C-NMR (151 MHz, CDCl3): δ / ppm = 154.4, 147.7, 143.4, 141.4, 139.0, 134.4, 129.0 (2C), 129.0 
(2C), 71.6. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3397, 1489, 1401, 1368, 1291, 1243, 1187, 1152, 1105, 1087, 
1037, 1013, 946, 875, 836, 821, 805, 779, 764, 749, 732, 722, 690, 674, 661, 658, 652. 
MS (EI, 70 eV): m/z (%) = 256 (17), 254 (26), 143 (16), 141 (48), 141 (34), 140 (20), 139 (100), 125 
(12), 116 (14), 115 (22), 114 (45), 113 (24), 111 (11), 79 (15), 77 (40), 75 (12). 
HRMS (EI): m/z calcd. for [C11H8Cl2N2O]: 254.0014; found 254.0007 (M+). 
  
C. EXPERIMENTAL PART    150 
(2,4-Dimethylphenyl)(3-fluoropyrazin-2-yl)methanol (31r) 
 
According to TP 9, a solution of 2-fluoropyrazine (28h, 0.200 M, 0.200 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of 2,4-dimethylbenzaldehyde (30p, 40 mg, 0.300 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 8:2) afforded the title compound 31r as a pale yellow oil (45 mg, 0.194 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.57 – 8.45 (m, 1H), 8.30 – 8.06 (m, 1H), 7.02 (s, 1H), 
6.96 – 6.85 (m, 2H), 6.19 (s, 1H), 2.46 (s, 3H), 2.28 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.5 (d, J = 255.0 Hz), 146.0 (d, J = 29.2 Hz), 140.6 (d, 
J = 8.4 Hz), 140.3 (d, J = 4.9 Hz), 138.3, 136.5, 135.6, 131.9, 127.3, 127.1, 67.8 (d, J = 5.9 Hz), 21.2, 
19.21 (d, J = 1.6 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3391, 3014, 2922, 1710, 1614, 1537, 1502, 1453, 1407, 1379, 
1265, 1198, 1171, 1110, 1037, 932, 893, 859, 838, 810, 762, 718. 
MS (EI, 70 eV): m/z (%) = 216 (11), 214 (13), 213 (100), 201 (23), 199 (13), 135 (16), 134 (99), 133 
(61), 107 (25), 105 (26), 99 (10), 91 (23), 79 (10). 
HRMS (EI): m/z calcd. for [C13H13FN2O]: 232.1012; found 232.1006 (M+). 
1-(2-Bromopyridin-3-yl)-2-ethylbutan-1-ol (31s) 
 
According to TP 9, a solution of 2-bromopyridine (28i, 0.190 M, 0.190 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 2-ethylbutanal (30q, 29 mg, 0.285 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31s as a yellow oil (32 mg, 0.124 mmol, 65%). 
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1H-NMR (599 MHz, CDCl3): δ / ppm = 8.25 (dd, J = 4.7, 2.0 Hz, 1H), 7.86 (dd, J = 7.7, 2.0 Hz, 1H), 
7.29 (dd, J = 7.7, 4.6 Hz, 1H), 5.07 (t, J = 4.0 Hz, 1H), 2.15 (s, 1H), 1.70 – 1.63 (m, 1H), 1.57 – 1.49 
(m, 1H), 1.40 – 1.29 (m, 3H), 1.01 (t, J = 7.5 Hz, 3H), 0.80 (t, J = 7.5 Hz, 3H).  
13C-NMR (151 MHz, CDCl3): δ / ppm = 148.7, 141.9, 140.6, 137.4, 122.9, 72.9, 45.6, 22.7, 19.9, 11.7, 
11.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2959, 2931, 2873, 1575, 1559, 1458, 1401, 1379, 1181, 1130, 
1103, 1065, 1052, 1040, 1016, 837, 805, 773, 754, 744, 735, 705. 
MS (EI, 70 eV): m/z (%) = 189 (55), 188 (98), 187 (56), 186 (100), 185 (17), 183 (12), 158 (10), 156 
(11), 130 (23), 122 (29), 108 (14), 107 (38), 106 (25), 105 (24), 81 (17), 79 (58), 78 (46). 
HRMS (EI): m/z calcd. for [C11H16BrNO]: 257.0415; found 257.0407 (M+). 
(6-Chloro-3-fluoropyridin-2-yl)(4-isopropylphenyl)methanol (31t) 
 
According to TP 9, a solution of 2-chloro-5-fluoropyridine (28j, 0.190 M, 0.190 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 4-isopropylbenzaldehyde (30r, 42 mg, 0.285 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 31t as white crystals (41 mg, 0.147 mmol, 77%). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.04 (s, 1H), 7.69 (d, J = 5.1 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 
7.22 (d, J = 8.2 Hz, 2H), 6.01 (d, J = 3.0 Hz, 1H), 2.89 (h, J = 13.9, 7.0 Hz, 1H), 2.70 (s, 1H), 1.23 (d, 
J = 6.9 Hz, 6H).  
13C-NMR (151 MHz, CDCl3): δ / ppm = 155.9 (d, J = 255.2 Hz), 149.8, 146.8 (d, J = 2.9 Hz), 143.3 
(d, J = 12.9 Hz), 138.2, 137.2 (d, J = 26.5 Hz), 127.2 (2C), 126.7 (d, J = 1.1 Hz, 2C), 122.1 (d, 
J = 1.9 Hz), 69.5 (d, J = 1.8 Hz), 34.0, 24.0 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3262, 3246, 3241, 3227, 2956, 1605, 1462, 1427, 1422, 1353, 
1297, 1285, 1256, 1244, 1194, 1180, 1164, 1090, 1052, 1018, 921, 895, 849, 837, 831, 814, 755, 717, 
663. 
MS (EI, 70 eV): m/z (%) = 264 (22), 262 (13), 261 (11), 248 (11), 238 (18), 236 (56), 160 (31), 159 
(16), 158 (100), 147 (13), 130 (17), 119 (22), 115 (11), 105 (12), 91 (24), 59 (10). 
HRMS (EI): m/z calcd. for [C15H15ClFNO]: 279.0826; found 279.0822 (M+). 
M.p. (°C): 105.8 – 107.2. 
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2-(Cyclohex-2-en-1-yl)-5-iodothiophene (31u) 
 
According to TP 9, a solution of 2-iodothiophene (28k, 0.195 M, 0.195 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 3-bromocyclohexene (30f, 79 mg, 0.488 mmol, 2.50 equiv) and CuCN∙2LiCl 
(0.01 mL, 1.0 M in THF, 5 mol%) in THF. The reaction was instantly quenched by the addition of sat. 
aq. NH4Cl. The aq. phase was extracted three times with EtOAc (3×10 mL) and the combined organic 
phases were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex) afforded the title compound 31u as a pale brown oil 
(43 mg, 0.148 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.06 (d, J = 3.6 Hz, 1H), 6.52 (dd, J = 3.7, 0.9 Hz, 1H), 
5.92 – 5.82 (m, 1H), 5.74 (dd, J = 9.9, 3.2 Hz, 1H), 3.73 – 3.61 (m, 1H), 2.13 – 1.95 (m, 3H), 
1.79 – 1.58 (m, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.8, 136.6, 129.1, 129.0, 125.4, 70.1, 37.1, 32.4, 25.0, 20.5. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3018, 2919, 2849, 1720, 1646, 1587, 1455, 1444, 1428, 1402, 
1377, 1347, 1309, 1295, 1253, 1133, 1050, 973, 940, 894, 869, 790, 753, 721, 684. 
MS (EI, 70 eV): m/z (%) = 163 (4), 135 (5), 127 (100). 
HRMS (EI): m/z calcd. for [C10H11IS]: 289.9626; found 289.9618 (M+). 
(3-Bromo-2-fluorophenyl)(methyl)sulfane (31v) 
 
According to TP 9, a solution of 1-bromo-2-fluorobenzene (28l, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of dimethyldisulfide (30s, 57 mg, 0.600 mmol, 3.00 equiv) in THF. The reaction was 
instantly quenched by the addition of 2 M NaOCl. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex) afforded the 
title compound 31v as a light orange oil (31 mg, 0.140 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.39 – 7.33 (m, 1H), 7.21 – 7.16 (m, 1H), 7.01 – 6.95 (m, 1H), 
2.48 (s, 3H).  
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13C-NMR (101 MHz, CDCl3): δ / ppm = 156.5 (d, J = 244.6 Hz), 130.5, 127.8 (d, J = 18.3 Hz), 127.6 
(d, J = 2.1 Hz), 125.3 (d, J = 4.5 Hz), 109.4 (d, J = 21.5 Hz), 15.8 (d, J = 2.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3069, 2923, 2853, 1710, 1583, 1559, 1442, 1434, 1319, 1286, 
1234, 1203, 1158, 1093, 1080, 1058, 970, 957, 880, 820, 758, 704. 
MS (EI, 70 eV): m/z (%) = 222 (99), 220 (100), 189 (41), 187 (41), 176 (15), 174 (16), 140 (14), 126 
(55). 
HRMS (EI): m/z calcd. for [C7H6BrFS]: 219.9358; found 219.9351 (M+). 
(3-Bromo-2-fluorophenyl)(3,4,5-trimethoxyphenyl)methanol (31w) 
 
According to TP 9, a solution of 1-bromo-2-fluorobenzene (28l, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of 3,4,5-trimethoxybenzaldehyde (30t, 59 mg, 0.300 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1 → 4:1 → 2:1) afforded the title compound 31w as a colorless liquid (59 mg, 
0.159 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.49 – 7.43 (m, 2H), 7.03 (td, J = 7.9, 0.8 Hz, 1H), 6.60 (s, 
2H), 6.05 (s, 1H), 3.82 (s, 6H), 3.81 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.2 (d, J = 247.1 Hz), 153.4 (2C), 138.1, 137.6, 132.7 (d, 
J = 14.0 Hz), 132.7, 126.7 (d, J = 3.5 Hz), 125.4 (d, J = 4.4 Hz), 109.2 (d, J = 21.2 Hz), 103.4 (d, 
J = 0.8 Hz, 2C), 70.1 (d, J = 2.9 Hz), 60.9, 56.2 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3480, 3393, 2966, 2936, 2836, 2827, 1592, 1505, 1450, 1415, 
1400, 1331, 1310, 1273, 1227, 1183, 1177, 1122, 1083, 1070, 1059, 996, 970, 921, 883, 861, 838, 829, 
796, 785, 766, 753, 734, 714, 677. 
MS (EI, 70 eV): m/z (%) = 372 (49), 370 (54), 203 (60), 201 (65), 169 (100), 154 (13), 138 (21). 
HRMS (EI): m/z calcd. for [C16H16BrFO4]: 370.0216; found 370.0208 (M+). 
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(3-Bromo-2-fluorophenyl)(phenyl)methanol (31x) 
 
According to TP 9, a solution of 1-bromo-2-fluorobenzene (28l, 0.210 M, 0.210 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.221 M in DMEA, 0.221 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of benzaldehyde (30b, 33 mg, 0.315 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 19:1) afforded the title compound 31x as a pale yellow oil (48 mg, 0.171 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.54 – 7.43 (m, 2H), 7.41 – 7.32 (m, 4H), 7.31 – 7.27 (m, 1H), 
7.08 – 7.01 (m, 1H), 6.13 (s, 1H), 2.39 (s, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.2 (d, J = 247.3 Hz), 142.3, 132.9, 132.7 (2C), 128.8 (2C), 
128.2, 126.8 (d, J = 3.6 Hz), 126.5 (d, J = 0.8 Hz), 125.4 (d, J = 4.4 Hz), 109.3 (d, J = 21.2 Hz), 70.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3320, 3064, 3031, 2915, 1950, 1881, 1809, 1683, 1602, 1573, 
1493, 1450, 1314, 1226, 1190, 1168, 1127, 1081, 1036, 1023, 918, 870, 818, 773, 725, 696. 
MS (EI, 70 eV): m/z (%) = 283 (13), 282 (86), 281 (13), 280 (88), 279 (14), 205 (10), 203 (100), 201 
(100), 185 (11), 184 (11), 183 (52), 172 (11), 165 (11), 152 (11), 123 (11), 107 (17), 105 (91), 96 (20), 
94 (18), 79 (56), 78 (70), 77 (33). 
HRMS (EI): m/z calcd. for [C13H10BrFO]: 279.9899; found 279.9893 (M+). 
3-(2-Chloropyridin-3-yl)-2,4-dimethylpentan-3-ol (33a) 
 
According to TP 9, a solution of 2-chloropyridine (28e, 0.195 M, 0.195 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −20 °C) and was subsequently injected in a flask containing 
a stirred solution of 2,4-dimethylpentan-3-one (32a, 33 mg, 0.293 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1  1:1) afforded the title compound 33a as colorless crystals (30 mg, 0.132 mmol, 
68%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.28 (dd, J = 4.6, 1.9 Hz, 1H), 8.09 (s, 1H), 7.24 (dd, J = 7.9, 
4.5 Hz, 1H), 2.77 (s, 2H), 0.95 (d, J = 6.7 Hz, 6H), 0.81 (d, J = 6.9 Hz, 6H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.6, 147.5, 140.1, 121.7, 81.6, 34.3 (2C), 18.6 (2C), 17.2 
(2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3374, 2993, 2962, 2935, 2877, 2848, 1591, 1573, 1554, 1463, 
1454, 1384, 1371, 1330, 1321, 1296, 1235, 1224, 1177, 1167, 1151, 1119, 1097, 1059, 1013, 996, 987, 
956, 912, 869, 834, 809, 752, 747, 658. 
MS (EI, 70 eV): m/z (%) = 186 (30), 184 (91), 182 (10), 148 (100), 142 (24), 140 (77), 133 (14), 130 
(34), 120 (20), 117 (11), 112 (17), 106 (15), 92 (10), 78 (23), 77 (11). 
HRMS (EI): m/z calcd. for [C12H16ClN]: 209.0971; found 209.0965 (M+ − H2O). 
M.p. (°C): 113.8 – 115.4. 
(2-Bromopyridin-3-yl)dicyclopropylmethanol (33b) 
 
According to TP 9, a solution of 2-bromopyridine (28i, 0.180 M, 0.180 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.189 M in DMEA, 0.189 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of dicyclopropylmethanone (32b, 31 µL, 0.27 mmol, 1.50 equiv) in THF. The reaction 
was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 33b as colorless crystals (26 mg, 0.100 mmol, 54%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.25 (dd, J = 4.6, 1.9 Hz, 1H), 8.07 (dd, J = 7.8, 2.0 Hz, 1H), 
7.25 (dd, J = 7.8, 4.6 Hz, 1H), 1.95 (s, 1H), 1.65 (tt, J = 8.2, 5.7 Hz, 2H), 0.81 – 0.72 (m, 2H), 0.62 (tdd, 
J = 8.3, 7.0, 4.6 Hz, 2H), 0.42 – 0.32 (m, 4H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.9, 144.0, 140.5, 137.2, 122.5, 73.0, 19.3 (2C), 4.2 (2C), 
1.1 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3377. 3083, 3007, 1571, 1555, 1434, 1427, 1389, 1314, 1261, 
1234, 1212, 1184, 1169, 1120, 1110, 1049, 1040, 1006, 973, 958, 920, 909, 853, 824, 795, 780, 735, 
731, 662. 
MS (EI, 70 eV): m/z (%) = 241 (21), 239 (23), 228 (53), 226 (53), 199 (12), 197 (11), 186 (95), 184 
(100), 160 (74), 158 (15), 156 (15), 154 (12), 132 (10), 130 (43), 118 (16), 117 (42), 115 (10), 91 (14), 
89 (13), 81 (13), 79 (13), 78 (17), 69 (19). 
HRMS (EI): m/z calcd. for [C10H10BrNO]: 238.9946; found 238.9939 (M+ − C2H4). 
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M.p. (°C): 137.9 – 139.7. 
1-(2-Bromopyridin-3-yl)-1-(2-fluorophenyl)ethan-1-ol (33c) 
 
According to TP 9, a solution of 2-bromopyridine (28i, 0.180 M, 0.180 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.189 M in DMEA, 0.189 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 1-(2-fluorophenyl)ethan-1-one (32c, 33 µL, 0.27 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 33c as a grey solid (30 mg, 0.101 mmol, 56%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.28 (dd, J = 4.7, 1.9 Hz, 1H), 8.20 – 8.15 (m, 1H), 7.70 (td, 
J = 8.1, 1.8 Hz, 1H), 7.35 (dd, J = 7.8, 4.6 Hz, 1H), 7.33 – 7.27 (m, 1H), 7.19 (td, J = 7.6, 1.3 Hz, 1H), 
6.92 (ddd, J = 11.8, 8.1, 1.3 Hz, 1H), 2.02 (d, J = 0.8 Hz, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.6 (d, J = 246.3 Hz), 148.8, 142.7 (d, J = 1.3 Hz), 140.5, 
136.5 (d, J = 2.9 Hz), 132.6 (d, J = 10.7 Hz), 129.8 (d, J = 8.6 Hz), 128.8 (d, J = 3.6 Hz), 124.0 (d, 
J = 3.4 Hz), 122.9, 116.3 (d, J = 22.4 Hz), 74.2, 28.1 (d, J = 1.3 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3262, 3076, 2982, 2923, 2867, 1770, 1728, 1609, 1574, 1556, 
1485, 1451, 1440, 1404, 1389, 1367, 1277, 1248, 1231, 1225, 1200, 1185, 1160, 1134, 1101, 1087, 
1052, 1039, 1031, 991, 922, 863, 845, 816, 803, 757, 748, 726, 661. 
MS (EI, 70 eV): m/z (%) = 283 (13), 282 (98), 281 (12), 280 (100), 200 (21), 198 (39), 186 (20), 184 
(22), 178 (14), 173 (10), 172 (40), 170 (16), 159 (25), 157 (23), 139 (25), 123 (20). 
HRMS (EI): m/z calcd. for [C13H11BrFNO]: 295.0008; found 294.9996 (M+). 
M.p. (°C): 101.8 – 102.0. 
1-(3-Fluoropyrazin-2-yl)-1-(3-methoxyphenyl)ethan-1-ol (33d) 
 
According to TP 9, a solution of 2-fluoropyrazine (28h, 0.200 M, 0.200 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of 1-(3-methoxyphenyl)ethan-1-one (32d, 45 mg, 0.300 mmol, 1.50 equiv) in THF. 
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The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 33d as a light yellow oil (38 mg, 0.153 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.53 – 8.46 (m, 1H), 8.22 (t, J = 2.2 Hz, 1H), 7.31 – 7.27 (m, 
1H), 7.06 – 7.00 (m, 2H), 6.87 – 6.82 (m, 1H), 5.35 (s, 1H), 3.82 (s, 3H), 2.06 (d, J = 1.8 Hz, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.0, 157.5 (d, J = 255.4 Hz), 148.9 (d, J = 27.1 Hz), 146.3, 
141.1 (d, J = 8.6 Hz), 139.6 (d, J = 5.0 Hz), 129.5, 118.2 (d, J = 1.8 Hz), 112.9, 112.0 (d, J = 1.5 Hz), 
74.1 (d, J = 6.8 Hz), 55.4, 26.6 (d, J = 4.0 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3428, 3071, 2983, 2938, 2836, 1600, 1584, 1538, 1486, 1452, 
1433, 1399, 1366, 1317, 1289, 1249, 1195, 1164, 1115, 1088, 1040, 996, 935, 857, 787, 769, 700, 684. 
MS (EI, 70 eV): m/z (%) = 249 (11), 248 (81), 233 (30), 229 (17), 205 (20), 151 (100), 150 (21), 135 
(37), 125 (33), 99 (10), 97 (28), 77 (11), 43 (23). 
HRMS (EI): m/z calcd. for [C13H13FN2O2]: 248.0961; found 248.0955 (M+). 
1-(3-Chloropyrazin-2-yl)cyclohexan-1-ol (33e) 
 
According to TP 9, a solution of 2-chloropyrazine (28g, 0.200 M, 0.200 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of cyclohexanone (32e, 29 mg, 0.300 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 33e as colorless crystals (30 mg, 0.141 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.46 (d, J = 2.4 Hz, 1H), 8.34 (d, J = 2.4 Hz, 1H), 4.90 (s, 1H), 
2.48 (td, J = 13.1, 4.5 Hz, 2H), 1.95 – 1.76 (m, 3H), 1.74 – 1.66 (m, 2H), 1.62 – 1.52 (m, 2H), 
1.45 – 1.33 (m, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.4, 147.1, 142.4, 140.1, 73.8, 34.3 (2C), 25.3, 22.0 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3413, 2953, 2922, 2890, 2852, 1446, 1440, 1388, 1365, 1341, 
1327, 1272, 1236, 1183, 1130, 1087, 1063, 1035, 1014, 982, 913, 867, 835, 789, 771. 
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MS (EI, 70 eV): m/z (%) = 212 (20), 194 (10), 186 (17), 184 (47), 171 (11), 149 (80), 141 (45), 130 
(12), 128 (35), 116 (11), 115 (19), 114 (25), 99 (11), 98 (25), 79 (13), 57 (18), 56 (12), 55 (15), 44 
(100), 43 (47), 42 (15), 41 (28). 
HRMS (EI): m/z calcd. for [C10H13ClN2O]: 212.0716; found 212.0707 (M+). 
M.p. (°C): 71.6 – 73.1. 
2-(3-Chloropyrazin-2-yl)butan-2-ol (33f) 
 
According to TP 9, a solution of 2-chloropyrazine (28g, 0.200 M, 0.200 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of butan-2-one (32f, 22 mg, 0.300 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 33f as a pale yellow oil (24 mg, 0.129 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.46 (d, J = 2.4 Hz, 1H), 8.35 (d, J = 2.4 Hz, 1H), 5.34 (s, 1H), 
2.33 (dq, J = 14.6, 7.4 Hz, 1H), 1.97 (dq, J = 14.2, 7.5 Hz, 1H), 1.68 (s, 3H), 0.69 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.8, 147.0, 142.6, 139.9, 74.6, 32.5, 26.5, 8.2. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3436, 2971, 2932, 2877, 1726, 1551, 1457, 1436, 1371, 1351, 
1286, 1236, 1197, 1130, 1061, 1035, 996, 927, 858, 796, 776. 
MS (EI, 70 eV): m/z (%) = 159 (29), 115 (17), 43 (37). 
HRMS (EI): m/z calcd. for [C8H11ClN2O]: 186.0560; found 186.0545 (M+). 
2-(5-Iodothiophen-2-yl)bicyclo[2.2.1]heptan-2-ol (33g) 
 
According to TP 9, a solution of 2-iodothiophene (28k, 0.195 M, 0.195 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of bicyclo[2.2.1]heptan-2-one (32g, 32 mg, 0.293 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
C. EXPERIMENTAL PART    159 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 95:5) afforded the title compound 33g as a colorless liquid (38 mg, 0.119 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.07 (d, J = 3.8 Hz, 1H), 6.65 (d, J = 3.8 Hz, 1H), 2.43 (d, 
J = 2.7 Hz, 1H), 2.34 – 2.29 (m, 1H), 2.24 (ddd, J = 13.1, 4.8, 2.8 Hz, 1H), 2.15 – 2.05 (m, 1H), 2.02 
(s, 1H), 1.68 – 1.57 (m, 2H), 1.53 – 1.37 (m, 3H), 1.37 – 1.31 (m, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.2, 136.5, 124.6, 79.6, 72.5, 50.0, 48.1, 38.9, 37.3, 28.8, 
22.4. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3409, 2948, 2867, 1731, 1474, 1452, 1445, 1423, 1373, 1308, 
1291, 1252, 1228, 1212, 1188, 1163, 1130, 1121, 1069, 1041, 1002, 964, 952, 929, 918, 821, 790, 753. 
MS (EI, 70 eV): m/z (%) = 302 (19), 274 (100), 252 (13), 237 (12), 193 (12), 175 (37), 147 (36), 127 
(55). 
HRMS (EI): m/z calcd. for [C11H13IOS]: 319.9732; found 319.9726 (M+). 
1-(5-Bromobenzofuran-2-yl)-2-methyl-1-phenylpropan-1-ol (33h) 
 
According to TP 9, a solution of 5-bromobenzofuran (28m, 0.195 M, 0.195 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 2-methyl-1-phenylpropan-1-one (32h, 43 mg, 0.293 mmol, 1.50 equiv) in THF. 
The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 95:5) afforded the title compound 33h as a colorless viscous liquid (61 mg, 0.177 mmol, 
91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.64 (d, J = 1.8 Hz, 1H), 7.61 – 7.56 (m, 2H), 7.39 – 7.30 (m, 
4H), 7.30 – 7.23 (m, 1H), 6.68 (s, 1H), 2.80 (hept, J = 6.8 Hz, 1H), 2.44 (s, 1H), 0.98 (d, J = 6.8 Hz, 
3H), 0.83 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.2, 153.6, 143.1, 130.4, 128.3 (2C), 127.4, 126.8, 125.7 
(2C), 123.7, 116.0, 112.8, 102.4, 78.8, 36.3, 17.4, 16.8. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3572, 3475, 3058, 3025, 2966 2931, 2874, 1609, 1599, 1585, 
1490, 1442, 1386, 1366, 1343, 1317, 1258, 1242, 1163, 1147, 1117, 1077, 1049, 1013, 981, 938, 901, 
865, 793, 749, 699, 673. 
MS (EI, 70 eV): m/z (%) = 328 (27), 326 (27), 324 (12), 303 (16), 302 (17), 300 (19), 231 (18), 225 
(23), 223 (27), 215 (13), 207 (24), 202 (20), 198 (11), 196 (12), 169 (10), 167 (10), 129 (15), 128 (13), 
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117 (14), 115 (33), 105 (79), 103 (10), 98 (18), 96 (19), 91 (12), 89 (10), 82 (31), 81 (100), 79 (91), 78 
(18), 77 (26). 
HRMS (EI): m/z calcd. for [C18H15BrO]: 326.0306; found 326.0300 (M+ − H2O). 
4-(2,6-Difluorophenyl)tetrahydro-2H-pyran-4-ol (33i) 
 
According to TP 9, a solution of 1,3-difluorobenzene (28b, 0.195 M, 0.195 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask containing 
a stirred solution of tetrahydro-4H-pyran-4-one (32i, 57 mg, 0.293 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 4:1) afforded the title compound 33i as a white solid (23 mg, 0.107 mmol, 55%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.25 – 7.17 (m, 1H), 6.88 (dd, J = 10.9, 8.4 Hz, 2H), 4.00 (t, 
J = 11.0 Hz, 2H), 3.81 (dd, J = 10.3, 5.0 Hz, 2H), 2.77 – 2.72 (m, 1H), 2.44 (td, J = 13.5, 4.8 Hz, 2H), 
2.01 (d, J = 13.8 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.0 (dd, J = 247.8, 9.0 Hz, 2C), 129.1 (t, J = 12.1 Hz, 2C), 
122.3 (t, J = 13.2 Hz), 114.3 – 111.5 (m), 71.9 (t, J = 2.3 Hz), 63.6 (2C), 38.0 (t, J = 4.6 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3357, 2975, 2962, 2935, 2923, 2881, 2853, 1618, 1578, 1571, 
1464, 1454, 1429, 1391, 1362, 1329, 1305, 1290, 1260, 1230, 1208, 1141, 1122, 1093, 1076, 1029, 
1019, 988, 966, 915, 836, 796, 730, 706. 
MS (EI, 70 eV): m/z (%) = 214 (17), 196 (47), 185 (15), 170 (100), 169 (18), 168 (76), 158 (14), 156 
(56), 142 (23), 141 (74), 140 (36), 139 (10), 127 (49), 114 (28), 113 (19), 100 (31), 73 (10), 72 (13), 57 
(10), 43 (74), 42 (53). 
HRMS (EI): m/z calcd. for [C11H12F2O2]: 214.0805; found 214.0804 (M+). 
M.p. (°C): 76.9 – 78.8. 
1-(3-Bromo-2-fluorophenyl)-1-cyclohexylethan-1-ol (33j) 
 
According to TP 9, a solution of 1-bromo-2-fluorobenzene (28l, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
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The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −60 °C) and was subsequently injected in a flask containing 
a stirred solution of 1-cyclohexylethan-2-one (32j, 38 mg, 0.300 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex) 
afforded the title compound 33j as a highly viscose colorless liquid (33 mg, 0.110 mmol, 55%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.49 (td, J = 7.6, 1.7 Hz, 1H), 7.44 (ddd, J = 8.0, 6.4, 1.7 Hz, 
1H), 6.99 (td, J = 7.9, 0.8 Hz, 1H), 1.90 – 1.76 (m, 4H), 1.72 – 1.61 (m, 2H), 1.59 (d, J = 1.8 Hz, 3H), 
1.36 – 0.96 (m, 6H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 155.6 (d, J = 246.2 Hz), 136.7 (d, J = 13.4 Hz), 132.1, 127.4 
(d, J = 4.5 Hz), 124.7 (d, J = 4.2 Hz), 110.0 (d, J = 23.5 Hz), 76.6 (d, J = 4.8 Hz), 46.5 (d, J = 3.2 Hz), 
27.5, 27.0, 26.7 (d, J = 0.5 Hz), 26.5, 26.0, 26.0. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3603, 3473, 2929, 2852, 1600, 1565, 1437, 1374, 1334, 1293, 
1245, 1225, 1197, 1175, 1159, 1127, 1086, 1059, 1030, 1004, 971, 939, 906, 892, 868, 847, 822, 800, 
778, 762, 731, 673, 656. 
MS (EI, 70 eV): m/z (%) = 219 (96), 217 (100), 216 (10). 
HRMS (EI): m/z calcd. for [C14H18BrFO]: 300.0525; found 300.0510 (M+). 
1-(5-Bromo-2-fluorophenyl)-1-(thiophen-2-yl)ethan-1-ol (33k) 
 
According to TP 9, a solution of 1-bromo-4-fluorobenzene (28n, 0.200 M, 0.200 mmol) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −40 °C) and was subsequently injected in a flask containing 
a stirred solution of 1-(furan-2-yl)ethan-1-one (32k, 38 mg, 0.300 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 33k as a pale orange oil (42 mg, 0.140 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.83 (dd, J = 7.2, 2.6 Hz, 1H), 7.40 (ddd, J = 8.6, 4.3, 2.6 Hz, 
1H), 7.25 (dd, J = 5.1, 1.3 Hz, 1H), 6.96 – 6.86 (m, 3H), 2.66 (d, J = 3.1 Hz, 1H), 2.05 (d, J = 1.1 Hz, 
3H).  
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13C-NMR (101 MHz, CDCl3): δ / ppm = 159.1 (d, J = 247.6 Hz), 151.3 (d, J = 1.0 Hz), 136.3 (d, 
J = 12.4 Hz), 132.4 (d, J = 8.7 Hz), 130.2 (d, J = 3.6 Hz), 126.8, 125.3, 124.3 (d, J = 1.7 Hz), 118.1 (d, 
J = 24.7 Hz), 116.9 (d, J = 3.3 Hz), 72.8 (d, J = 2.0 Hz), 30.1 (d, J = 3.7 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3422, 3104, 3072, 2976, 2934, 1572, 1475, 1447, 1434, 1391, 
1374, 1351, 1322, 1254, 1234, 1219, 1195, 1163, 1127, 1087, 1078, 1053, 1015, 917, 893, 859, 843, 
813, 785, 749, 698, 669. 
MS (EI, 70 eV): m/z (%) = 287 (10), 285 (11), 284 (61), 281 (15), 203 (26), 202 (100), 201 (14), 184 
(15), 183 (15), 170 (31), 159 (13), 157 (15), 101 (18). 
HRMS (EI): m/z calcd. for [C12H10BrFOS]: 299.9620; found 299.9612 (M+). 
2-(5-Bromo-3-chloro-2-fluorophenyl)adamantan-2-ol (33l) 
 
According to TP 9, a solution of 4-bromo-2-chloro-1-fluorobenzene (28o, 0.190 M, 0.190 mmol) in 
THF (total volume: 1 mL) and a solution of NaDA (0.200 M in DMEA, 0.200 mmol, 1.05 equiv) were 
prepared. The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The 
combined stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask 
containing a stirred solution of adamantan-2-one (32l, 45 mg, 0.300 mmol, 1.50 equiv) in THF. The 
reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three 
times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and 
filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 33l as a white solid (40 mg, 0.114 mmol, 57%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.48 (s, 1H), 7.46 (s, 1H), 2.60 (s, 2H), 2.39 (dd, J = 12.8, 
3.0 Hz, 2H), 1.91 – 1.78 (m, 4H), 1.76 – 1.65 (m, 6H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.6 (d, J = 252.0 Hz), 136.0 (d, J = 11.3 Hz), 132.1, 130.3 
(d, J = 4.6 Hz), 123.8 (d, J = 21.8 Hz), 116.4 (d, J = 4.2 Hz), 77.1 (d, J = 2.3 Hz), 37.5, 35.8, 35.8, 35.2 
(2C) , 33.0 (2C), 27.1, 26.6 (d, J = 1.0 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3358, 3335, 2935, 2899, 2847, 1562, 1451, 1388, 1384, 1355, 
1331, 1244, 1220, 1195, 1173, 1166, 1161, 1102, 1082, 1052, 1009, 997, 985, 942, 921, 877, 854, 838, 
754, 735, 688, 668. 
MS (EI, 70 eV): m/z (%) = 342 (31), 340 (25), 237 (31), 235 (24), 225 (20), 223 (12), 210 (14), 208 
(11), 207 (31), 206 (19), 184 (12), 183 (28), 171 (11), 170 (26), 165 (11), 151 (24), 149 (18), 133 (15), 
128 (16), 121 (13), 93 (39), 92 (11), 91 (52), 81 (75), 80 (23), 79 (100), 78 (31), 77 (19), 67 (25), 45 
(17), 44 (66), 42 (27). 
HRMS (EI): m/z calcd. for [C16H17BrClFO]: 358.0135; found 358.0131 (M+). 
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M.p. (°C): 98.2 – 101.0. 
4-Fluoro-3-(hydroxy(phenyl)methyl)benzonitrile (36a) 
 
According to TP 9, a solution of 4-fluorobenzonitrile (34, 0.220 M, 0.220 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.199 M in DMEA, 0.199 mmol, 0.9 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of benzaldehyde (30b, 35 mg, 0.330 mmol, 1.50 equiv) in THF. The reaction was 
instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 36a as a colorless crystals (34 mg, 0.150 mmol, 75%). 
scale-up:  
In addition, a convenient scale-up of the reaction according to TP 9 was demonstrated. A solution of 4-
fluorobenzonitrile (34, 0.228 M) in THF (total volume: 30 mL, 6.84 mmol) and a solution of NaDA 
(0.205 M in DMEA, 30 mL, 6.15 mmol, 0.9 equiv) were prepared. The solutions were injected into 
6 mL loading coils and subsequently precooled and mixed with an overall 10 mLmin−1 flow rate in a 
T-mixer. The combined stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently 
injected in a flask containing a stirred solution of benzaldehyde (30b, 1.05 g, 9.90 mmol, 1.50 equiv) 
in THF. This procedure was repeated 5 times, leading to a total amount of 30 mL collected in the same 
flask. Stirring was continued for 5 min at 0 °C before sat. aq. NH4Cl was added to quench the reaction. 
The aq. phase was extracted three times with EtOAc (3×100 mL) and the combined organic phases 
were dried over anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash 
chromatographical purification (silica gel, i-hex:EtOAc = 9:1) afforded the title compound 36a as 
colorless crystals (1.06 g, 4.67 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00 – 7.93 (m, 1H), 7.56 (ddd, J = 8.5, 4.8, 2.2 Hz, 1H), 
7.43 – 7.29 (m, 5H), 7.10 (dd, J = 9.6, 8.5 Hz, 1H), 6.10 (s, 1H), 2.51 (s, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 162.1 (d, J = 256.6 Hz), 141.7, 133.5 (d, J = 9.6 Hz), 133.2 
(d, J = 14.6 Hz), 132.2 (d, J = 5.6 Hz), 129.0 (2C), 128.5 (2C), 126.5 (d, J = 1.2 Hz), 118.3, 116.9 (d, 
J = 23.3 Hz), 108.8 (d, J = 3.8 Hz), 69.6 (d, J = 2.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3496, 2922, 2904, 2232, 1606, 1586, 1486, 1453, 1412, 1393, 
1346, 1300, 1280, 1244, 1219, 1190, 1133, 1112, 1076, 1044, 1026, 927, 911, 837, 808, 760, 695, 685, 
656. 
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MS (EI, 70 eV): m/z (%) = 227 (58), 225 (19), 208 (24), 205 (11), 149 (12), 148 (100), 122 (17), 121 
(37), 105 (66), 100 (10), 79 (43), 78 (17), 77 (33). 
HRMS (EI): m/z calcd. for [C14H10FNO]: 227.0746; found 227.0741 (M+). 
M.p. (°C): 103.7 – 105.6. 
3-((4-Bromophenyl)(hydroxy)(phenyl)methyl)-4-fluorobenzonitrile (36b) 
 
According to TP 9, a solution of 4-fluorobenzonitrile (34, 0.230 M, 0.230 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.207 M in DMEA, 0.207 mmol, 0.9 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of (4-bromophenyl)(phenyl)methanone (32m, 90 mg, 0.345 mmol, 1.50 equiv) in 
THF. The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted 
three times with EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 
and filtrated. After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 36b as white crystals (71 mg, 0.186 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.66 (ddd, J = 8.4, 4.6, 2.2 Hz, 1H), 7.51 – 7.46 (m, 2H), 
7.40 – 7.35 (m, 3H), 7.33 (dd, J = 7.4, 2.2 Hz, 1H), 7.25 – 7.13 (m, 5H), 3.28 (d, J = 6.8 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.0 (d, J = 256.7 Hz), 143.8, 143.4, 135.9 (d, J = 11.7 Hz), 
134.4 (d, J = 10.3 Hz), 134.2 (d, J = 4.7 Hz), 131.6 (2C), 129.3 (d, J = 1.1 Hz), 128.7, 128.6 (3C), 
127.3, 122.5, 118.1, 118.1, 117.8, 108.7 (d, J = 3.7 Hz), 80.3. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3453, 2237, 1585, 1484, 1446, 1403, 1398, 1338, 1262, 1236, 
1195, 1189, 1171, 1134, 1108, 1073, 1033, 1021, 1008, 970, 917, 892, 835, 829, 816, 768, 734, 727, 
707, 702, 691, 675, 667, 659, 654. 
MS (EI, 70 eV): m/z (%) = 304 (10), 281 (12), 263 (22), 261 (22), 226 (10), 207 (45), 185 (37), 183 
(36), 154 (13), 148 (100), 105 (30), 77 (12). 
HRMS (EI): m/z calcd. for [C20H13BrFNO]: 381.0165; found 381.0160 (M+). 
M.p. (°C): 168.1 – 170.3. 
4-Fluoro-3-(pyridin-2-ylthio)benzonitrile (36c) 
 
According to TP 9, a solution of 4-fluorobenzonitrile (34, 0.228 M, 0.228 mmol) in THF (total volume: 
1 mL) and a solution of NaDA (0.205 M in DMEA, 0.205 mmol, 0.9 equiv) were prepared. The 
precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
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a stirred solution of aldrithiol (30k, 126 mg, 0.570 mmol, 2.50 equiv) in THF. The reaction was 
instantly quenched by the addition of 2 M NaOCl. The aq. phase was extracted three times with EtOAc 
(3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. After 
removal of the solvent in vacuo, flash chromatographical purification (silica gel, i-hex:EtOAc = 4:1) 
afforded the title compound 36c as white crystals (38 mg, 0.165 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.41 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.89 (dd, J = 6.4, 2.1 Hz, 
1H), 7.70 (ddd, J = 8.6, 4.6, 2.1 Hz, 1H), 7.59 (ddd, J = 8.0, 7.5, 1.9 Hz, 1H), 7.26 (t, J = 8.4 Hz, 1H), 
7.20 (dt, J = 8.0, 1.0 Hz, 1H), 7.12 (ddd, J = 7.5, 4.9, 1.1 Hz, 1H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.8 (d, J = 258.2 Hz), 156.3 (d, J = 1.3 Hz), 150.2, 140.0 
(d, J = 2.4 Hz), 137.3, 135.0 (d, J = 9.4 Hz), 122.9, 121.7 (d, J = 19.7 Hz), 121.5, 117.6 (d, 
J = 24.4 Hz), 117.5, 109.5 (d, J = 4.3 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 2228, 1576, 1559, 1483, 1456, 1415, 1389, 1267, 1245, 1115, 
1070, 1044, 985, 906, 830, 759, 735, 731, 721, 713, 676. 
MS (EI, 70 eV): m/z (%) = 230 (20), 212 (10), 211 (100), 78 (19). 
HRMS (EI): m/z calcd. for [C12H6FN2S]: 229.0236; found 229.0231 (M+ − H). 
M.p. (°C): 106.7 – 108.3. 
(Z)-2-(Hydroxy(p-tolyl)methyl)-3-phenylacrylonitrile (39a) 
 
According to TP 9, a solution of cinnamonitrile (37a, 0.200 M, 0.200 mmol; E/Z >99:1) in THF (total 
volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were prepared. 
The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The combined 
stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask containing 
a stirred solution of 4-methylbenzaldehyde (30u, 36 mg, 0.300 mmol, 1.50 equiv) in THF. The reaction 
was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was extracted three times with 
EtOAc (3×10 mL) and the combined organic phases were dried over anhydrous MgSO4 and filtrated. 
After removal of the solvent in vacuo, flash chromatographical purification (silica gel, 
i-hex:EtOAc = 9:1) afforded the title compound 39a as a light yellow solid (46 mg, 0.185 mmol, 93%; 
E/Z = 5:95). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.45 – 7.37 (m, 6H), 7.35 – 7.31 (m, 2H), 7.23 (d, J = 8.0 Hz, 
2H), 5.73 (d, J = 5.2 Hz, 1H), 2.38 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 145.5, 138.9, 137.1, 133.3, 130.1, 129.9 (2C), 129.4 (2C), 
129.0 (2C), 126.3 (2C), 118.8, 118.5, 69.6, 21.3. 
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IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3498, 3026, 2918, 2855, 2214, 1613, 1574, 1513, 1491, 1446, 
1390, 1358, 1320, 1304, 1246, 1213, 1192, 1181, 1159, 1134, 1122, 1078, 1040, 1021, 1000, 950, 931, 
896, 866, 843, 826, 796, 755, 739, 697, 666. 
MS (EI, 70 eV): m/z (%) = 283 (10), 282 (14), 281 (73), 267 (13), 265 (24), 249 (15), 248 (75), 234 
(29), 232 (14), 231 (100), 230 (79), 227 (10), 225 (37), 221 (10), 220 (33), 217 (11), 216 (75). 
HRMS (EI): m/z calcd. for [C17H14NO]: 248.1075; found 248.1071 (M+ − H). 
M.p. (°C): 115.9 – 117.9. 
Configuration of the double bond of the major stereoisomer was determined by X-ray crystallography. 
See crystallographic data section for details.  
(Z)-2-(Hydroxy(4-(trifluoromethyl)phenyl)methyl)-3-methoxyacrylonitrile (39b) 
 
According to TP 9, a solution of 3-methoxyacrylonitrile (37b, E/Z = 83:17, 0.200 M, 0.200 mmol) in 
THF (total volume: 1 mL) and a solution of NaDA (0.210 M in DMEA, 0.210 mmol, 1.05 equiv) were 
prepared. The precooled solutions were mixed with an overall 10 mL min−1 flow rate in a T-mixer. The 
combined stream passed a 0.02 mL reactor tube (0.5 s, −78 °C) and was subsequently injected in a flask 
containing a stirred solution of (4-trifluoromethyl)benzaldehyde (30v, 52 mg, 0.300 mmol, 1.50 equiv) 
in THF. The reaction was instantly quenched by the addition of sat. aq. NH4Cl. The aq. phase was 
extracted three times with EtOAc (3×10 mL) and the combined organic phases were dried over 
anhydrous MgSO4 and filtrated. After removal of the solvent in vacuo, flash chromatographical 
purification (silica gel, i-hex:EtOAc = 3:1) afforded the title compound 39b as a pale orange solid 
(36 mg, 0.140 mmol, 70%; E/Z < 1:99). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.63 (d, J = 8.2 Hz, 2H), 7.56 (d, J = 8.1 Hz, 2H), 6.88 (d, 
J = 0.8 Hz, 1H), 5.80 (s, 1H), 3.92 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.3, 144.7 (d, J = 1.4 Hz), 130.5 (q, J = 32.4 Hz, 2C), 
126.2, 125.8 (q, J = 3.8 Hz, 2C), 124.2 (q, J = 272.2 Hz), 116.9, 97.5, 66.5, 62.7. 
IR (Diamond-ATR, neat): 𝜈 / cm−1 = 3391, 2952, 2922, 2852, 2224, 1712, 1632, 1457, 1446, 1411, 
1319, 1259, 1206, 1161, 1148, 1118, 1110, 1064, 1052, 1015, 973, 961, 917, 869, 853, 788, 771, 724, 
700. 
MS (EI, 70 eV): m/z (%) = 257 (12), 256 (65), 240 (13), 238 (22), 236 (16), 228 (26), 227 (13), 226 
(25), 225 (34), 224 (94), 223 (17), 223 (20), 222 (42), 214 (73), 210 (11), 208 (68), 207 (34), 206 (88), 
203 (12), 200 (17), 198 (30), 197 (100), 196 (99), 195 (66), 194 (25), 188 (52), 187 (10), 186 (15), 185 
(11). 
HRMS (EI): m/z calcd. for [C12H9F3NO2]: 256.0585; found 256.0579 (M+ − H). 
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M.p. (°C): 99.9 – 101.8. 
Configuration of the double bond of the major stereoisomer was determined by X-ray crystallography. 
See crystallographic data section for details.  
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6 Crystallographic Data  
Single Crystal X-Ray Diffraction Studies 
Single crystals of compound 5g, 8d, 10, 39a, and 39b suitable for X-ray diffraction, were obtained 
by slow evaporation of a DCM solutions. The crystals were introduced into perfluorinated oil and 
a suitable single crystal was carefully mounted on the top of a thin glass wire. Data collection was 
performed with an Oxford Xcalibur 3 diffractometer equipped with a Spellman generator (50  kV, 
40 mA) and a Kappa CCD detector, operating with Mo-Kα radiation (Ȝ = 0.71071 Ǻ).  
Data collection was performed with the CrysAlis CCD software;  146 CrysAlis RED software147 was 
used for data reduction. Absorption correction using the SCALE3 ABSPACK multiscan method 148 
was applied. The structures were solved with SHELXS-97, 149 refined with SHELXL-97150 and 
finally checked using PLATON. 151  
  
                                                     
146
 CrysAlis CCD, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
147
 CrysAlis RED, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
148
 SCALE3 ABSPACK – An Oxford Diffraction Program (1.0.4, gui:1.0.3) (C), Oxford Diffraction, Ltd., 2005. 
149
 Sheldrick, G. M. (1997) SHELXS-97: Program for Crystal Structure Solution, University of 
Göttingen,Germany. 
150
 Sheldrick, G. M. (1997) SHELXL-97: Program for the Refinement of Crystal Structures, University of 
Göttingen, Germany. 
151
 Spek, A. L. (1999) PLATON: A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The 
Netherlands. 
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(E)-Ethyl 2'-methoxy-5'-(phenyldiazene)-[1,1'-biphenyl]-4-carboxylate (5g) 
CCDC 1532299 containes the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Figure 1: Molecular structure of compound 5g in the crystal, DIAMOND152 representation; thermal ellipsoids are 
drawn at 50% probability level. The ethoxy group is disordered over two positions; only one position has been 
shown for clarity. 
  
                                                     
152
 DIAMOND, Crystal Impact GbR., Version 3.2i. 
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Table 14: Details for X-ray data collection and structure refinement for compound 5g.  
Chemical formula C22H20N2O3 
Formula mass 360.4 
Crystal system, space group monoclinic, P21/n 
Temperature (K) 173(2) 
a, b, c [Å] 14.0620(4), 7.4549(3), 18.2784(6) 
α, ȕ, Ȗ [°] 90.0, 104.220(4), 90.0 
V [Å3] 1857.43(11) 
Z 4 
ρcalcd. [g cm−3] 1.289 
Radiation type Mo Ko 
µ [mm−1] 0.087 
Crystal size [mm] 0.20 × 0.10 × 0.10 
Crystal description orange yellow block 
Absorption correction Multi-scan 
F(000) 760 
Θ range [°] 4.22 – 25.24 
Index ranges −18 ≤ h ≤ 19; −9 ≤ k ≤ 10; −25 ≤ l ≤ 25 
No. of collected, unique and observed reflections 18815, 5202. 3678 
Rint 0.0316 
R1, wR2 (2σ data) 0.0450, 0.1007 
R1, wR2 (all data) 0.0702, 0.1152 
GOOF on F2 1.021 
Peak/hole [e Å−3] 0.230 / −0.179 
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Table 15: Selected bond lengths [Å] of compound 5g.  
O1 – C10 1.363(1) C4 – C3 1.376(2) 
O1 – C13 1.428(2) C4 – C5 1.384(2) 
C11 – C12 1.388(2) C2 – C3 1.387(2) 
C11 – C10 1.407(2) C20 – O3A 1.325(11) 
C11 – C14 1.485(2) C20 – O3B 1.369(9) 
C16 – C15 1.382(2) C22A – C21A 1.497(9) 
C16 – C17 1.395(2) C21A – O3A 1.463(16) 
C10 – C9 1.396(2) C22B – C21B 1.498(9) 
C15 – C14 1.395(2) C21B – O3B 1.464(14) 
C19 – C18 1.386(2) C1 – C6 1.389(2) 
C19 – C14 1.399(2) C12 – C7 1.388(2) 
N2 – N1 1.252(1) C17 – C20 1.486(2) 
N2 – C1 1.428(2) O2 – C20 1.199(2) 
C18 – C17 1.392(2) C9 – C8 1.384(2) 
N1 – C7 1.425(2) C7 – C8 1.393(2) 
C1 – C2 1.386(2) C6 – C5 1.386(2) 
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Table 16: Selected bond angles [°] of compound 5g.  
C10 – O1 – C13 118.0(1) C1 – C2 – C3 120.1(1) 
C12 – C11 – C10 118.1(1) O2 – C20 – O3A 123.1(5) 
C12 – C11 – C14 119.9(1) O2 – C20 – O3B 122.5(4) 
C10 – C11 – C14 122.0(1) O2 – C20 – C17 124.6(1) 
C15 – C16 – C17 120.4(1) O3A – C20 – C17 111.4(5) 
O1 – C10 – C9 123.5(1) O3B – C20 – C17 112.0(4) 
O1 – C10 – C11 116.0(1) C4 – C5 – C6 120.7(1) 
C9 – C10 – C11 120.5(1) C4 – C3 – C2 120.2(1) 
C16 – C15 – C14 120.6(1) O3A – C21A – C22A 111.9(7) 
C18 – C19 – C14 120.8(1) C20 – O3A – C21A 115.3(9) 
N1 – N2 – C1 114.5(1) O3B – C21B – C22B 107.5(6) 
C15 – C14 – C19 118.8(1) C20 – O3B – C21B 118.8(7) 
C15 – C14 – C11 121.2(1) C18 – C17 – C20 118.5(1) 
C19 – C14 – C11 120.0(1) C16 – C17 – C20 122.0(1) 
C19 – C18 – C17 120.0(1) C8 – C9 – C10 120.2(1) 
N2 – N1 – C7 114.3(1) C12 – C7 – C8 119.6(1) 
C2 – C1 – C6 119.9(1) C12 – C7 – N1 115.6(1) 
C2 – C1 – N2 115.4(1) C8 – C7 – N1 124.9(1) 
C6 – C1 – N2 124.7(1) C5 – C6 – C1 119.4(1) 
C7 – C12 – C11 121.7(1) C3 – C4 – C5 119.8(1) 
C18 – C17 – C16 119.5(1) C9 – C8 – C7 120.0(1) 
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Table 17: Selected torsion angles [°] of compound 5g.  
C13 – O1 – C10 – C9 −2.0(2) C11 – C12 – C7 – N1 −180.0(1) 
C13 – O1 – C10 – C11 176.8(1) N2 – N1 – C7 – C12 −174.8(1) 
C12 – C11 – C10 – O1 −178.2(1) N2 – N1 – C7 – C8 6.3(2) 
C14 – C11 – C10 – O1 0.4(2) C2 – C1 – C6 – C5 0.5(2) 
C12 – C11 – C10 – C9 0.6(2) N2 – C1 – C6 – C5 −179.6(1) 
C14 – C11 – C10 – C9 179.2(1) C10 – C9 – C8 – C7 0.4(2) 
C17 – C16 – C15 – C14 0.2(2) C12 – C7 – C8 – C9 0.5(2) 
C16 – C15 – C14 – C19 0.3(2) N1 – C7 – C8 – C9 179.4(1) 
C16 – C15 – C14 – C11 178.4(1) C6 – C1 – C2 – C3 −0.1(2) 
C18 – C19 – C14 – C15 −0.5(2) N2 – C1 – C2 – C3 180.0(1) 
C18 – C19 – C14 – C11 −178.6(1) C18 – C17 – C20 – O2 1.1(2) 
C12 – C11 – C14 – C15 −126.3(1) C16 – C17 – C20 – O2 −179.4(1) 
C10 – C11 – C14 – C15 55.0(2) C18 – C17 – C20 – O3A 170.6(3) 
C12 – C11 – C14 – C19 51.7(2) C16 – C17 – C20 – O3A −10.0(3) 
C10 – C11 – C14 – C19 −127.0(1) C18 – C17 – C20 – O3B −168.5(3) 
C14 – C19 – C18 – C17 0.2(2) C16 – C17 – C20 – O3B 10.9(4) 
C1 – N2 – N1 – C7 −179.7(1) C3 – C4 – C5 – C6 0.0(2) 
N1 – N2 – C1 – C2 175.4(1) C1 – C6 – C5 – C4 −0.5(2) 
N1 – N2 – C1 – C6 −4.5(2) C5 – C4 – C3 – C2 0.4(2) 
C10 – C11 – C12 – C7 0.4(2) C1 – C2 – C3 – C4 −0.3(2) 
C14 – C11 – C12 – C7 −178.3(1) O2 – C20 – O3A – C21A −10.7(7) 
C19 – C18 – C17 – C16 0.4(2) O3B – C20 – O3A – C21A 84.(2) 
C19 – C18 – C17 – C20 179.8(1) C17 – C20 – O3A – C21A 179.7(5) 
C15 – C16 – C17 – C18 −0.5(2) C22A – C21A – O3A – C20 −85.0(9) 
C15 – C16 – C17 – C20 −180.0(1) O2 – C20 – O3B – C21B 12.1(8) 
O1 – C10 – C9 – C8 177.7(1) O3A – C20 – O3B – C21B −86.(3) 
C11 – C10 – C9 – C8 −1.0(2) C17 – C20 – O3B – C21B −177.9(5) 
C11 – C12 – C7 – C8 −1.0(2) C22B – C21B – O3B – C20 100.4(7) 
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(E)-2-Iodo-4-(phenyldiazenyl)benzonitrile (8d) 
CCDC 1532300 containes the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Figure 2: Molecular structure of compound 8d in the crystal, DIAMOND152 representation; thermal ellipsoids 
are drawn at 50% probability level.  
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Table 18: Details for X-ray data collection and structure refinement for compound 8d.  
Chemical formula C13H8IN3 
Formula mass 333.12 
Crystal system, space group orthorhombic, P212121 
Temperature (K) 173(2) 
a, b, c [Å] 4.5407(2), 11.7732(5), 22.2216(9) 
α, ȕ, Ȗ [°] 90.0, 90.0, 90.0 
V [Å3] 1187.94(9) 
Z 4 
ρcalcd. [g cm−3] 1.863 
Radiation type Mo Ko 
µ [mm−1] 2.675 
Crystal size [mm] 0.22 × 0.07 × 0.02 
Crystal description orange yellow rod 
Absorption correction Multi-scan 
F(000) 640 
Θ range [°] 4.42 – 25.24 
Index ranges −5 ≤ h ≤ 6; −15 ≤ k ≤ 15; −29 ≤ l ≤ 29 
No. of collected, unique and 
observed reflections 
11029, 2918, 2517 
Rint 0.0693 
R1, wR2 (2σ data) 0.0412, 0.0848 
R1, wR2 (all data) 0.0518, 0.0890 
GOOF on F2 1.024 
Peak/hole [e Å−3] 1.442 / −0.583 
 
 
Table 19: Selected bond lengths [Å] of compound 8d.  
I1 – C11 2.086(7) C4 – C5 1.380(12) 
C7 – C12 1.384(11) C4 – C3 1.389(12) 
C7 – C8 1.384(11) C6 – C5 1.381(11) 
C7 – N2 1.434(10) C6 – C1 1.394(11) 
C13 – N3 1.135(10) C10 – C9 1.388(10) 
C13 – C10 1.452(11) C10 – C11 1.392(11) 
N2 – N1 1.250(9) C12 – C11 1.398(10) 
C8 – C9 1.389(11) C2 – C3 1.383(11) 
N1 – C1 1.434(10) C2 – C1 1.387(11) 
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Table 20: Selected bond angles [°] of compound 8d.  
C12 – C7 – C8 120.7(8) C11 – C10 – C13 121.3(7) 
C12 – C7 – N2 113.9(7) C7 – C12 – C11 120.3(7) 
C8 – C7 – N2 125.4(8) C2 – C1 – C6 120.2(8) 
N3 – C13 – C10 176.2(9) C2 – C1 – N1 124.9(7) 
N1 – N2 – C7 113.0(7) C6 – C1 – N1 115.0(7) 
C7 – C8 – C9 119.5(8) C10 – C9 – C8 120.0(7) 
N2 – N1 – C1 114.1(7) C2 – C3 – C4 120.6(8) 
C3 – C2 – C1 119.3(8) C4 – C5 – C6 120.1(8) 
C5 – C4 – C3 119.9(8) C10 – C11 – C12 118.7(7) 
C5 – C6 – C1 119.9(8) C10 – C11 – I1 122.1(6) 
C9 – C10 – C11 120.8(7) C12 – C11 – I1 119.2(6) 
C9 – C10 – C13 117.9(7)   
 
Table 21: Selected torsion angles [°] of compound 8d.  
C12 – C7 – N2 – N1 −177.6(7) C11 – C10 – C9 – C8 0.4(12) 
C8 – C7 – N2 – N1 1.1(11) C13 – C10 – C9 – C8 179.7(7) 
C12 – C7 – C8 – C9 −0.5(12) C7 – C8 – C9 – C10 −0.1(12) 
N2 – C7 – C8 – C9 −179.1(8) C1 – C2 – C3 – C4 −0.9(13) 
C7 – N2 – N1 – C1 −179.6(6) C5 – C4 – C3 – C2 0.6(13) 
C8 – C7 – C12 – C11 0.8(12) C3 – C4 – C5 – C6 0.0(13) 
N2 – C7 – C12 – C11 179.5(7) C1 – C6 – C5 – C4 −0.3(13) 
C3 – C2 – C1 – C6 0.6(13) C9 – C10 – C11 – C12 −0.2(11) 
C3 – C2 – C1 – N1 179.4(8) C13 – C10 – C11 – C12 −179.4(7) 
C5 – C6 – C1 – C2 0.0(13) C9 – C10 – C11 – I1 −179.4(6) 
C5 – C6 – C1 – N1 −178.9(7) C13 – C10 – C11 – I1 1.3(10) 
N2 – N1 – C1 – C2 0.6(11) C7 – C12 – C11 – C10 −0.4(11) 
N2 – N1 – C1 – C6 179.5(8) C7 – C12 – C11 – I1 178.8(6) 
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(E)-1-(4-Butyl-2,6-dichlorophenyl)-2-(2,6-dichloro-3-iodophenyl)diazene (10) 
CCDC 1532301 containes the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 3: Molecular structure of compound 10 in the crystal, DIAMOND152 representation; thermal ellipsoids are 
drawn at 50% probability level. 
Table 22: Details for X-ray data collection and structure refinement for compound 10.  
Chemical formula C16H13Cl4IN2 
Formula mass 501.98 
Crystal system, space group triclinic, P-1 
Temperature (K) 173(2) 
a, b, c [Å] 8.1132(2), 10.9951(3), 11.5650(3) 
α, ȕ, Ȗ [°] 63.992(2), 87.106(2), 77.999(2) 
V [Å3] 905.95(4) 
Z 2 
ρcalcd. [g cm−3] 1.840 
Radiation type Mo Ko 
µ [mm−1] 2.356 
Crystal size [mm] 0.42 × 0.24 × 0.07 
Crystal description orange red block 
Absorption correction Multi-scan 
F(000) 488 
Θ range [°] 4.22 – 25.24 
Index ranges −11 ≤ h ≤ 11; −15 ≤ k ≤ 15; −16 ≤ l ≤ 16 
No. of collected, unique and 
observed reflections 
18484, 5511, 4670 
Rint 0.0234 
R1, wR2 (2σ data) 0.0315, 0.0761 
R1, wR2 (all data) 0.0402, 0.0818 
GOOF on F2 1.033 
Peak/hole [e Å−3] 1.252 / −0.708 
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Table 23: Selected bond lengths [Å] of compound 10.  
I1 – C5 2.087(2) C2 – C3 1.388(3) 
Cl3 – C12 1.737(2) C3 – C4 1.377(4) 
Cl1 – C2 1.729(2) C11 – C10 1.397(4) 
Cl4 – C8 1.735(2) C14 – C15 1.451(6) 
Cl2 – C6 1.728(2) C10 – C9 1.379(4) 
N2 – N1 1.247(3) C9 – C8 1.388(3) 
N2 – C7 1.426(3) C15 – C16 1.564(5) 
C1 – C2 1.386(3) C12 – C11 1.380(3) 
C1 – C6 1.399(3) C13 – C14 1.464(5) 
C1 – N1 1.439(3) C13 – C10 1.515(3) 
C7 – C12 1.395(3) C6 – C5 1.391(3) 
C7 – C8 1.399(3) C5 – C4 1.393(4) 
 
 
Table 24: Selected bond angles [°] of compound 10.  
N1 – N2 – C7 114.7(2) C15 – C14 – C13 117.3(3) 
C2 – C1 – C6 119.2(2) C9 – C10 – C11 118.6(2) 
C2 – C1 – N1 122.7(2) C9 – C10 – C13 120.4(2) 
C6 – C1 – N1 118.1(2) C11 – C10 – C13 120.9(2) 
C12 – C7 – C8 117.1(2) C3 – C4 – C5 120.7(2) 
C12 – C7 – N2 117.1(2) C10 – C9 – C8 121.1(2) 
C8 – C7 – N2 125.6(2) C9 – C8 – C7 121.0(2) 
N2 – N1 – C1 111.1(2) C9 – C8 – Cl4 117.6(2) 
C11 – C12 – C7 122.1(2) C7 – C8 – Cl4 121.3(2) 
C11 – C12 – Cl3 118.8(2) C14 – C15 – C16 114.2(4) 
C7 – C12 – Cl3 119.1(2) C4 – C5 – I1 118.5(2) 
C14 – C13 – C10 116.4(3) C1 – C2 – C3 120.7(2) 
C5 – C6 – C1 120.3(2) C1 – C2 – Cl1 120.9(2) 
C5 – C6 – Cl2 121.5(2) C3 – C2 – Cl1 118.3(2) 
C1 – C6 – Cl2 118.3(2) C4 – C3 – C2 119.7(2) 
C6 – C5 – C4 119.3(2) C12 – C11 – C10 120.0(2) 
C6 – C5 – I1 122.1(2)   
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Table 25: Selected torsion angles [°] of compound 10.  
N1 – N2 – C7 – C12 138.0(2) C1 – C2 – C3 – C4 −2.1(4) 
N1 – N2 – C7 – C8 −47.2(3) Cl1 – C2 – C3 – C4 179.6(2) 
C7 – N2 – N1 – C1 178.2(2) C7 – C12 – C11 – C10 1.6(3) 
C2 – C1 – N1 – N2 −66.6(3) Cl3 – C12 – C11 – C10 −176.0(2) 
C6 – C1 – N1 – N2 116.4(2) C10 – C13 – C14 – C15 63.1(5) 
C8 – C7 – C12 – C11 1.4(3) C12 – C11 – C10 – C9 −3.5(3) 
N2 – C7 – C12 – C11 176.6(2) C12 – C11 – C10 – C13 173.8(3) 
C8 – C7 – C12 – Cl3 179.0(2) C14 – C13 – C10 – C9 −96.9(4) 
N2 – C7 – C12 – Cl3 −5.9(3) C14 – C13 – C10 – C11 85.9(4) 
C2 – C1 – C6 – C5 3.7(3) C2 – C3 – C4 – C5 2.0(4) 
N1 – C1 – C6 – C5 −179.1(2) C6 – C5 – C4 – C3 1.0(4) 
C2 – C1 – C6 – Cl2 −175.7(2) I1 – C5 – C4 – C3 −177.5(2) 
N1 – C1 – C6 – Cl2 1.5(3) C11 – C10 – C9 – C8 2.4(4) 
C1 – C6 – C5 – C4 −3.9(3) C13 – C10 – C9 – C8 −174.9(3) 
Cl2 – C6 – C5 – C4 175.5(2) C10 – C9 – C8 – C7 0.6(4) 
C1 – C6 – C5 – I1 174.5(2) C10 – C9 – C8 – Cl4 −175.5(2) 
Cl2 – C6 – C5 – I1 −6.1(3) C12 – C7 – C8 – C9 −2.5(3) 
C6 – C1 – C2 – C3 −0.7(3) N2 – C7 – C8 – C9 −177.2(2) 
N1 – C1 – C2 – C3 −177.7(2) C12 – C7 – C8 – Cl4 173.5(2) 
C6 – C1 – C2 – Cl1 177.5(2) N2 – C7 – C8 – Cl4 −1.3(3) 
N1 – C1 – C2 – Cl1 0.5(3) C13 – C14 – C15 – C16 170.4(3) 
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(Z)-2-(Hydroxy(p-tolyl)methyl)-3-phenylacrylonitrile (39a) 
CCDC 1831884 containes the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 4: Molecular structure of compound 39a in the crystal, DIAMOND152 representation; thermal ellipsoids 
are drawn at 50% probability level. The ethoxy group is disordered over two positions; only one position has been 
shown for clarity. 
 
Figure 5: Hydrogen bonding in the crystal of compound 39a, DIAMOND152 representation; thermal ellipsoids 
are drawn at 50% probability level. Symmetry code for the second (not labeled) molecule: 1+x, y, z. 
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Table 26: Details for X-ray data collection and structure refinement for compound 39a.  
Chemical formula C17H15NO 
Formula mass 249.30 
Crystal system, space group monoclinic, P21/c 
Temperature (K) 143(2) 
a, b, c [Å] 5.43338(5), 15.5658(15), 15.8523(12) 
α, ȕ, Ȗ [°] 90.0, 90.515(7), 90.0 
V [Å3] 1340.8(2) 
Z 4 
ρcalcd. [g cm−3] 1.235 
Radiation type Mo Ko 
µ [mm−1] 0.077 
Crystal size [mm] 0.49 × 0.12 × 0.07 
Crystal description colorless rod 
Absorption correction Multi-scan 
F(000) 528 
Θ range [°] 4.17 – 25.24 
Index ranges −6 ≤ h ≤ 6; −19 ≤ k ≤ 19; −19 ≤ l ≤ 18 
No. of collected, unique and 
observed reflections 
9448, 2726, 1501 
Rint 0.0744 
R1, wR2 (2σ data) 0.0570, 0.1081 
R1, wR2 (all data) 0.1207, 0.1329 
GOOF on F2 0.994 
Peak/hole [e Å−3] 0.197 / −0.204 
 
Table 27: Selected bond lengths [Å] of compound 39a.  
O1 – C10 1.434(3) C14 – C13 1.384(3) 
C8 – C7 1.342(3) C14 – C15 1.386(3) 
C8 – C9 1.443(3) C14 – C17 1.509(3) 
C8 – C10 1.521(3) C12 – C13 1.387(3) 
C11 – C12 1.387(3) C6 – C5 1.382(4) 
C11 – C16 1.392(3) C3 – C4 1.377(4) 
C11 – C10 1.512(3) C5 – C4 1.384(4) 
C1 – C6 1.391(3) N1 – C9 1.148(3) 
C1 – C2 1.395(3) C16 – C15 1.387(3) 
C1 – C7 1.466(3) C2 – C3 1.388(3) 
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Table 28: Selected bond angles [°] of compound 39a.  
C7 – C8 – C9 119.5(2) C15 – C14 – C17 121.4(2) 
C7 – C8 – C10 126.9(2) C13 – C12 – C11 120.7(2) 
C9 – C8 – C10 113.6(2) C5 – C6 – C1 120.5(3) 
C12 – C11 – C16 118.3(2) C14 – C15 – C16 121.6(2) 
C12 – C11 – C10 122.3(2) C4 – C3 – C2 120.5(3) 
C16 – C11 – C10 119.4(2) C6 – C5 – C4 120.3(3) 
O1 – C10 – C11 107.7(2) C14 – C13 – C12 121.4(2) 
O1 – C10 – C8 108.3(2) C3 – C4 – C5 119.6(3) 
C11 – C10 – C8 114.2(2) N1 – C9 – C8 177.5(3) 
C6 – C1 – C2 118.9(2) C8 – C7 – C1 127.1(2) 
C6 – C1 – C7 119.4(2) C3 – C2 – C1 120.1(2) 
C2 – C1 – C7 121.7(2) C13 – C14 – C15 117.6(2) 
C15 – C16 – C11 120.3(2) C13 – C14 – C17 120.9(2) 
 
Table 29: Selected torsion angles [°] of compound 39a.  
C12 – C11 – C10 – O1 −132.8(2) C7 – C1 – C2 – C3 179.5(2) 
C16 – C11 – C10 – O1 48.3(3) C16 – C11 – C12 – C13 −1.0(3) 
C12 – C11 – C10 – C8 −12.5(3) C10 – C11 – C12 – C13 −179.9(2) 
C16 – C11 – C10 – C8 168.7(2) C2 – C1 – C6 – C5 2.8(3) 
C7 – C8 – C10 – O1 −129.0(2) C7 – C1 – C6 – C5 −178.6(2) 
C9 – C8 – C10 – O1 48.0(2) C13 – C14 – C15 – C16 −1.7(4) 
C7 – C8 – C10 – C11 111.0(3) C17 – C14 – C15 – C16 177.6(2) 
C9 – C8 – C10 – C11 −71.9(2) C11 – C16 – C15 – C14 0.5(4) 
C12 – C11 – C16 – C15 0.9(3) C1 – C2 – C3 – C4 −0.6(3) 
C10 – C11 – C16 – C15 179.8(2) C1 – C6 – C5 – C4 −1.3(3) 
C9 – C8 – C7 – C1 177.4(2) C15 – C14 – C13 – C12 1.6(4) 
C10 – C8 – C7 – C1 −5.7(4) C17 – C14 – C13 – C12 −177.7(2) 
C6 – C1 – C7 – C8 141.0(2) C11 – C12 – C13 – C14 −0.3(4) 
C2 – C1 – C7 – C8 −40.5(3) C2 – C3 – C4 – C5 2.2(4) 
C6 – C1 – C2 – C3 −1.9(3) C6 – C5 – C4 – C3 −1.3(4) 
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(Z)-2-(Hydroxy(4-(trifluoromethyl)phenyl)methyl)-3-methoxyacrylonitrile (39b) 
CCDC 1831885 containes the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 6: Molecular structure of compound 39b in the crystal, DIAMOND152 representation; thermal ellipsoids 
are drawn at 50% probability level. The CF3 group is disordered over two positions.  
 
Figure 7: Hydrogen bonding in the crystal of compound 39b, DIAMOND152 representation; thermal ellipsoids 
are drawn at 50% probability level. Symmetry code for the second (not labeled) molecule: −x, −0.5+y, 0.5−z. 
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Table 30: Details for X-ray data collection and structure refinement for compound 39b.  
Chemical formula C12H10F3NO2 
Formula mass 257.21 
Crystal system, space group monoclinic, P21/c 
Temperature (K) 143(2) 
a, b, c [Å] 12.3101(13), 8.1799(6), 12.7623(11) 
α, ȕ, Ȗ [°] 90.0, 112.598(12), 90.0 
V [Å3] 1186.4(2) 
Z 4 
ρcalcd. [g cm−3] 1.440 
Radiation type Mo Ko 
µ [mm−1] 0.129 
Crystal size [mm] 0.44 × 0.12 × 0.06 
Crystal description colorless rod 
Absorption correction Multi-scan 
F(000) 528 
Θ range [°] 4.16 – 25.24 
Index ranges −16 ≤ h ≤ 16; −10 ≤ k ≤ 10; −16 ≤ l ≤ 17 
No. of collected, unique and 
observed reflections 
10879, 2943, 2130 
Rint 0.0425 
R1, wR2 (2σ data) 0.0491, 0.1053 
R1, wR2 (all data) 0.0719, 0.1204 
GOOF on F2 1.044 
Peak/hole [e Å−3] 0.275 / −0.284 
 
 
Table 31: Selected bond lengths [Å] of compound 39b.  
C9 – C11 1.340(2) C6 – C7 1.381(2) 
C9 – C10 1.426(2) C1 – F1A 1.312(4) 
C9 – C8 1.519(2) C1 – F2A 1.356(4) 
C8 – O1 1.418(2) C1 – F3A 1.408(5) 
C8 – C5 1.512(2) C10 – N1 1.146(2) 
O2 – C11 1.333(2) C2 – C3 1.383(2) 
O2 – C12 1.440(2) C2 – C7 1.384(2) 
C5 – C6 1.386(2) C2 – C1 1.494(2) 
C5 – C4 1.391(2) C4 – C3 1.386(2) 
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Table 32: Selected bond angles [°] of compound 39b.  
C11 – C9 – C10 117.2(1) C7 – C6 – C5 120.8(2) 
C11 – C9 – C8 123.6(1) C6 – C7 – C2 119.8(2) 
C10 – C9 – C8 119.0(1) F1A – C1 – F2A 102.4(4) 
O1 – C8 – C5 107.3(1) F1A – C1 – F3A 116.8(4) 
O1 – C8 – C9 111.3(1) F2A – C1 – F3A 98.3(3) 
C5 – C8 – C9 113.6(1) F1A – C1 – C2 113.5(2) 
C11 – O2 – C12 115.2(1) F2A – C1 – C2 112.5(2) 
C6 – C5 – C4 118.9(2) F3A – C1 – C2 111.9(2) 
C6 – C5 – C8 119.8(1) C7 – C2 – C1 118.7(2) 
C4 – C5 – C8 121.2(2) C3 – C4 – C5 120.5(2) 
N1 – C10 – C9 179.1(2) O2 – C11 – C9 121.1(1) 
C3 – C2 – C7 120.1(2) C2 – C3 – C4 119.8(2) 
C3 – C2 – C1 121.1(2)   
 
Table 33: Selected torsion angles [°] of compound 39b.  
C11 – C9 – C8 – O1 104.5(2) C3 – C2 – C1 – F1A −140.1(4) 
C10 – C9 – C8 – O1 −71.0(2) C7 – C2 – C1 – F1A 37.1(5) 
C11 – C9 – C8 – C5 −134.3(2) C3 – C2 – C1 – F2A 104.1(3) 
C10 – C9 – C8 – C5 50.1(2) C7 – C2 – C1 – F2A −78.6(3) 
O1 – C8 – C5 – C6 −145.4(2) C3 – C2 – C1 – F3A −5.3(3) 
C9 – C8 – C5 – C6 91.2(2) C7 – C2 – C1 – F3A 172.0(2) 
O1 – C8 – C5 – C4 31.6(2) C1 – C2 – C7 – C6 −175.5(2) 
C9 – C8 – C5 – C4 −91.8(2) C1 – C2 – C3 – C4 175.2(2) 
C6 – C5 – C4 – C3 1.7(2) C5 – C4 – C3 – C2 0.2(2) 
C8 – C5 – C4 – C3 −175.3(1) C4 – C5 – C6 – C7 −2.0(2) 
C12 – O2 – C11 – C9 −173.1(2) C8 – C5 – C6 – C7 175.1(2) 
C10 – C9 – C11 – O2 178.9(2) C5 – C6 – C7 – C2 0.3(3) 
C8 – C9 – C11 – O2 3.3(2) C3 – C2 – C7 – C6 1.8(3) 
C7 – C2 – C3 – C4 −2.0(2)   
 
